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Three investigations were conducted in order to investigate the effect of dietary 
probiotics on tilapia (Oreochromis niloticus) growth performance, intestinal morphology, 
intestinal microbiology and immunity.  
The first experiment demonstrated that Bacillus subtilis, Lactobacillus reuteri and 
Pediococcus acidilactici supplemented individually and as a mixed probiotic (in addition to 
Enterococcus faecium; AquaStar
®
 Growout) were capable of modulating intestinal microbial 
populations as determined by culture dependent methods and DGGE. Furthermore, high-
throughput sequencing reported that >99% of 16S rRNA reads in the mixed probiotic group 
belonged to the probiotic genera, predominantly assigned to Enterococcus (52.50%) and 
Bacillus (45.94%). Tilapia in the mixed probiotic group displayed significantly higher 
intraepithelial leucocyte (IEL) populations in the mid intestine when compared to the control 
and L. reuteri treatment. The mixed probiotic also improved microvilli density and had a 
higher absorptive surface area when compared to the control.  
In the second trial, after six weeks of supplementing tilapia diets with AquaStar
®
 
Growout at 3g kg
-1
, fish demonstrated significantly higher final weight, weight gain and SGR 
when compared to that of the control (void of probiotic) treatment or an initial probiotic feed 
(lasting two weeks) followed by control feeding. Probiotic supplementation at 3g kg
-1
 also 
caused an increase in the abundance of intestinal IELs and goblet cells and an up-regulation 
in the gene expression of intestinal caspase-3, PCNA and HSP70 and immunity genes TLR2, 
TNFα, IL-1β, TGFβ and IL-10 when compared with the expression of control replicates. 
These changes were not observed when supplementing tilapia diets with a lower dose (1.5g 
kg
-1
), nor when supplementing the probiotic in either a pulsed manner or as an initial feed 
(two weeks) followed by control feeding.  
Trial three revealed that the probiotic had a more discrete effect on the intestinal 
allochthonous microbiota as 16S rRNA reads assigned to probiotic genera only accounted for 
5-10% of total reads. Nevertheless, the supplementation of dietary AquaStar
®
 Growout at 3g 
kg
-1
 improved the localised immune response in tilapia, through the regulation of immunity 
genes TLR2, MYD88, NFκB, TNFα, IL-1β, TGFβ and IL-10, larger populations of goblet 
cells and a higher recruitment of IELs. Furthermore, the probiotic also improved the systemic 
immune response through the regulation of immunity genes (mentioned above) in the head 
kidney and significantly higher circulating leucocyte levels in whole blood. The extent of 
these changes were dependent on the probiotic treatment (i.e. continuously supplemented in 
feed or alternating weekly between probiotic at 3 g kg
-1 
and control feeding), the duration of 
feeding and the parameter investigated.  
This research demonstrates that B. subtilis, L. reuteri, P. acidilactici and AquaStar
®
 
Growout can modulate the intestinal microbiota. In addition, AquaStar
®
 Growout can 
improve intestinal morphology, growth performance and modulate both the localised and 
systemic immune responses of tilapia when supplemented through the feed at the appropriate 
dosage and feeding regime.  
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Chapter 1. Introduction 1 
 2 
1.1 Aquaculture 3 
The Food and Agriculture Organization of the United Nations (FAO) defines 4 
aquaculture as “the farming of aquatic organisms including fish, molluscs, crustaceans and 5 
aquatic plants where some sort of intervention is made to enhance production” (FAO 1995). 6 
In 2012 aquaculture production reached a record high of 90.4 million tonnes with an 7 
estimated value of US$144.4 billion (FAO 2014). Aquaculture is an important source of 8 
income and livelihood for millions of people worldwide as well as a crucial production sector 9 
for high-protein food and in 2013 global production of farmed fish for human consumption 10 
was 70.5 million tonnes (FAO 2014). In the last three decades alone (1980-2010) global food 11 
fish production has grown at an average annual rate of 8.8% (FAO 2012) and this increased 12 
by a further 5.8% in 2013 (FAO 2014). This consistent growth is attributed to an increasing 13 
demand for affordable protein sources, particularly in third world countries, coupled with 14 
declining stocks of capture fisheries. Indeed, farmed fish contributed to 42.2% of the total 15 
fish produced (including non-food uses) by both aquaculture and capture fisheries in 2012, an 16 
increase from previous years (Fig 1.1).  17 
Global aquaculture can be categorised into inland aquaculture and mariculture. Inland 18 
aquaculture primarily uses freshwater whereas mariculture predominantly uses sea water. 19 
Since 1980 inland aquaculture has seen average annual growth rates of 9.2% (compared with 20 
7.6% for mariculture) increasing its share in total aquaculture from 50% in 1980 to 63% in 21 
2012. This contribution increases to 86% when taking into account farmed fish alone (FAO 22 
2014). Inland aquaculture is expected to be the lead sector in achieving long-term food 23 
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security and meeting the added demands of population growth in many developing countries 24 
in the coming decades (FAO 2014). 25 
 26 
27 
 28 
Figure 1.1: Share of aquaculture in total fish production. Source: FAO (2014). 29 
 30 
1.1.1 Tilapia aquaculture 31 
 Tilapia are a freshwater species belonging to the Cichlidae family. They are native to 32 
Africa but today have a global presence due to aquaculture, recreational fishing, aquatic weed 33 
control and scientific research purposes (El-Sayed 2006). Tilapia have a number of attributes 34 
which make them a popular choice for aquaculture. These include fast growth, tolerance to a 35 
wide range of physical and environmental conditions, relative resistance to stress and disease, 36 
ability to reproduce in captivity, have a short generation time and are able to convert low cost 37 
feed into high quality protein (El-Sayed 2006). This has given tilapia a reputation of being the 38 
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‘aquatic chicken’. The FAO has recorded tilapia production in 135 countries (FAO 2014), 39 
most notably China (~ 1.6 million tonnes), Indonesia (~ 947, 000 tonnes), Egypt (~ 636, 000 40 
tonnes), the Philippines (~ 269, 000 tonnes) and Thailand (~ 213, 000 tonnes) (FIGIS 2013). 41 
During the 1950’s to 1970’s tilapia culture grew slowly, gaining momentum in the 1980’s 42 
and in 1993 aquaculture production outpaced landings from capture fisheries. Today, 43 
technological innovations have seen the rapid growth in tilapia culture with total production 44 
over 4.8 million tonnes in 2013 and a value of over US$8.2 billion (FIGIS 2013) (Fig 1.2).  45 
 46 
 47 
Figure 1.2: Global tilapia production and value between 1980 and 2013. Source: (FIGIS 48 
2013).  49 
 50 
The main species produced is Nile tilapia (Oreochromis niloticus; 3.4 million tonnes) 51 
but other popular species for culture include Mozambique tilapia (Oreochromis mossambicus; 52 
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34,206 tonnes) and various hybrids of which Nile tilapia and blue tilapia are most popular (O. 53 
niloticus x Oreochromis aureus; 414,475 tonnes) (Fig 1.3). 54 
With an increasing pressure to farm species at lower trophic levels, the expansion of 55 
tilapia aquaculture reflects a positive future for the species. This is especially true with the 56 
increasing interest of many countries to farm tilapia such as the Americas, where there is a 57 
huge availability of freshwater resources. Technological innovation in genetics including 58 
GIFT (Genetically Improved Farmed Tilapia), GMT (Genetically Male Tilapia), GST 59 
(GenoMar Supreme Tilapia) and GET EXCEL strains have improved growth performance, 60 
temperature and salinity tolerance, colouration, stress and disease resistance. These 61 
improvements, along with others in genetics, nutrition, disease management, and farming 62 
systems have all contributed to an exciting and secure future for tilapia culture.   63 
 64 
 65 
Figure 1.3:  Aquaculture output by tilapia species groups in 2013. Source: (FIGIS 2013). 66 
 67 
 68 
O. niloticus
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1.2 Stress and disease 69 
The aquatic environment supports a number of opportunistic and secondary pathogens 70 
as well as beneficial microbes. However, the rearing technology for intensive production of 71 
fish creates a highly artificial environment which promotes bacterial growth and may affect 72 
the bacterial selection negatively. Thus, in intensive facilities, environmental conditions 73 
(oxygen levels, pH, water quality and temperature) and poor husbandry practises (inadequate 74 
nutrition, overfeeding, transportation and stocking density) can be stressful for the organisms 75 
involved, which can compromise the immune response and increase susceptibility to 76 
infection and disease. In addition to this, bacteria may be introduced via artificial or natural 77 
feeds, inlet water and less often via vertical transmission. These disease outbreaks can have 78 
large economic impacts in the leading fish producing countries (Bondad-Reantaso et al. 79 
2005).  80 
The main culprits that contribute to severe disease outbreaks in tilapia include 81 
Aeromonas hydrophila, Edwardsiella tarda and Streptococcus iniae. Certain opportunistic 82 
pathogens, including A. hydrophila, do not cause disease in a healthy fish; indeed, they are 83 
routinely found as minor components in the intestinal tract of healthy fish but emerge as 84 
pathogens under certain circumstances. One of the most commonly attributed causal factors 85 
for disease outbreaks in aquaculture scenarios is stress. As aquaculture intensifies, and fish 86 
densities increase, stress and disease are likely to play a more important role in years to come. 87 
Certainly, this is the case with streptococcosis, a septicaemic disease affecting a number of 88 
fish species including tilapia (Toranzo et al. 2005), caused by the etiological agents St. iniae 89 
and St. agalactiae. Streptococcosis has increased in prevalence over the last decade with 90 
annual losses estimated to be worth US$100 million in the 1990’s (Shoemaker et al. 2001) 91 
and in the 2010’s, over US$250 million (Amal and Zamri-Saad 2011).  92 
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 The employment of membrane filters, ozone and/or UV contributes to the removal of 93 
pathogens but the total elimination of pathogens is difficult to achieve. Traditionally 94 
antibiotics and other antimicrobial chemicals have been used to combat disease. Abuse of 95 
these antimicrobials has resulted in the evolution of antimicrobial resistance amongst 96 
pathogenic bacteria (Baquero et al. 2008) as well as having residual effects in the host and 97 
environment. Furthermore the loss of a stable microbial balance via disinfection leaves an 98 
environment which is vulnerable to attack by opportunistic pathogenic bacteria. This has 99 
been reflected in the EU moratorium on the banning of antibiotic growth promoters in animal 100 
feeds, including fish (EU 2005).  101 
Whilst being an effective strategy against certain diseases, vaccination can be 102 
expensive, labour intensive and can have variable results. As new pathogens constantly 103 
emerge and mutations arise within existing pathogens, vaccination is impractical and is not 104 
sufficient as a strategy to defend against all diseases. This has fuelled a growing trend to 105 
explore novel feed compounds to provide various functional attributes to the health of fish 106 
and shrimp, and has also helped facilitate consumer perceptions of bio-security and eco-107 
friendly aquaculture. Therefore, the development of effective strategies for manipulating 108 
microbial communities to promote and sustain the health of the host have been explored.  109 
 110 
1.3 Host-microbiota interactions within the gastrointestinal tract of fish 111 
Aquatic animals are constantly in contact with the microbial composition and changes 112 
in their surrounding environment. Pathogens, many of which are opportunistic in nature,  may 113 
be able to maintain themselves in the water column and proliferate independently of the host 114 
causing disease or rendering aquatic animals immunocompromised (Moriarty 1998). The GI 115 
tract is one of the key sites of interaction with the external world and is considered one of the 116 
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major portals and infection loci for a number of pathogens in fish (Ringø et al. 2007). The 117 
establishment of a normal microbiota is vital, as this can affect a wide range of biological 118 
processes including development and assembly of the gut associate lymphoid tissue (GALT), 119 
nutrient digestion and absorption, angiogenesis, epithelial integrity and renewal and activity 120 
of the enteric nervous system (Husebye et al. 1994; Stappenbeck et al. 2002; Rawls et al. 121 
2004; Gómez and Balcázar 2008; Perez-Sanchez et al. 2010) to such an extent, some authors 122 
refer to it as an ‘extra organ’ (O' Hara and Shanahan 2006).  123 
It is often difficult to fully assess host-microbe interactions, since microbial 124 
communities in fish reared in conventional systems are extremely dynamic which can cause 125 
experimental complications. The development of gnotobiotic models using germ-free (GF) 126 
animals has enabled researchers to have increased control of variables, enhanced 127 
reproducibility of results and more accurate experimental designs (Coates 1975). Successful 128 
gnotobiotic models have been developed in a number of fish including platyfish 129 
(Platypoecilus maculatus) (Baker et al. 1942), zebrafish (Danio rerio) (Pham et al. 2008), 130 
tilapia (Situmorang et al. 2014), salmonids (Trust 1974), European seabass (Dicentrarchus 131 
labrax) (Dierckens et al. 2009; Rekecki et al. 2009), turbot (Scophthalmus maximus) (Munro 132 
et al. 1995), Atlantic halibut (Hippoglossus hippoglossus) (Verner-Jeffreys et al. 2003), cod 133 
(Gadus morhua) (Forberg et al. 2011) and red drum (Sciaenops ocellatus) (Douillet and Holt 134 
1994). Using GF zebrafish, Rawls et al. (2007) used a defective Pseudomonas containing 135 
deletions in genes relating to motility and pathogenesis, to observe host-microbe interactions 136 
when compared with non-mutant Pseudomonas. Mutant Pseudomonas were unable to 137 
interact with the host suggesting that flagella function, including swimming motility, is an 138 
important component in order for the host to detect and monitor such microbes. 139 
In a novel investigation, Rawls et al. (2006) performed reciprocal transplants of the 140 
microbiotas of conventional zebrafish and mice into GF zebrafish and mice. Researchers 141 
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discovered that the microbial assemblages resembled that of the original community, 142 
however, differences in community structure between zebrafish and mice arise, at least in 143 
part, from selection pressures imposed within the intestinal habitat of each host. This suggests 144 
that each host species has a core microbiome, a concept which has been evidenced in fish 145 
(Roeselers et al. 2011; Wong et al. 2013). 146 
 147 
1.3.1 Indigenous intestinal microbiota of tilapia 148 
Our current understanding of the microbiota composition has predominantly been 149 
derived from farmed fish. To limit mortalities at an early life stage, intensive aquaculture 150 
practices often employ the disinfection of eggs and larvae. To some extent, this is perhaps 151 
counter-intuitive since fish microbiota are the first line of defence (Boutin et al. 2012). 152 
Bacteria initially colonise the chorion of the egg with any taxonomic differences likely to be 153 
caused through precursors of innate immunity (Llewellyn et al. 2014). Once the egg hatches, 154 
the initial colonization of the gut is derived from the intake of water by fry to maintain 155 
osmotic balance and from grazing on suspended particle’s and egg debris (Reitan et al. 1998; 156 
Olafsen 2001). In adult fish the intestinal microbiome is more stable and can be separated 157 
into two distinct groups; autochthonous and allochthonous. Allochthonous microbiota, are 158 
associated with the digesta whereas autochthonous microbiota are potential residents and 159 
have more intimate associations with the epithelial mucosa in the stomach and/or intestine.  160 
A number of authors have observed a large microbial diversity within the intestinal 161 
tract of tilapia. Cultivable bacterial levels were reported to be in the range of 10
6
-10
8
 CFU g
-1
 162 
(Al-Harbi and Uddin 2003, 2005) although this may fluctuate depending on the season (Al-163 
Harbi and Uddin 2004). Al-Harbi and Uddin (2003) enumerated the bacterial flora of pond 164 
water, pond sediment, tilapia gills and intestine and reported a comparable microbiota 165 
___________________________________________________________________ Chapter 1 
 
24 
between these environments, although there was a larger diversification in the tilapia intestine. 166 
In this study Corynebacterium urealyticum, Shewanella putrefaciens and A. hydrophila were 167 
the predominant bacterial species in tilapia intestines. Later studies by the same authors 168 
calculated between 77-87% of the total isolates were Gram-negative rods (Al-Harbi and 169 
Uddin 2004; Al-Harbi and Uddin 2005). These were identified predominantly as A. 170 
hydrophila, Sh. putrefaciens, Escherichia coli, Vibrio cholerae, Pseudomonas spp., 171 
Photobacterium damselae and Pasteurella spp. Al Harbi and Uddin, (2005) reported that 172 
Vibrio made up 58% of the total isolates; these were further identified as Vibrio 173 
parahaemolyticus , Vibrio carchariae, Vibrio alginolyticus and Vibrio vulnificus. Other 174 
constituents included Bacillus sp., Cellulomonus sp., C. urealyticum and Streptococcus sp. 175 
Using culture based techniques, Tsuchiya et al. (2008) identified Cetobacterium somerae as a 176 
major component in the tilapia intestine. This species was confirmed using 16S rRNA 177 
sequencing.  178 
Culture dependent approaches are not sufficient on their own and it is more 179 
appropriate to use them in conjunction with culture independent approaches. He et al. (2010; 180 
2013) used DGGE followed by 16S rRNA sequencing to identify multiple phyla present in 181 
the hybrid tilapia intestine including Proteobacteria, Actinobacteria, Cyanobacteria, 182 
Fusobacteria and Firmicutes. Specifically, Lactobacillus plantarum isolated from the tilapia 183 
intestine were able to inhibit the growth of several pathogens in vitro and improved the 184 
immune system and growth performance of tilapia in vivo (Jatobá et al. 2011). Fluorescent in 185 
situ hybridisation (FISH) has also been employed to identify and quantify specific taxa in the 186 
tilapia intestine. Pseudomonas fluorescens constituted ca. 15% of total bacterial abundance,  187 
Lactobacillus brevis and Lactobacillus collinoides constituted ca. 10% and Lactobacillus 188 
coryniformis, Lactobacillus farciminis and Vibrio spp. were present at approximately 5% of 189 
total bacterial abundance in the tilapia intestine (Del'Duca et al. 2015). Lactobacillus and 190 
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Weisella has been recovered in the intestine of Nile tilapia by other researchers (Merrifield et 191 
al. 2010b; Jatobá et al. 2011). 192 
Besides bacteria, it is important to remember that there are other constituents in the 193 
intestinal tract, namely yeasts, Archaea and viruses. Despite this, very little work has been 194 
conducted investigating these in tilapia. In extreme environments, such as in deep sea fish, 195 
yeasts can account for a greater proportion of the cultivable microbiota than bacteria 196 
(Ohwada et al. 1980). Whilst this is likely to be an exception, yeasts have been routinely 197 
found in healthy fish, although the diversity and density is extremely variable (Gatesoupe 198 
2007). It is important to remember however that yeast cells can be hundreds of times larger 199 
than bacterial cells (for example, 200-300 µm3 for brewer’s yeast vs 1 µm3 for Pseudomonas) 200 
and therefore exert a greater effect than their lower CFU levels may suggest.  201 
Using 16S rRNA clone libraries, van der Maarel et al. (1998) demonstrated that the 202 
digesta of grey mullet (Mugil cephalus) and flounder (Platichthys flesus) was dominated by 203 
group II marine Archaea. Furthermore, similar clones were also identified in water samples 204 
from two stations in the North Sea. A number of 16S rRNA sequences with 97.6-99.5% 205 
similarity to Methanococcoides methylutens (marine methanogenic Archaea) were also found 206 
in the intestine of flounder (van der Maarel et al. 1999). Conversely, Fidopiastis et al. (2006) 207 
and Smriga et al. (2010) reported negative PCR amplification when using Archaea specific 208 
primers in fish faeces.  209 
It has been proposed that bacteriophages likely exert a strong selection pressure on the 210 
diversity and population structure of bacterial communities within the intestine (Breitbart et 211 
al. 2003) and these mechanisms could be exploited in order to reduce infectious diseases in 212 
aquaculture (Nakai and Park 2002). Whether bacteriophages are present in the intestines of 213 
healthy fish remain to be investigated fully but they have been identified from diseased ayu 214 
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(Plecoglossus altivelis) as well as fish commonly found in Mexico and Chile (Park et al. 215 
2000; Bastías et al. 2010).  216 
  Future work should focus on identifying and quantifying populations of Archaea, 217 
bacteriophage and yeast in tilapia. 218 
 219 
1.3.2 Role of GI microbiota in nutrition 220 
The GI microbiota is involved in a number of nutritional functions including digestion, 221 
nutrient utilisation and the production of amino acids, enzymes, short-chain fatty acids 222 
(SCFA’s), vitamins and minerals (Nayak 2010b). Smriga et al. (2010) suggested that in coral 223 
reef fish, members of Bacteroidetes, Firmicutes, Fusobacteria and Proteobacteria may 224 
contribute to digestion by producing a variety of enzymes. In a comprehensive review, Ray et 225 
al. (2012) described that the GI microbiota can produce an extensive range of enzymes which 226 
aid the digestive process including amylase, cellulase, lipase, protease, chitinases and phytase. 227 
Possible contributors to enzyme production include Bacillus, Enterobacteriaceae, 228 
Acinetobacter, Aeromonas, Flavobacterium, Photobacterium, Pseudomonas, Vibrio, 229 
Microbacterium, Micrococcus, Staphylococcus, other unidentified anaerobes and yeasts. 230 
However, as the authors highlight, in contrast to endothermic animals, it is difficult to 231 
conclude the exact contribution of the GI microbiota due to the complexity and variable 232 
ecology of the digestive tract of different fish species, the presence of a stomach or pyloric 233 
caeca and the relative length of the intestine. Mukherjee and colleagues (2014) isolated B. 234 
subtilis, Bacillus methylotrophicus and Enterobacter hormaechei from the intestinal tract of 235 
Indian major carp, Catla catla, demonstrating their enzymatic contribution by the production 236 
of amylase, protease, lipase, cellulase, phytase and xylanase.  237 
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Roeselers et al. (2011) used a pyrosequencing approach to identify Fusobacteria in the 238 
zebrafish intestine. The majority of these Fusobacteria sequences were closely aligned to Ct. 239 
somerae which has been isolated in many different fish species including zebrafish, rainbow 240 
trout, Oncorhynchus mykiss, common carp, Cyprinus carpio, goldfish, Carassius auratus, 241 
ayu, channel catfish, Ictalurus punctatus, largemouth bass, Micropterus salmoides, bluegill, 242 
Lepomis macrochirus, and tilapia (Kim et al. 2007; Tsuchiya et al. 2008; Larsen et al. 2014) 243 
and is known to produce large quantities of vitamin B12 (cobalamin). Consequently certain 244 
freshwater fish, including tilapia, where Ct. somerae is routinely found as an indigenous GI 245 
constituent, have no dietary requirement for this particular vitamin (Sugita et al. 1991; 246 
Tsuchiya et al. 2008; NRC 2011).  247 
The microbiota of fish, particularly those of a herbivorous and omnivorous nature, use 248 
fermentation to convert carbohydrates into simpler compounds, such as SCFA’s. The SCFA’s 249 
produced are rapidly absorbed by the host and used for energy generation and biosynthesis 250 
(Stevens and Hume 1995). The importance of SCFA’s to overall energy supply and 251 
metabolism has not yet been quantified but it is likely to be substantial in fish with a high 252 
fibre diet. Mountfort et al. (2002) estimated the rates of SCFA production in the hindgut of 253 
three species of temperate marine fish (Odax pullus, Aplodactylus arctidens and Kyphosus 254 
sydneyanus) concluding that acetate levels were highest followed by propionate and butyrate. 255 
The SCFA turnover rates were similar to those in the intestinal tracts of herbivorous reptiles 256 
and mammals, an interesting insight considering the ectothermic nature of fish. Clements et 257 
al. (2007) observed that the hindguts of these fish species were dominated by different 258 
taxonomic members of the bacterial group Clostridia. Clostridia are mostly polymer 259 
degraders, using polysaccharides and proteins as substrates producing SCFA’s as 260 
fermentation products. This is consistent with the results of Mountfort et al. (2002). In 261 
addition to nutritional benefits, SCFA production by GI microbes has an added benefit of 262 
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creating an acidic, hostile environment preventing pathogenic invasion. Furthermore, in 263 
human studies SCFA’s have been shown to inhibit cholesterol synthesis, reduce the risk of 264 
cardiovascular disease and certain cancers (Wong et al. 2006).  265 
The contribution of the indigenous microbiota to nutrition is also evident at the 266 
transcriptional level. Using DNA microarrays, Rawls et al. (2004) demonstrated that the 267 
absence of a microbiota in GF zebrafish is associated with a compromised ability to utilise 268 
nutrients and the assumption of a metabolic state which shares features commonly associated 269 
with fasting.  270 
 271 
1.3.3 Role of GI microbiota in immunity 272 
To understand the function of the intestinal microbiota in the context of both barrier 273 
function and immunity, the fish immune system as a whole and how an immune response is 274 
provoked must be considered. Due to the antigenic nature of the aquatic environment, 275 
mucosal tissues (such as the intestine) are under constant threat and thus mucosal immunity is 276 
of utmost importance to the host. The GALT orchestrates a network of immunological and 277 
non-immunological defences which must provide protection against pathogens, whilst at the 278 
same time tolerating commensal organisms.  279 
The immune system can be divided into two main branches, the innate and adaptive 280 
immune response. The innate immune system lacks the ability to acquire memory and 281 
specific recognition when confronted with foreign agents; this means however that the innate 282 
immune system has developed to be non-specific and is able to antagonise a wide range of 283 
pathogenic insults. Innate immunity in fish contributes to a larger proportion of overall 284 
immunity in fish when compared their mammalian counterparts (Ellis 2001; Whyte 2007). 285 
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This is due to the poikilothermic nature of fish; adaptive immune defences take considerable 286 
time to respond (antibody production in salmonids can take between 4-6 weeks, even at 287 
optimum temperatures, compared to just hours or days for the innate response) (Ellis 2001). 288 
The immediate lines of defence consist of a physical barrier of commensal bacteria and 289 
mucus. Indigenous microbes will compete with pathogens for adhesion sites on epithelial 290 
cells, energy and nutrients. Furthermore they will antagonise potential pathogens directly 291 
through the production of inhibitory compounds, for example bacteriocins. Mucus is vital to 292 
the defensive barrier and is produced at all mucosal surfaces including the intestinal tract 293 
where it is synthesised by goblet cells. Mucus functions to trap and remove pathogens, 294 
preventing their attachment to the epithelia and is consequently in a permanent state of 295 
translocation. In addition to mucin components (mucopolysaccharides) and glycoproteins, 296 
mucus also contains a number of secretory factors with a wide range of functions including 297 
pathogen antagonism (Ellis 2001; Whyte 2007). Commensal organisms can affect the mucus 298 
layer via alterations in mucin gene expression as well as mucus composition by modulating 299 
the local release of bioactive compounds (Deplancke and Gaskins 2001).  300 
GI microbiota can also modulate the immune system to benefit the host, particularly 301 
through innate mechanisms. Indigenous bacteria in the lumen express microbe associated 302 
molecular patterns (MAMP’s) which are recognised by pattern recognition receptors (PRR’s). 303 
One of the most documented PRR’s are toll-like receptors (TLR’s). These receptors activate a 304 
signalling cascade which finely tunes the epithelial translation of a number of proteins 305 
including cytokines, chemokines and defensins. Such immune signals initiate, and regulate, 306 
intestinal inflammation and chemotaxis of immune cells. Further to this, the intestinal 307 
microbiota can affect the expression of several immunity related genes. Using DNA 308 
microarray comparisons of the gene expression in the intestinal tract of GF zebrafish larvae, 309 
Rawls et al. (2004) demonstrated that the microbiota regulated a number of genes involved in 310 
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innate immunity, including those coding for serum amyloid A1, C-reactive protein, 311 
complement component 3, glutathione peroxidase and myeloperoxidase. These genes were all 312 
up-regulated in conventional zebrafish, when compared to GF zebrafish. Furthermore, out of 313 
the 212 genes investigated, 59 were conserved in murine models. Given the great 314 
evolutionary distance and the differences in the microbiota composition, it could be 315 
speculated that commensal microbiota in other teleost species share a similar role.  316 
 317 
1.3.4 Role of GI microbiota in intestinal development 318 
Gnotobiotic studies in zebrafish highlight the role microbiota play on host epithelial 319 
development, maturation and function. Bates et al. (2006) observed that in the absence of 320 
microbiota the gut epithelium was arrested in aspects of its differentiation, revealed by the 321 
lack of brushborder alkaline phosphatase activity, the maintenance of immature patterns of 322 
glycan expression and a reduction in the numbers of goblet and endocrine cells. Interestingly, 323 
the introduction of a complex microbiota at later stages of development was enough to 324 
reverse the GF phenotypes. Furthermore, the introduction of heat-inactivated preparations of 325 
intestinal microbiota or bacterial lipopolysaccharides (LPS) could only restore alkaline 326 
phosphatase activity indicating that the host can respond to the microbiota via at least two 327 
distinct pathways. Rawls et al. (2004) linked the role of the zebrafish microbiota to epithelial 328 
renewal and enterocyte morphology. GF zebrafish had reduced rates of epithelial 329 
proliferation where the enterocytes were characterised by large nuclear vacuoles filled with 330 
clear electron-lucent material compared with electron-dense eosinophilic material in 331 
conventional fish. Similar results have been observed in European sea bass where, after nine 332 
days post hatching, the intestinal epithelium consisted of cuboidal to columnar enterocytes in 333 
conventional larvae, as opposed to cuboidal to squamous in GF larvae (Rekecki et al. 2009). 334 
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1.4 Probiotics: history and definitions  335 
The word probiotic originates from the Latin words pro (for) and bios (life). In 336 
modern society, probiotics are fairly commonplace in health promoting “functional foods” for 337 
humans. Yet the probiotic concept was first theorised in the first half of the twentieth century 338 
by Metchnikoff  who suggested that the longevity of Bulgarian peasants was linked to their 339 
heavy consumption of fermented milk (Metchnikoff 1907). Early research focused on how 340 
probiotics could be used as a remedy to intestinal disorders in infants. The probiotic concept 341 
reached the animal production industry in the 1960’s initially in poultry feeds and in the last 342 
few decades aquaculture too (Gatesoupe 1999). 343 
The etymology of the word ‘probiotic’ has evolved and differs greatly depending on 344 
the source. Fuller (1989) defined probiotics as “live microbial feed supplements which 345 
beneficially affects the host animal by improving its intestinal balance”. Gatesoupe (1999) 346 
broadened this definition to encompass not just the improvement of the intestinal balance, 347 
since this is often not reported, but also to include the improvement of general health. 348 
Salminen (1999) argued that a probiotic need not be alive but in fact could be “any microbial 349 
preparation or the components of microbial cells” as long as it confers a benefit to the health 350 
of the host, thus introducing concepts of viable vs non-viable cells. Verschuere et al. (2000) 351 
identified that fish occupy a medium where pathogens are able to maintain themselves and 352 
proliferate (i.e. the water column) and argued that a probiotic may also act to improve the 353 
“ambient microbial community” or “the quality of the ambient environment”. Microbial 354 
applications which improve water quality via the breakdown or organic matter have been 355 
termed bioaugmentation or bioremediation (Moriarty 1997; Moriarty 1998). Early definitions 356 
referred to probiotics as a feed supplement but it is now clear that they can also confer 357 
benefits to the host when administered via the water (Taoka et al. 2006; Zhou et al. 2010a). 358 
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Thus a probiotic can be considered “any microbial cell provided via the diet or rearing water 359 
that benefits the host fish, fish farmer or fish consumer, which is achieved, in part at least, by 360 
improving the microbial balance of the fish” (Merrifield et al. 2010a). Direct benefits to the 361 
host may manifest themselves as immunostimulation, increased disease resistance, reduced 362 
stress response, improved GI morphology and microbiota composition and benefits to the 363 
farmer or consumer as improved fish appetite, growth performance, feed and energy 364 
utilisation, carcass and flesh quality, and reduced malformations (Merrifield et al. 2010a). As 365 
well as having some favourable characteristics which can benefit the host (e.g. pathogen 366 
antagonism, production of digestive enzymes etc.), a suitable probiotic candidate must 367 
conform to a number of essential criteria as well as others which can be considered 368 
favourable as detailed in Merrifield et al. (2010a). Essential requirements are:  369 
 must not be pathogenic to the host, other aquatic species or humans  370 
 must be free of plasmid-encoded antibiotic resistance genes  371 
 must be resistant to bile salts and low pH  372 
Currently, any microbial application to be used in the EU must have undergone 373 
rigorous scrutiny by the European Food Safety Authority (EFSA). This is conducted through 374 
a Qualified Presumption of Safety (QPS) which is a generic risk assessment approach applied 375 
by EFSA (Leuschner et al., 2010). Lactobacillus is generally considered non-pathogenic; 376 
however its presence on the QPS list is under regular review since L. rhamnosus has been 377 
isolated from immunocompromised patients indicating that under certain conditions it can act 378 
as an opportunistic pathogen. Pediococcus species are generally accepted subject to antibiotic 379 
resistance tests. Another commonly used probiotic, Bacillus, is on the list subject to a proven 380 
safety record and the absence of toxigenic material (i.e. B. anthracis and B. cereus produce 381 
toxins and are not on the list). Also not on the list is Enterococcus which have a wide 382 
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prevalence of antibiotic resistance genes and can cause disease under certain scenarios. The 383 
inclusion of this genus of probiotic is therefore assessed on a case by case basis.  384 
 385 
1.5 Probiotic use in aquaculture 386 
Probiotics are now widely used in aquaculture. Rico and colleagues (2013) assessed 387 
the use of veterinary medicines, feed additives and probiotics in aquaculture facilities in Asia. 388 
Out of 252 facilities investigated, 74% of Thai and 8% of Chinese tilapia farms reported 389 
using probiotics. Interestingly, this compared with 9.7% and 16% of farms which routinely 390 
use antibiotics in Thailand and China, respectively. Consequently research investigating the 391 
supplementation of probiotics in fish and shellfish has increased in recent years. This has 392 
resulted in the publication of a number of recent reviews describing probiotic use in 393 
aquaculture in a generalised sense (Nayak 2010a; Dimitroglou et al. 2011; Martínez Cruz et 394 
al. 2012; C. De et al. 2014; Lazado and Caipang 2014b; Newaj-Fyzul et al. 2014; Pérez-395 
Sánchez et al. 2014), in respect to specific fish groups (Merrifield et al. 2010a; Welker and 396 
Lim 2011; Hoseinifar et al. 2014; Lazado and Caipang 2014a; van Hai 2015) and shrimp (van 397 
Hai and Fotedar 2010).  398 
Numerous probiotics have been investigated in tilapia studies. These have been 399 
isolated from a wide range of sources including the intestines of tilapia and their rearing 400 
systems (i.e. rearing water and sediment) (Aly et al. 2008a; Apún-Molina et al. 2009; 401 
Del'Duca et al. 2013; Eissa and Abou-El Gheit 2014) and even tilapia gonads (Aly et al. 402 
2008a; Abd El-Rhman et al. 2009).  403 
One of the main groups of bacteria which have been investigated as potential 404 
probiotics are lactic acid bacteria (LAB), so named because of their ability to produce lactic 405 
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acid as a product of fermentative metabolism (Ringø and Gatesoupe 1998). This group are 406 
generally catalase negative and contain both rods (e.g. lactobacilli and carnobacteria) and 407 
cocci (e.g. streptococci and enterococci). A number of LAB have proved effective probiotics 408 
in tilapia including Lactobacillus acidophilus, L. plantarum, Lactobacillus rhamnosus, 409 
Lactococcus lactis, Enterococcus faecium and Pediococcus acidilactici (Pirarat et al. 2006; 410 
Ferguson et al. 2010; Zhou et al. 2010b; Jatobá et al. 2011; Pirarat et al. 2011; Ren et al. 411 
2013; Standen et al. 2013; Villamil et al. 2014).  412 
Bacillus spp. have also received considerable attention as suitable probiotic 413 
candidates in tilapia, most notably B. subtilis but also Bacillus amyloliquefaciens, Bacillus 414 
coagulans, Bacillus firmus, Bacillus pumilus, Bacillus thermophylus, Bacillus licheniformis 415 
and Bacillus toyoi (Aly et al. 2008a; Zhou et al. 2010a; Mohamed and Ahmed Refat 2011; 416 
Ridha and Azad 2012; Nakandakare et al. 2013; Mehrim et al. 2014; Ng et al. 2014; Telli et 417 
al. 2014). Although a few yeasts have been investigated in other fish species, Saccharomyces 418 
cerevisae is the only one to be assessed in tilapia (Abdel-Tawwab et al. 2008; Abdel-Tawwab 419 
et al. 2010; Abdel-Tawwab 2012).  420 
Controversially, genera which contain pathogens have been also been investigated as 421 
potential probiotics in tilapia; these include Citrobacter, Micrococcus, Pseudomonas and 422 
Streptococcus (Aly et al. 2008a; Abd El-Rhman et al. 2009; Ayyat et al. 2014; Eissa and 423 
Abou-El Gheit 2014).  424 
Probiotic investigations in tilapia have reported a number of benefits to the host 425 
including modulation of the intestinal microbiota, improved growth performance, modulation 426 
of the immune response and improved disease resistance and reproductive success. These 427 
will be explored further in the subsequent sections.  428 
 429 
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1.6 Probiotic mechanisms of action 430 
 Due to the ethical and methodological limitations of animal studies, together with 431 
complicated relationships between possible modes of action, it is difficult to understand the 432 
exact mechanisms by which probiotics function. Theoretically, a probiotic bacterium need 433 
only possess a single mode of action. However, it has been suggested that multi-species 434 
probiotics can have advantages since they may provide complimentary modes of action, thus 435 
conferring multiple benefits to the host (Timmerman et al. 2004; Salinas et al. 2008).  436 
 437 
1.6.1 Probiotic colonisation and microbiota modulation 438 
The continual supplementation of probiotic cells can result in the temporal 439 
colonisation of the intestinal tract and modulation of the indigenous microbiota. Surprisingly, 440 
less than 25% of probiotic studies in tilapia assess the gut microbiota, and those that do are 441 
generally interested in probiotic recovery. It is important, but not essential depending on the 442 
definition, that a probiotic survives the gastric process in order to reach the intestine where it 443 
can exert its beneficial effects. Intestinal probiotic levels are typically much lower than the 444 
original supplementation dose. For example, Bucio Galindo (2009) aimed to quantify the 445 
kinetic passage of L. plantarum from feed to faeces in tilapia. After feeding, at time zero, 446 
there were no L. plantarum in the faeces, however levels peaked between 3.6 and 5.1 hours 447 
post probiotic feeding and following this the probiotic disappeared in an exponential decay 448 
pattern until it could not be detected after three days post ingestion. When supplemented at 449 
10
8
 CFU g
-1
 approximately 6.46% of probiotic cells could be recovered, proving this strain is 450 
capable of surviving the digestive process. When supplemented at a higher dose, 10
11
 CFU g
-
451 
1
, daily ingestion of L. plantarum lead to a survival fraction equal to 10
9
 CFU g
-1
 of dry 452 
matter faeces, similar numerical levels to the total cultivable anaerobic flora.  453 
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Other studies have reported that probiotic bacteria may persist in the tilapia intestine 454 
after reverting to control (non-supplemented) diets. Ferguson et al. (2010) used a DGGE 455 
approach to demonstrate that after reverting to a basal diet, P. acidilactici can persist in the 456 
gut for at least 17 days. Interestingly, this probiotic also provided antagonism towards 457 
unidentified bacterium EU697160 (previously isolated from the posterior intestine of Atlantic 458 
salmon, Salmo salar). The ability of other probiotics including Carnobacterium spp., 459 
Lactobacillus spp., Lactococcus spp., Leuconostoc spp. and Bacillus spp. to persist in the 460 
gastrointestinal tract of salmonids and catfish has been investigated, demonstrating temporal 461 
colonisation lasting from < 3 days to > 3 weeks (Nikoskelainen et al. 2003; Kim and Austin 462 
2006; Balcázar et al. 2007; Ran et al. 2012). Thus it is evident the length of time a probiont 463 
may remain in the intestine of fish, after probiotic feeding has ceased, is dependent on the 464 
probiotic species, host species, environmental factors, dosage and duration of probiotic 465 
supplementation. Persisting within the gut may enable any probiotic benefits to continue even 466 
when probiotic feeding has ceased. For example, the application of B. amyloliquefaciens 467 
significantly elevated intestinal total viable counts (TVC) when compared to the control of 468 
Lactobacillus sp. fed groups. These levels remained higher 61 days after the cessation of 469 
probiotic feeding (Ridha and Azad 2012).   470 
Probiotic administration can alter the indigenous intestinal composition in fish, as 471 
well as total population levels. The effect of probiotics on TVC of aerobic bacteria within the 472 
intestine of tilapia is unclear since there are conflicting results. Some authors report that 473 
probiotics increase intestinal TVC (He et al. 2013; Ridha and Azad 2012), some report the 474 
reduction of TVC (Jatobá et al. 2011) whilst others report no differences (Ferguson et al. 475 
2010; Standen et al. 2013). A culture dependent approach has also been employed to 476 
demonstrate that probiotics can increase the intestinal abundance of specific groups of 477 
bacteria including LAB, Bacillus sp. and yeast (Shelby et al. 2006; Ferguson et al. 2010; He 478 
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et al. 2013; Standen et al. 2013; Iwashita et al. 2015) and decrease Pseudomonas aeruginosa 479 
levels (Jatobá et al. 2011).  480 
DGGE has also been utilised to demonstrate the effect of probiotics on the indigenous 481 
microbiota of tilapia (He et al. 2013; Liu et al. 2013). A clustering effect, indicating 482 
similarity, was observed between the microbiota of tilapia fed a control diet when compared 483 
to tilapia fed a P. acidilactici supplemented diet (Ferguson et al. 2010). This data suggests 484 
that a potential mechanism for the modulation of the microbiota, including the reduction of 485 
potential pathogens, may be via competitive exclusion. This is discussed in the next section. 486 
 487 
1.6.2 Competitive exclusion 488 
As discussed previously, probiotic bacteria may be able to colonize the intestine, at 489 
least temporarily, by adhering and growing within the intestinal mucus and mucosa, reducing 490 
the available receptor sites for the attachment of pathogens and stimulating their removal 491 
from infected regions (Verschuere et al. 2000). Irianto & Austin (2002) suggested that this 492 
application strategy may be beneficial when probiotics are administered to juvenile or first 493 
feeding fish, or to older animals immediately after antibiotic treatment. Considering this 494 
mode of action is widely accepted, there is a scarcity of research which focuses on this 495 
mechanism. Ren et al. (2013) used the intestinal sac model to demonstrate the ex vivo 496 
interactions of probiotic, L. plantarum, and pathogen, A. hydrophila, in the intestine of tilapia. 497 
Damage which was caused by the pathogen was alleviated by the pre-treatment of L. 498 
plantarum. The authors attributed this in part to competition for adhesion sites along with 499 
improved host immunity.  500 
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Probiotics can also compete for nutrients. Iron is essential to carry out vital 501 
physiological and metabolic processes for all microorganisms. Although abundant in nature it 502 
is not easily available in its preferred state since Fe
2+
 will undergo rapid oxidation to Fe
3+
 and 503 
finally forms insoluble ferric oxyhydroxide which cannot be taken up by microbes (Saha et al. 504 
2012). Siderophores, iron-binding agents, are extracellular substances which allow the 505 
acquisition of this limited nutrient and are a mechanism of virulence for a number of 506 
pathogens (Saha et al. 2012). Brunt et al. (2007) recovered Bacillus sp. and Aeromonas 507 
sobria from the intestine of rainbow trout and carp, respectively, and demonstrated the 508 
effectiveness as probiotics for the control of infections caused by Aeromonas salmonicida, 509 
Lactococcus garvieae, St. iniae, Vibrio anguillarum, Vibrio ordali and Yersinia ruckeri. The 510 
authors hypothesised that the reductions in mortality were at least in part due to the probiotics’ 511 
ability to produce siderophores, most notably A. sobria. Korkea-aho et al. (2011) investigated 512 
the ability of Pseudomonas M174 to inhibit the growth of Flavobacterium psychrophilum in 513 
iron sufficient and iron deficient media, as well as an in vivo challenge trial. Siderophore 514 
production was only detected in Pseudomonas cultures under iron limiting conditions. 515 
Growth inhibition of Fl. psychrophilum was observed using cell-free supernatants from 516 
Pseudomonas cultures and this antagonism was enhanced when cultured under iron deficient 517 
conditions. Furthermore, the application of Pseudomonas M174 significantly reduced 518 
mortality due to Fl. psychrophilum infection. These studies suggest siderophore production 519 
may be an important attribute for a potential probiotic, in order to provide antagonism against 520 
pathogens. It is also likely that probiotics compete with pathogens for other inorganic and 521 
organic nutrients too. To the author’s knowledge, no work has been carried out investigating 522 
this in tilapia however.  523 
 524 
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1.6.3 Probiotic effects on nutrient utilisation, digestion and growth 525 
Probiotic effects on growth performance are arguably the most widely investigated. 526 
This is also true for tilapia where multiple studies report mixed results regarding growth 527 
performance (Table 1.1). Improved growth performance has been reported in tilapia with the 528 
application of B. coagulans, B. pumilus, B. subtilis, Bifidobacterium bifidum, E. faecium, L. 529 
acidophilus, L. plantarum, L. rhamonosus, Lc lactis, Micrococcus luteus, Ps. fluorescens, 530 
Rhodopseudomonas palustris, S. cerevisae and Streptococcus thermophilus (Abdel-Tawwab 531 
et al. 2008; Aly et al. 2008b; Aly et al. 2008c; Wang et al. 2008; Abd El-Rhman et al. 2009; 532 
Zhou et al. 2010a; Zhou et al. 2010b; Gonçalves et al. 2011; Jatobá et al. 2011; Ayyat et al. 533 
2014; Eissa and Abou-El Gheit 2014; Ridha and Azad 2015). These improvements can result 534 
in considerable economic gains (El-Haroun et al. 2006). The mechanisms which underpin 535 
these improvements have not been fully elucidated. Ghazalah et al. (2010) demonstrated that 536 
the supplementation of Biogen
®
 (containing B. subtilis & B. licheniformis) significantly 537 
increased the final weight of tilapia even when diets contained a lower proportion of protein 538 
(27.5% in probiotic diets compared to 30% in control diets). Not only does this demonstrate 539 
that probiotics can improve protein digestibility but they can have further economic 540 
implications since diets could be produced with lower protein levels.  541 
Probiotics can also elevate GI digestive enzyme activities in fish supplemented with 542 
probiotics. For example, Essa et al. (2010) reported improved growth performance in tilapia. 543 
Researchers observed elevated amylase, protease and lipase activities in tilapia supplemented 544 
with B. subtilis and/ or L. rhamnosus and elevated protease activity in fish supplemented with 545 
S. cerevisae.  546 
Other potential mechanisms could include improved intestinal morphology. For 547 
example, after supplementing diets with L. rhamnosus for 30 days, Pirarat et al. (2011) 548 
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reported longer mucosal folds within the proximal intestine in tilapia fed the probiotic, when 549 
compared to those receiving the control diet. Having said this, authors didn’t observe any 550 
differences with regards to growth performance. Further research is needed to optimise 551 
dosage and feeding duration in order to achieve improved growth performance. 552 
The developmental stage of the fish can also affect the efficacy of a probiotic with 553 
regards to improving growth performance. Ridha and Azad (2015) supplemented diets for 554 
juvenile (approx. 28g) and adult (approx. 94g) tilapia  with B. subtilis and L. acidophilus 555 
singularly and in combination for 15 weeks. When administered singularly L. acidophilus 556 
failed to affect the SGR in juvenile tilapia; however, when administered to adult fish SGR 557 
was significantly lower in probiotic fed fish when compared to the control treatment. The 558 
administration of B. subtilis and the combination with L. rhamnosus improved final weight, 559 
SGR and feed intake in juvenile tilapia. Furthermore, the probiotic mix also improved the 560 
FCR in juveniles. However, these changes were not observed in adult fish, despite the dose 561 
and feed duration being constant. This could be due to the fact that smaller fish have larger 562 
scope for increased growth performance, relative to their original size within a given time 563 
period. Furthermore, the intestinal microbiota and probiotic colonisation dynamics differs 564 
depending on the developmental stage of the host (Llewellyn et al. 2014). Future work should 565 
consider the developmental stage of the fish as this may affect probiotic efficacy. 566 
Numerous studies have reported no difference in growth performance in tilapia after 567 
probiotic treatment (Shelby et al. 2006; Abd El-Rhman et al. 2009; Ali et al. 2010; Zhou et al. 568 
2010a; Ridha and Azad 2012; He et al. 2013; Liu et al. 2013; Standen et al. 2013; Ng et al. 569 
2014; Telli et al. 2014; Ridha and Azad 2015) and some have reported impaired growth 570 
performance (Shelby et al. 2006; Abd El-Rhman et al. 2009; Abumourad et al. 2013). It 571 
should be noted that growth performance similar to control treatments (i.e. no difference in 572 
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growth performance) is not a negative result, if the probiotic can manifest other benefits such 573 
as immune modulation and disease resistance which likely requires energy and resources. 574 
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Table 1.1: Tilapia studies reporting growth performance data, based on actual values, after probiotic administration. 575 
Potential probiont Dosage (Duration) Observation Reference 
Nile tilapia 
ALL-LACTM (containing St. 
faecium* & L. acidophilus) 
0.1% (63 days) ↑ SR, FW, SGR PER; ↓ FCR (Lara-Flores et al. 2003) 
B. amyloliquefaciens 10
8
 CFU g
-1
 (99 days) ↔ FW, WG, SGR, FCR (Ridha and Azad 2012) 
B. coagulans 10
7
 CFU ml
-1
 (40 days) ↑ FW, WG, SGR; ↔ SR (Zhou et al. 2010a) 
B. pumilus 106, 1012 CFU g-1 (2 months) ↑ WG (dose and duration dependent) (Aly et al. 2008c) 
B. subtilis 10
6
 CFU g-1 (84 days) ↔ FW, FL, WG, FCR, FI, SR (Telli et al. 2014) 
B. subtilis 10
7
 CFU ml
-1
 (40 days) ↔ FW, SR, WG, SGR (Zhou et al. 2010a) 
B. subtilis 10
7
 CFU g
-1
 (2 months) ↑ WG; ↔ SR (Aly et al. 2008b) 
B. subtilis 108 CFU g
-1
 (105 days) ↑ FW, SGR, FI; ↔ FCR (juvenile fish): 
↔ FW, SGR, FI, FCR (adult fish) 
(Ridha and Azad 2015) 
B. subtilis 108 CFU g
-1
 (84 days) ↔ FW, SGR, FI, FCR (Ridha and Azad 2015) 
B. subtilis + Aspergillus oryzae + 
S. cerevisae 
0.5, 1% (28 days) ↓ FCR, ↔ FW, WG, FI (dose dependent) (Iwashita et al. 2015) 
B. subtilis + L. acidophilus 108 CFU g
-1
 (105 days) ↑ FW, SGR, FI; ↓ FCR (juvenile fish): ↔ 
FW, SGR, FI, FCR (adult fish) 
(Ridha and Azad 2015) 
B. subtilis + L. acidophilus 10
7
 CFU g
-1
 (2 months) ↑ SR; ↔ WG (Aly et al. 2008b) 
Bacillus sp. 10
3
 CFU ml
-1 (134 days) ↑ FW, SGR; ↔ SR, WG (Apún-Molina et al. 2009) 
Bacillus sp. + presumptive LAB Bacilli (10
3
 CFU ml
-1
), LAB 
(10
4
 CFU g
-1
) (134 days) 
↑ FW, WG, SGR; ↔ SR (Apún-Molina et al. 2009) 
Bactocell PA10 MD (containing P. 
acidilactici) 
108 CFU g
-1
 (63 days) ↓ WG; ↔ SR (Shelby et al. 2006) 
Bi. bifidum 105 CFU g
-1
 (98 days) ↑ FI;  ↔ FW, WG, FCR, SR (Ayyat et al. 2014) 
Biogen® (containing B. subtilis & 
B. licheniformis) 
0.5, 1.5, 2.0, 2.5%
 
(120 days) ↑ FW, WG, SGR, PER, PPV, ER; ↓ FCR; 
↔ FI (dose dependent) 
(El-Haroun et al. 2006) 
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Biogen® (containing B. subtilis & 
B. licheniformis) 
0.3% (98 days) ↑ FW, SGR, WG; ↓ FCR; ↔ SR 
(dependent on stocking density) 
(Mehrim 2009) 
Biogen® (containing B. subtilis & 
B. licheniformis) 
0.2% (4 months) ↑ FW, WG (Ghazalah et al. 2010) 
Biogen® (containing B. subtilis & 
B. licheniformis) 
0.1, 0.2, 0.3% (4 months) ↔ FW, WG, SGR (dose dependent) (Ali et al. 2010) 
Biomate SF-20 (containing E. 
faecium) 
106 CFU g
-1
 (39 days) ↔ WG, SR (Shelby et al. 2006) 
Bio-Nutra 200 (containing B. 
subtilis, As. oryzae & yeast) 
0.1, 0.2, 0.3% (150 days) ↑ FW, WG, SGR, PPV; ↓ FCR; ↔ PER 
(dose dependent) 
(Salem 2010) 
Bioplus 2B (containing B. Subtilis 
& B. licheniformis) 
Exp. I: 106 CFU g
-1
 (39 days) 
Exp. II: 108 CFU g
-1
 (63 days) 
↔ WG, SR (Experiment I) 
↓ WG; ↑ SR (Experiment II) 
(Shelby et al. 2006) 
BioSafTM (containing S. cerevisae) 0.1% (63 days) ↑ SR, FW, SGR, PER; ↓ FCR (Lara-Flores et al. 2003) 
Biostim (containing Lactobacillus 
sporogenes*, L. acidophilus, B. 
subtilis, B. licheniformis & S. 
cerevisae) 
108 CFU g
-1
 (84 days) ↑ FW, SGR; ↓ FCR; ↔ FI (Ridha and Azad 2015) 
Biostim (containing L. 
sporogenes*, L. acidophilus, B. 
subtilis, B. licheniformis & S. 
cerevisae) + B. subtilis 
108 CFU g
-1
 (84 days) ↑ SGR; ↔ FW, FI, FCR (Ridha and Azad 2015) 
Biotics (containing B. subtilis, L. 
acidophilus, S. cerevisae & As. 
oryzae) 
0.1, 0.2% (120 days) ↑ FW, WG, SGR, SR; ↓ FCR (dose 
dependent)  
(Ahmed et al. 2014) 
E. faecium 10
7
 CFU ml
-1
(40 days) ↑ FW, WG; ↔ SR (Wang et al. 2008) 
HydroYeast Aquaculture® 
(yeast ,L. acidophilus, 
Bifidobacterium longum, B. 
0.5, 0.1, 0.15% (56 days) ↑ SR (males), K-factor (females) (dose 
dependent) 
(Mehrim et al. 2014) 
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thermophylus & St. faecium*) 
L. acidophilus 108 CFU g
-1
 (105 days) ↔ FW, SGR, FI, FCR (juvenile fish): ↔ 
FW, FI, FCR; ↓ SGR (adult fish) 
(Ridha and Azad 2015) 
L. acidophilus 10
7
 CFU g
-1
 (2 months) ↑ WG; ↔ SR (Aly et al. 2008b) 
L. acidophilus 104 CFU g-1 (98 days) ↑ FW, WG, FI; ↔ FCR, SR (Ayyat et al. 2014) 
L. acidophilus + Bi. Bifidum +  St. 
thermophilus + S. cerevisae 
105 CFU g
-1
 (98 days) ↑ FW, WG, FI;  ↔ FCR, SR (Ayyat et al. 2014) 
L. acidophilus + Bi. bifidum + St. 
thermophilus 
105 CFU g
-1
 (98 days) ↑ FW, WG, FI;  ↔ FCR, SR (Ayyat et al. 2014) 
Lactobacillus sp. 10
8
 CFU g
-1
 (99 days) ↔ FW, WG, SGR, FCR (Ridha and Azad 2012) 
L. plantarum 10
6
 CFU 
-1
 (30 days) ↑ WG; ↑ FCR; ↔ FW, FI, PER, SR (Abumourad et al. 2013) 
L. plantarum 10
8
 CFU g
-1
 (84 days) ↑ FW, FER; ↔ SR (Jatobá et al. 2011) 
L. rhamnosus 10
10 
CFU g
-1
 (30 days) ↔ FW, WG, SGR, FCR (Pirarat et al. 2011) 
L. rhamnosus 10
10
 CFU g
-1
 (3 weeks) ↑ FW; ↔ WG, SGR, FER (Gonçalves et al. 2011) 
Lc. lactis 10
7
 CFU ml
-1
 (40 days) ↑ FW, WG; ↔ SR (Zhou et al. 2010b) 
Levucell SB 20 (containing S. 
cerevisae) 
108 CFU g
-1
 (63 days) ↓ WG; ↔ SR (Shelby et al. 2006) 
M. luteus 10
7
 CFU g
-1
 (90 days) ↑ FW, WG; ↓ FCR; ↔ SGR, FI, PER, SR (Abd El-Rhman et al. 2009) 
M. luteus + Pseudomonas sp. 10
7
 CFU g
-1
 (90 days) ↔ FW, WG, SGR, FI, FCR, PER, SR (Abd El-Rhman et al. 2009) 
Organic GreenTM (containing L. 
acidophilus, B. subtilis, 
Saccharomyces & As. oryzae) 
0.1, 0.2% (2 months) ↑ WG (dose and duration dependent) (Aly et al. 2008c) 
P. acidilactici 10
7
 CFU g
-1
 (32 days) ↑ SR; ↔ FW, WG, SGR, FCR, PER (Ferguson et al. 2010) 
P. acidilactici 10
6
 CFU g
-1
 (42 days) ↔ FW, WG, SGR, FCR, FI, PER, K-
factor 
(Standen et al. 2013) 
PAS TR
®
 (containing B. subtilis 
and B. toyoi) 
0.4% (63 days) ↑ FW; ↓ FCR; ↔ FL, FI, WG, SR (Nakandakare et al. 2013) 
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Presumptive LAB 10
4
 CFU g
-1 (134 days) ↑ FW, WG, SGR; ↔ SR (Apún-Molina et al. 2009) 
Ps. fluorescens 108 CFU g-1 (45 days) ↑ FW, WG, SGR (Eissa and Abou-El Gheit 
2014) 
Pseudomonas sp. 10
7
 CFU g
-1
 (90 days) ↓ FW, WG, SGR, PER, SR; ↔ FI, FCR (Abd El-Rhman et al. 2009) 
R. palustris 10
7
 CFU ml
-1
 (40 days) ↑ FW, WG, SGR; ↔ SR (Zhou et al. 2010a) 
S. cerevisae 106 CFU g
-1
 (98 days) ↑ FW, WG, FI;  ↔ FCR, SR (Ayyat et al. 2014) 
S. cerevisiae 0.025, 0.05, 0.1, 0.2, 0.5% (84 
days) 
↑ FW, WG, SGR, FI, PER; ↓ FCR; ↔ SR (Abdel-Tawwab et al. 2008) 
S. cerevisiae 0.05, 0.1, 0.2, 0.5% (84 days) ↑ FW, FI; ↔ SGR, FCR, SR (Abdel-Tawwab 2012) 
St. thermophilus 105 CFU g
-1
 (98 days) ↑ FI;  ↔ FW, WG, FCR, SR (Ayyat et al. 2014) 
 
Hybrid tilapia 
B. licheniformis 0.1, 0.3% (56 days) ↔ FW, WG, SGR, FCR, FL, SR (Ng et al. 2014) 
B. subtilis 105 CFU g
-1
 (56 days) ↔ FW, WG, FCR, SR (He et al. 2013) 
B. subtilis 0.1, 0.3% (56 days) ↔ FW, WG, SGR, FCR, FL, SR (Ng et al. 2014) 
Bacillus spp. + Pediococcus spp. 0.1% (56 days) ↔ FW, WG, SGR, FCR, FL, SR (Ng et al. 2014) 
L. acidophilus 10
5
, 10
7
, 10
9
 CFU g
-1
 (35 days) ↔ WG, FCR, SR (Liu et al. 2013) 
L. brevis 10
5
, 10
7
, 10
9
 CFU g
-1
 (35 days) ↔ WG, FCR, SR (Liu et al. 2013) 
Galilee tilapia (Sarotherodon galilaeus L.) 
S. cerevisiae 1% (6 weeks) ↑ FW, WG, SGR, FI, PER; ↓ FCR; ↔ SR (Abdel-Tawwab et al. 2010) 
Upward facing arrows indicate increasing values whilst downward facing arrows indicate decreasing values. Horizontal arrows indicate no 
change. Green arrows represent improvements whilst red indicates a negative effect on growth performance. 
* St. faecium and L. sporogenes have now been reclassified to E. faecium and B. coagulans respectively. 
FCR = Feed conversion ratio 
FER = Feed efficiency ratio 
FI = Feed intake  
FL = Final length 
FW = Final weight 
K-factor = Condition factor 
PER = Protein efficiency ratio 
SGR = Standard growth rate 
SR = Survival rate 
WG = Weight gain 
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1.6.4 Probiotic production of inhibitory substances 566 
Probiotics can produce a wide range of chemical substances that have bactericidal or 567 
bacteriostatic effects on other microbial populations. These compounds include antibiotics, 568 
bacteriocins, siderophores, lysozymes, proteases, hydrogen peroxide, organic acids, ammonia 569 
and diacetyl (Verschuere et al. 2000). The presence of these substances is thought to aid the 570 
barrier function against opportunistic pathogens.  571 
Agar diffusion methods, or variations of, are often used to assess the production of 572 
inhibitory substances in vitro. Cell free supernatants from Bacillus sp., L. acidophilus and L. 573 
plantarum have shown antagonism against Vibrio sp., A. hydrophila and Ps. fluorescens 574 
(Apún-Molina et al. 2009; Abumourad et al. 2013; Villamil et al. 2014). Other authors have 575 
used whole cell preparations to demonstrate the in vitro antagonism of Bacillus sp., B. subtilis, 576 
B. pumilus, Citrobacter freundii, Enterococcus sp., L. acidophilus, L. brevis, Lc. lactis, M. 577 
luteus and Pseudomonas sp. to pathogens A. hydrophila, Ps. fluoresecns, Pseudomonas 578 
putida and St. iniae (Aly et al. 2008a; Aly et al. 2008b; Abd El-Rhman et al. 2009; Zhou et al. 579 
2010b; Del'Duca et al. 2013; Liu et al. 2013).  580 
Mukherjee and colleagues (2014) screened a number of intestinal bacterial strains to 581 
investigate their ability to produce inhibitory intracellular, extracellular, whole cell and heat-582 
killed cellular components. Out of 208 strains investigated, four showed antagonism against 583 
four or more pathogens. Intracellular, extracellular, whole cell and heat-killed cellular 584 
components of B. subtilis showed antagonism against A. hydrophila, A. salmonicida, 585 
Pseudomonas sp., Ps. fluorescens and Ps. putida but not Aeromonas veronii. Equally all 586 
cellular components of B. methylotrophicus and En. hormaechei provided antagonism against 587 
A. hydrophila, A. salmonicida and Ps. fluorescens.  588 
 589 
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1.6.5 Probiotic effects on immunity 590 
Many studies have investigated the effect of probiotics on the immune system in 591 
tilapia, focusing on both the innate and adaptive immune response as well as the localised (i.e. 592 
intestine) and systemic (whole organism) response (Table 1.2). At the systemic level, 593 
probiotics have commonly been reported to improve serum lysozyme, alternative 594 
complement and bactericidal activities, total immunoglobulin (Ig) levels, elevate circulating 595 
leucocyte levels, modulate the proportion of leucocyte subpopulations, enhance head kidney 596 
chemiluminescence activity, respiratory burst activity and modulate cytokine gene expression 597 
in immunologically important organs (Pirarat et al. 2006; Taoka et al. 2006; Aly et al. 2008b; 598 
Aly et al. 2008c; Wang et al. 2008; Ali et al. 2010; Ferguson et al. 2010; Zhou et al. 2010a; 599 
Zhou et al. 2010b; Jatobá et al. 2011; Pirarat et al. 2011; Ridha and Azad 2012; Liu et al. 600 
2013; Villamil et al. 2014; Iwashita et al. 2015; Ridha and Azad 2015). Other studies have 601 
demonstrated that haematological profiles can also be modified by probiotics (Taoka et al. 602 
2006; Abdel-Tawwab et al. 2008; Aly et al. 2008b; Abd El-Rhman et al. 2009; Mehrim 2009; 603 
Ferguson et al. 2010; Abdel-Tawwab 2012; Eissa and Abou-El Gheit 2014; Mehrim et al. 604 
2014; Ng et al. 2014; Telli et al. 2014; Iwashita et al. 2015).  605 
At the localised level, L. rhamnosus significantly elevated the abundance of 606 
intraepithelial leucocytes (IEL’s) and acidophilic granulocytes in the proximal intestine of 607 
tilapia, as well as significantly increasing populations of goblet cells in the distal intestine, 608 
when fed at 10
10
 CFU g
-1
 for 30 days (Pirarat et al. 2011). Larger populations of IEL’s and 609 
goblet cells were also been reported in the mid intestine of tilapia supplemented with P. 610 
acidilactici (Standen et al. 2013). The improvements to the epithelial barrier function, 611 
reported by Pirarat et al. (2011), may be the mechanism behind the reduced intestinal damage 612 
following an Aeromonas challenge after tilapia were supplemented with the same probiotic, L. 613 
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rhamnosus (Ngamkala et al. 2010). Protective effects of L. plantarum have also been 614 
demonstrated using an ex vivo model (Ren et al. 2013). Using the intestinal sac method 615 
researchers observed that damage caused by A. hydrophila could be alleviated by L. 616 
plantarum, demonstrating its probiotic potential.  617 
Within the intestine, probiotics can affect the gene expression of both pro- and anti-618 
inflammatory cytokines (He et al. 2013; Liu et al. 2013; Ren et al. 2013; Standen et al. 2013). 619 
The probiotic modulation of cytokine expression is not limited to the intestine, indeed authors 620 
have reported similar results in the spleen and head kidney (Pirarat et al. 2011; Liu et al. 621 
2013; Villamil et al. 2014). An up-regulation of both head kidney and spleen IL-1β and 622 
transferrin could explain reduction in mortality when tilapia were exposed to A. hydrophila 623 
(Villamil et al. 2014). The observations by Liu et al. (2013) reveal that these effects can be 624 
complex and can be affected by probiotic species, dose, duration of supplementation and the 625 
organ and gene of interest. These results demonstrate that probiotics can provide elevated 626 
resistance to pathogens and improve the immune-readiness of the host, were it to come into 627 
contact with a potential pathogen. Certainly, Pirarat et al. (2006) suggested that protection 628 
against Ed. tarda infection after supplementation with L. rhamnosus was accomplished by 629 
enhancing the alternative complement activity. Complement components facilitate 630 
chemotaxis, opsonisation and pathogen destruction (Holland and Lambris 2002) and provides 631 
an important link between the innate and adaptive immune system (Morgan et al. 2005). To 632 
the authors’ knowledge, only two studies have investigated the adaptive immune response in 633 
tilapia through the measurement of total immunoglobulins (Ig’s) (Shelby et al. 2006; Ridha 634 
and Azad 2012). The abundance of serum Ig’s was increased after supplementing tilapia diets 635 
with B. amyloliquefaciens and Lactobacillus sp. (Ridha and Azad 2012) but no difference 636 
was observed after supplementing tilapia diets with commercial probiotics Bactocell PA10 637 
MD, Biomate SF-20, Bioplus 2B or Levucell SB20 (Shelby et al. 2006).  638 
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Table 1.2: Tilapia studies reporting immunological data, based on actual values, after probiotic administration. 639 
Probiotic Dose (duration) Parameters investigated Reference 
Nile tilapia    
B. amyloliquefaciens 10
8
 CFU g
-1
 (99 days) ↑ SLys, SOD, TIg, HAT; ↔ SPro, WBC, 
RBC, HB, HT, Neut, Lymph, Mono 
(Ridha and Azad 2012) 
B. coagulans  10
7
 CFU ml
-1
 (40 days) ↑ SPro, SGlo, SOD, CAT, RBA, MPO; ↔ 
SAlb, A/G, T-AOC, SLys 
(Zhou et al. 2010a) 
B. pumilus 106, 1012 CFU g-1 (2 months) ↑ RBA, WBC, Lymph, Mono; ↓ Neut, 
Eosin; ↔ HT, Baso (dose and duration 
dependent) 
(Aly et al. 2008c) 
B. subtilis 10
7
 CFU g
-1
 (56 days) ↑ RBA, SLys, SBA; ↔ HT (Aly et al. 2008b) 
B. subtilis 106 (84 days) ↓ HT; ↑ SLys, MCHC, Throm, IP; ↔ RBC, 
Hg, MCV, MCH, WBC, Neut, Mono, SGlu, 
SCort, PA 
(Telli et al. 2014) 
B. subtilis 10
7
 CFU ml
-1
 (40 days) ↑ SOD, CAT, RBA; ↔ SPro, SAlb, SGlo, 
A/G, T-AOC, SLys, MPO 
(Zhou et al. 2010a) 
B. subtilis 108 CFU g
-1
 (105 days) ↑ SOD, PA; ↔ SLys, ACA, HAT 
(dependent on developmental stage) 
(Ridha and Azad 2015) 
B. subtilis 108 CFU g
-1
 (84 days) ↑ SLys, ACA, PA; ↔ SOD, HAT (Ridha and Azad 2015) 
B. subtilis + As. oryzae + S. 
cerevisae 
0.5, 1% (28 days) ↑ RBA, HT, Lymph, Mono, SGlu, SCort, 
SAlb; ↓ RBC; ↑↓ Throm; ↔ HB, MCV, 
MCHC, WBC, Neut, SPro, SGlo (dose and 
duration dependent) 
(Iwashita et al. 2015) 
B. subtilis + L. acidophilus 10
7
 CFU g
-1
 (56 days) ↑ HT (dependent on duration), RBA, SLys, 
SBA 
(Aly et al. 2008b) 
B. subtilis + L. acidophilus 108 CFU g
-1
 (105 days) ↑ PA; ↓ SOD; ↔ SLys, ACA, HAT 
(dependent on developmental stage) 
(Ridha and Azad 2015) 
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B. subtilis + L. acidophilus, 
Clostridium butyricum + S. 
cerevisiae  
1% (30 days) ↑ SPro. SLys, LLys, HB, SBA; ↓ RBA; ↔ 
SMLys (dependent on probiotic viability 
and route of administration) 
(Taoka et al. 2006) 
Bactocell PA10 MD (containing P. 
acidilactici) 
108 CFU g
-1
 (63 days) ↔ SLys, TIg, ACA (Shelby et al. 2006) 
Bi. bifidum 105 CFU g
-1
 (98 days) ↓ SAlb, AST; ↔ SPro, SGlo, ALT (Ayyat et al. 2014) 
Bi. bifidum + L. acidophilus + St. 
thermophiles + S. cervisae 
105 CFU g
-1
 (98 days) ↔ SPro, SGlo, ALT, SAlb, AST (Ayyat et al. 2014) 
Bi. bifidum + L. acidophilus + St. 
thermophilus 
105 CFU g
-1
 (98 days) ↔ SPro, SGlo, ALT, SAlb, AST (Ayyat et al. 2014) 
Biogen® (containing B. subtilis & 
B. licheniformis) 
0.1, 0.2, 0.3% (4 months) ↑ WBC, Lymph; ↓ Mono, Eosin (Ali et al. 2010) 
Biogen® (containing B. subtilis & 
B. licheniformis) 
0.3% (98 days) ↑ HB, RBC, HT, WBC, SPro, SAlb, SGlo, 
A/G; ↔ MCV, MCH, MCHC, Throm, 
Lymph, Mono, Neut, Eosin (dependent on 
stocking density) 
(Mehrim 2009) 
Biomate SF-20 (containing E. 
faecium) 
106 CFU g
-1
 (39 days) ↔ SLys, TIg (Shelby et al. 2006) 
Bio-Nutra 200 (containing B. 
subtilis, As. oryzae & yeast) 
0.1, 0.2, 0.3% (150 days) ↑ SPro, SGlo; ↓ SAlb, ALT; ↔ A/G, AST 
(dose dependent) 
(Salem 2010) 
Bioplus 2B (containing B. Subtilis 
& B. licheniformis) 
Exp. I: 106 CFU g
-1
 (39 days) 
Exp. II: 108 CFU g
-1
 (63 
days) 
↔ SLys, TIg (Experiment I): ↔ SLys, TIg, 
ACA (Experiment II) 
(Shelby et al. 2006) 
Biostim (containing L. 
sporogenes*, L. acidophilus, B. 
subtilis, B. licheniformis & S. 
cerevisae) 
108 CFU g
-1
 (84 days) ↑ SLys, ACA, PA; ↔ SOD, HAT (Ridha and Azad 2015) 
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Biostim (containing L. 
sporogenes*, L. acidophilus, B. 
subtilis, B. licheniformis & S. 
cerevisae) + B. subtilis 
108 CFU g
-1
 (84 days) ↑ PA; ↓ ACA; ↔ SLys, SOD, HAT (Ridha and Azad 2015) 
E. faecium 10
7
 CFU ml
-1
(40 days) ↑ ACA, SLys, MPO, RBA; ↔ SPro, SAlb, 
SGlo, A/G 
(Wang et al. 2008) 
HydroYeast Aquaculture® 
(yeast ,L. acidophilus, Bi. longum, 
B. thermophylus & Streptococcus 
faecium*) 
0.5, 0.1, 0.15% (56 days) ↑ RBC, HT, WBC, HB, Spr, SAl, SGl; ↓ 
A/G; ↔ MCV, MCH, MCHC, Throm (dose 
dependent) 
(Mehrim et al. 2014) 
L. acidophilus 10
7
 CFU g
-1
 (56 days) ↑ RBA, SLys, SBA; ↔ HT (Aly et al. 2008b) 
L. acidophilus 108 CFU g
-1
 (105 days) ↑ SOD, PA; ↔ SLys, ACA, HAT 
(dependent on developmental stage) 
(Ridha and Azad 2015) 
L. acidophilus 104 CFU g-1 (98 days) ↓ SAlb; ↔ SPro, SGlo, ALT, AST (Ayyat et al. 2014) 
Lactobacillus sp. 10
8
 CFU g
-1
 (99 days) ↑ SLys, SOD, TIg, HAT; ↔ SPro, WBC, 
RBC, HB, HT, Neut, Lymph, Mono 
(Ridha and Azad 2012) 
L. acidophilus 10
6
 CFU g
-1
 (15 days) ↑ Cyt, TFE (Villamil et al. 2014) 
L. plantarum 10
6
 CFU 
-1
 (30 days) ↑ SPro; ↓ LDH; ↔ SGlu, AST, ALT, Cyt (Abumourad et al. 2013) 
L. plantarum 10
8
 CFU g
-1
 (12 weeks) ↑ Throm, WBC, Lymph; ↔ SGlu, HT, RBC, 
Neut, Mono 
(Jatobá et al. 2011) 
L. plantarum 109 CFU ml-1 (ex vivo) ↑ Cyt, HSP70 (Ren et al. 2013) 
L. rhamnosus 10
10 
CFU g
-1
 (30 days) ↑ IEL, AG, GC, ACA, Cyt, SBA; ↓ IP, 
SLys; ↔ PA, HK-CA 
(Pirarat et al. 2011) 
L. rhamnosus 10
8, 10
10
 CFU g
-1
 (28 days) ↑ ACA; ↔ CA, SLys (Pirarat et al. 2006) 
Lc. lactis 10
7
 CFU ml
-1
 (40 days) ↑ SPro, SGlo, RBA, SLys; ↔ SAlb, A/G (Zhou et al. 2010b) 
Levucell SB 20 (containing S. 
cerevisae) 
108 CFU g
-1
 (63 days) ↔ SLys, TIg, ACA (Shelby et al. 2006) 
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M. luteus 10
7
 CFU ml
-1
 (90 days) ↔ RBC, HB, HT, SGlu, SPro, AST, ALT, 
LDH 
(Abd El-Rhman et al. 2009) 
M. luteus + Pseudomonas sp.  10
7
 CFU ml
-1
 (90 days) ↓ RBC, HT, SPro, AST, ALT, LDH; ↑ 
SGlu; ↔ HB;  
(Abd El-Rhman et al. 2009) 
Organic GreenTM (containing L. 
acidophilus, B. subtilis, 
Saccharomyces & As. oryzae) 
0.1, 0.2% (2 months) ↑ RBA,; ↓ Neut, Eosin; ↔ HT, WBC, 
Lymph, Baso, Mono (dose and duration 
dependent) 
(Aly et al. 2008c) 
P. acidilactici 10
7
 CFU g
-1
 (32 days) ↓ HT; ↑ WBC, SLys; ↔ Hg, RBC, MCV, 
MCH, MCHC, SAlb, SGlo, A/G, SPro, 
ACA, IEL 
(Ferguson et al. 2010) 
P. acidilactici 10
6
 CFU g
-1
 (6 weeks) ↑ Cyt, IEL, Neut, Mono; ↔ HT, Hg, RBC, 
WBC, MCV, MCH, MCHC, SLys, GC, 
Lymph, Throm 
(Standen et al. 2013) 
Ps. fluorescens 108 CFU g-1 (45 days) ↑ RBC, HB, WBC, HT, Lymph, Mono, 
MCHC, SPro, SGlo, SGlu, AST, ALT, LDH; 
↓ MCV, MCH, SAlb 
(Eissa and Abou-El Gheit 
2014) 
Pseudomonas sp.  10
7
 CFU ml
-1
 (90 days) ↓ RBC, HB, HT, SPro, AST, ALT, LDH; ↑ 
SGlu,  
(Abd El-Rhman et al. 2009) 
R. palustris 10
7
 CFU ml
-1
 (40 days) ↑ SOD, CAT, RBA, MPO; ↔ SPro, SAlb, 
SGlo, A/G, T-AOC, SLys 
(Zhou et al. 2010a) 
S. cerevisae 106 CFU g
-1
 (98 days) ↑ AST; ↓ SAlb; ↔ SPro, SGlo, ALT (Ayyat et al. 2014) 
S. cerevisiae 0.025, 0.05, 0.1, 0.2, 0.5% 
(84 days) 
↑ RBC, HB, Ht, SGlu, SLip, SPr, SAl, SGl 
(dose dependent) 
(Abdel-Tawwab et al. 2008) 
S. cerevisiae 0.05, 0.1, 0.2, 0.5% (84 days) ↑ RBC, HB, HT, SGlu, SLip, SPr, BA (dose 
dependent) 
(Abdel-Tawwab 2012) 
St. thermophilus 105 CFU g
-1
 (98 days) ↔ SPro, SGlo, ALT, SAlb, AST (Ayyat et al. 2014) 
Hybrid tilapia   
B. licheniformis 0.1, 0.3% (56 days) ↔ HT (Ng et al. 2014) 
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B. subtilis 105 CFU g-1 (56 days) ↑ Cyt; ↓ HSP70 (He et al. 2013) 
B. subtilis 0.1, 0.3% (56 days) ↑ HT (dose dependent) (Ng et al. 2014) 
Bacillus spp. + Pediococcus spp. 0.1% (56 days) ↔ HT (Ng et al. 2014) 
L. acidophilus 10
5
, 10
7
, 10
9
 CFU g
-1
 (35 
days) 
↑↓ Cyt, HSP70 (dose and time dependent) (Liu et al. 2013) 
L. brevis 10
5
, 10
7
, 10
9
 CFU g
-1
 (35 
days) 
↑↓ Cyt, HSP70 (dose and time dependent) (Liu et al. 2013) 
Galilee tilapia  
S. cerevisiae 1% (6 weeks) ↑ SGlu, SPr, SLip; ↔ Creat, AST, ALT (Abdel-Tawwab et al. 2010) 
Upward facing arrows indicate increasing values whilst downward facing arrows indicate decreasing values. Horizontal arrows indicate no 
change. 
* St. faecium and L. sporogenes have now been reclassified to E. faecium and B. coagulans respectively.
A/G = serum albumin: globulin ratio 
ACA = alternative complement activity 
ALT = alanine aminotransferase 
AST = aspartate aminotransferase 
Baso = basophils 
CAT = catalase 
Creat = creatinine 
Cyt = cytokine expression 
Eosin = eosinophils 
GC = goblet cell 
HAT = haemagglutination titer 
HB = Haemoglobin 
HK-CA = head kidney chemiluminescence 
activity 
HSP70 = heat shcok protein 70 
HT = Haematocrit 
IEL = intraepithelial leucocyte 
IP = index of phagocytosis 
LDH = lactate dehydrogenase 
LLys = liver lysozyme 
Lymph = lymphocytes 
MCH = mean corpuscular haemoglobin 
MCHC = mean corpuscular haemoglobin 
concentration 
MCV = mean corpuscular volume 
Mono = monocytes 
MPO = myeloperoxidase 
Neut = Neutrophils 
PA = phagocytic activity 
RBA = respiratory burst activity 
RBC = red blood cells 
SAlb = serum albumin 
SBA = serum bactericidal activity 
SCort = serum cortisol 
SGlo = Serum globulin 
SGlo = serum globulin 
SGlu = serum glucose 
SLip = serum lipid 
SLys = Serum lysozyme 
SMLys = skin mucus lysozyme 
SOD = superoxide dismutase 
SPro = serum protein 
T-AOC = total antioxidant competency 
TFE = transferrin expression 
Throm = thrombocytes 
TIg = Total immunoglobulins 
WBC = white blood cells
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1.6.6 Probiotic effects on disease resistance 640 
The use of probiotics as biological control agents for disease is fairly well established 641 
in aquaculture (Newaj-Fyzul et al. 2014). Probiotics can provide antagonism towards 642 
pathogens, either directly through competitive mechanisms and the production of inhibitory 643 
substances or indirectly by modulating the hosts own immune system. Numerous researchers 644 
have investigated disease resistance after administering probiotics in tilapia, with many 645 
reporting positive data (Table 1.3). The majority of disease challenge investigations use an 646 
intraperitoneal (IP) injection to administer the pathogen. As Merrifield et al. (2010a) 647 
discussed, this route of infection by-passes one of the possible methods, probiotic competitive 648 
exclusion within the intestine, which could reduce or even prevent the infection in the first 649 
place. In effect, IP challenges demonstrate the effect of probiotics on infected fish, thus it is 650 
likely that probiotics have been undervalued when it comes to assessing disease resistance.   651 
In respect to probiotic investigations in tilapia, most challenge trials have focused on 652 
improving disease resistance against A. hydrophila with some studies reporting lower 653 
cumulative mortality after the application of B. firmus, B. subtilis, Ci. freundii, L. acidophilus, 654 
L. brevis, M. luteus, Pseudomonas sp. and S. cerevisae (Villamil et al. 2014; Abd El-Rhman 655 
et al. 2009; Abdel-Tawwab 2012; Aly et al. 2008b). In hybrid tilapia, L. acidophilus failed to 656 
reduce mortalities whereas L. brevis was capable of reducing mortalities when fish were 657 
exposed to A. hydrophila (Liu et al. 2013). Aly et al. (2008a) demonstrated that whilst B. 658 
firmus conferred limited protection against A. hydrophila, B. pumilus and Ci. freundii 659 
conferred better protection as did a mixture of the three probiotics, as indicated by 660 
significantly higher survival. Other probiotic mixes have been effectively utilised to reduce 661 
mortalities in tilapia upon exposure to A. hydrophila (Iwashita et al. 2015) whilst others 662 
appear to be ineffective (Aly et al. 2008c; Ayyat et al. 2014). 663 
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Aly et al. (2008b) investigated the protective effects of B. subtilis and L. acidophilus, 664 
alone and in combination, against three bacterial pathogens, A. hydrophila, Ps. fluorescens 665 
and St. iniae. Both probiotics, when supplemented singularly, increased the relative level of 666 
protection against all three pathogens. Furthermore, when supplemented together, the 667 
probiotics provided the highest level of protection against each pathogen. B. subtilis, B. 668 
licheniformis, both administered singularly and in combination, have also been used to 669 
provide protection against Streptococcus agalactiae when using an immersion challenge in 670 
hybrid tilapia (Ng et al. 2014).  671 
To the authors’ knowledge, only two studies have investigated the effect of probiotics 672 
on resistance to edwardsiellosis, cause by the aetiological agent Ed. tarda. Protective effects 673 
by L. rhamnosus and a multi-species application consisting of B. subtilis, L. acidophilus, 674 
Clostridium butyricum and S. cerevisae have been demonstrated (Pirarat et al. 2006; Taoka et 675 
al. 2006). Additionally, Taoka et al. compared the administration of probiotics through the 676 
diet, or added to the water supply. Although the cumulative mortality was doubled in the 677 
water supply group when compared to the dietary route, these differences were not significant.  678 
Disease resistance studies in tilapia have primarily focused on the antibacterial effect 679 
of probiotics. There is evidence to suggest that probiotics can be used to protect fish against 680 
non-bacterial pathogens but such information is not yet available in tilapia. In shrimp 681 
(Litopenaeus vannamei), it has been demonstrated that Bacillus sp. can confer protection 682 
against white spot syndrome virus (WSSV) (Li et al. 2009). The protection of rainbow trout 683 
from Ichthyophthirius multifiliis (Ich), an epidermal protozoan parasite, has also been 684 
successful (Pieters et al. 2008). However, B. subtilis and Bacillus cereus were unable to 685 
control parasitic infections by Gyrodactylus spp., Apiosoma spp., Epistylis sp., Ich. multifiliis 686 
or Ambiphyra spp in tilapia (Marengoni et al. 2015). Very little work has been conducted on 687 
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how probiotics could be used to counter fungal insults, nonetheless early evidence suggest 688 
that they may also have antifungal characteristics (Lategan and Gibson 2003; Lategan et al. 689 
2004). Clearly probiotics have the capability of providing protection from bacterial pathogens. 690 
It is not unreasonable to assume therefore that by stimulating the host’s immune system they 691 
can also have a protective effect against other types of pathogen such as viruses, protozoa or 692 
fungi. More research is needed to explore this in all commercially important fish species, 693 
including tilapia. 694 
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Table 1.3: Tilapia studies reporting disease resistance data using challenge trials, based on actual values, after probiotic administration. 695 
Pathogen Probiotic Challenge Observation Reference 
Nile tilapia (O. niloticus) 
A. hydrophila B. subtilis, As. oryzae & S. cerevisae IP injection ↓ Mortality; ↑ RLP (Iwashita et al. 2015) 
A. hydrophila L. acidophilus IP injection ↔ Mortality, RLP (Ayyat et al. 2014) 
A. hydrophila Bi. bifidum IP injection ↔ Mortality, RLP (Ayyat et al. 2014) 
A. hydrophila St. thermophilus IP injection ↔ Mortality, RLP (Ayyat et al. 2014) 
A. hydrophila S. cerevisae IP injection ↔ Mortality, RLP (Ayyat et al. 2014) 
A. hydrophila L. acidophilus, Bi. bifidum & St. thermophilus  IP injection ↔ Mortality, RLP (Ayyat et al. 2014) 
A. hydrophila L. acidophilus, Bi. bifidum,  St. thermophilus 
& S. cerevisae 
IP injection ↔ Mortality, RLP (Ayyat et al. 2014) 
A. hydrophila L. acidophilus IP injection ↓ Mortality (Villamil et al. 2014) 
A. hydrophila L. rhamnosus Oral EI ↓ Intestinal damage ↔ 
Mortality 
(Ngamkala et al. 2010) 
A. hydrophila M. luteus IP injection ↓ Mortality; ↔ Morbidity (Abd El-Rhman et al. 2009) 
A. hydrophila Pseudomonas sp. IP injection ↓ Mortality; ↔ Morbidity (Abd El-Rhman et al. 2009) 
A. hydrophila Ps. fluorescens IP injection ↓ Mortality (Eissa and Abou-El Gheit 
2014) 
A. hydrophila S. cerevisae IP injection ↓ Mortality (Abdel-Tawwab et al. 2008) 
A. hydrophila S. cerevisae IP injection ↓ Mortality (Abdel-Tawwab 2012) 
A. hydrophila B. subtilis IP injection ↑ RLP (Aly et al. 2008b) 
A. hydrophila L. acidophilus IP injection ↑ RLP (Aly et al. 2008b) 
A. hydrophila B. subtilis & L. acidophilus IP injection ↑ RLP (Aly et al. 2008b) 
A. hydrophila B. pumilus  IP injection ↔ RLP (Aly et al. 2008c) 
A. hydrophila Organic Green (containing L. acidophilus, B. 
subtilis, Saccharomyces & As. oryzae) 
IP injection ↔ RLP (Aly et al. 2008c) 
A. hydrophila B. pumilus IP injection ↓ Mortality (Aly et al. 2008a) 
A. hydrophila B. firmus IP injection ↓ Mortality (Aly et al. 2008a) 
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A. hydrophila Ci. freundii IP injection ↓ Mortality (Aly et al. 2008a) 
A. hydrophila B. pumilus, B. firmus & Ci. freundii IP injection ↓ Mortality (Aly et al. 2008a) 
Ed. tarda B. subtilis, L. acidophilus, Ch. butyricum & S. 
cerevisae 
IP injection ↓ Mortality (Taoka et al. 2006) 
Ed. tarda L. rhamnosus IP injection ↓ Mortality (Pirarat et al. 2006) 
Flavobacterium 
columnare 
B. subtilis IM injection ↓ Mortality (Mohamed and Ahmed 
Refat 2011) 
Proteus vulgaris B. subtilis IP injection ↓ Mortality  (Ridha and Azad 2015) 
P. vulgaris L. acidophilus IP injection ↔ Mortality (Ridha and Azad 2015) 
P. vulgaris B. subtilis + L. acidophilus IP injection ↓ Mortality (Ridha and Azad 2015) 
P. vulgaris Biostim (containing L. sporogenes*, L. 
acidophilus, B. subtilis, B. licheniformis & S. 
cerevisae) 
IP injection ↓ Mortality (Ridha and Azad 2015) 
P. vulgaris Biostim (containing L. sporogenes*, L. 
acidophilus, B. subtilis, B. licheniformis & S. 
cerevisae) + B. subtilis 
IP injection ↓ Mortality (Ridha and Azad 2015) 
Ps. fluorescens L. plantarum IP injection ↔ Mortality (Abumourad et al. 2013) 
Ps. fluorescens B. subtilis IP injection ↑ RLP (Aly et al. 2008b) 
Ps. fluorescens L. acidophilus IP injection ↑ RLP (Aly et al. 2008b) 
Ps. fluorescens B. subtilis & L. acidophilus IP injection ↑ RLP (Aly et al. 2008b) 
St. iniae                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             B. subtilis, As. oryzae & S. cerevisae IP injection ↓ Mortality; ↑ RLP (Iwashita et al. 2015)
St. iniae Biomate SF-20 (containing E. faecium) IP injection ↔ Mortality (Shelby et al. 2006) 
St. iniae Bioplus 2B (containing B. Subtilis & B. 
licheniformis) 
IP injection ↔ Mortality (Shelby et al. 2006) 
St. iniae Levucell SB 20 (containing S. cerevisae) IP injection ↔ Mortality (Shelby et al. 2006) 
St. iniae Bactocell PA10 MD (containing P. 
acidilactici) 
IP injection ↔ Mortality (Shelby et al. 2006) 
St. iniae B. subtilis IP injection ↑ RLP (Aly et al. 2008b) 
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St. iniae L. acidophilus IP injection ↑ RLP (Aly et al. 2008b) 
St. iniae B. subtilis & L. acidophilus IP injection ↑ RLP (Aly et al. 2008b) 
Hybrid tilapia 
A. hydrophila L. acidophilus Immersion ↔ Mortality (Liu et al. 2013) 
A. hydrophila L. brevis Immersion ↓ Mortality (Liu et al. 2013) 
St. agalactiae B. subtilis Immersion ↓ Mortality (Ng et al. 2014) 
St. agalactiae B. licheniformis Immersion ↓ Mortality (Ng et al. 2014) 
St. agalactiae Bacillus sp. & Pediococcus sp. Immersion ↓ Mortality (Ng et al. 2014) 
Upward facing arrows indicate increasing values whilst downward facing arrows indicate decreasing values. Horizontal arrows indicate no 696 
change. Green arrows represent improvements whilst red indicates a negative effect on disease resistance. 697 
* Now reclassified as B. coagulans698 
IP = Intraperitoneal injection 
EI = Endotracheal intubation 
IM = Intramuscular injection 
RLP = Relative level of protection 
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1.6.7 Probiotic effects on reproduction 699 
The numbers of fish which have been domesticated are increasing continuously, due 700 
to the development of aquaculture for food fish and ornamental aquaculture. One of the 701 
biggest limiting factors in the expansion of aquaculture is broodstock management and 702 
ultimately obtaining sufficient fry which satisfy both quantity and quality assurances. Only a 703 
single study has investigated how probiotics may affect the reproductive success in tilapia 704 
(Mehrim et al. 2014). The authors fed male and female tilapia with diets containing 705 
increasing levels (0, 5, 10 and 15 g kg
-1
) of Hydroyeast Aquaculture
®
, a commercial probiotic 706 
containing L. acidophilus, Bi. longhun, B. thermophylus, St. faecium (now reclassified as E. 707 
faecium) and yeast together with oligosaccharides and enzymes. After eight weeks, there 708 
were increasing concentrations of testosterone and progesterone in male and female serum, 709 
respectively, with increasing dose of probiotic. The highest dose resulted in significantly 710 
higher testes weight and gonad somatic index (GSI) in male fish. Further to this, the sperm 711 
count was elevated in the highest dose when compared to the control treatment (179.33 ± 712 
7.96 vs 91.00 ± 2.51 x 10
6
 ml
-1
, respectively). These sperm also showed significantly higher 713 
viability, lower abnormalities and lower mortalities when compared with the control 714 
treatment. Although GSI and egg number remained unchanged in female fish, the ova weight 715 
was significantly higher in the treatments receiving 5 and 10 g kg
-1
 of the probiotic, with the 716 
highest being observed in 10 g kg
-1
. Consequently, absolute and relative fecundity were both 717 
improved in these probiotic groups, when compared to the control treatment, with the highest 718 
in tilapia receiving 10 g kg
-1
.  719 
Probiotics, including B. subtilis and L. rhamnosus, have also been reported to improve 720 
reproductive success in poecilid fish, zebrafish and killifish (Ghosh et al. 2007; Gioacchini et 721 
al. 2010; Gioacchini et al. 2011; Lombardo et al. 2011; Chitra and Krishnaveni 2013).  722 
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1.7 Conclusions 723 
The literature available provides clear evidence that a wide range of probiotic 724 
applications can improve growth performance, modulate intestinal microbiota and intestinal 725 
morphology, stimulate the host’s immune system and improve reproductive success. 726 
Furthermore they can improve disease resistance, rendering them an important asset in the 727 
battle to reduce the usage of antibiotics and other chemical therapies. Their efficacy depends 728 
on a number of factors including probiotic and host species, dosage, duration of feeding, 729 
mode of supplementation and environmental conditions and these may provide a basis for 730 
varied results. Future work must focus on applications of probiotics, their industrial scale up 731 
as well as determining the mechanisms involved which will enable aqua culturists to use 732 
probiotics to their maximum efficiency.  733 
 734 
1.8 Thesis aims and objectives 735 
The overall aim of this project was to investigate the effects of probiotics (specifically 736 
those in AquaStar
®
 Growout) on tilapia health and growth performance, define the 737 
mechanisms behind their action and investigate how its efficacy is affected by its application 738 
regime (i.e. monospecies vs multispecies), dosage and feeding regime.  739 
As discussed in section 1.3, the establishment of the ‘normal’ microbiota and the 740 
intimate relationships with the host epithelial cells effectively primes regulatory mechanisms 741 
and stimulates gastric development. However, these populations in fish are unstable and are 742 
often subject to microbial imbalance, termed ‘dysbiosis’. Probiotics offer an attractive 743 
approach to fortify these intestinal microbial communities. Despite this, many studies fail to 744 
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assess the impact of probiotics on resident communities within the intestine. This is true for 745 
tilapia and consequently it will be one of the objectives of the current study.  746 
It is also essential that the host is capable of mounting an immune response were it to 747 
come into contact with a pathogen. Therefore, determining the effects of probiotics on the 748 
localised mucosal immune response as well as the systemic immune response is key. In 749 
addition, the probiotic effect on growth performance will also be assessed.  750 
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Chapter 2. General materials and methods 1 
 2 
The following analytical protocols were fundamental to the experimental analyses and 3 
were carried out as described unless otherwise stated. Other methods relating to specific trials 4 
(including specific dietary formulations) are described in the relevant chapters. Unless 5 
otherwise specified, all materials, chemicals and reagents were supplied by Sigma-Aldrich 6 
and Fisher Scientific Ltd. Where the work was carried out in Plymouth, all experimental 7 
work involving fish was carried out under the Home Office project license # 30/2644 and 8 
personal license # 30/9994. Approval was also given by Plymouth University ethical 9 
committee.  10 
 11 
2.1 Aquarium facilities and water quality management 12 
 Trial’s I and II were conducted in system ‘A’ (Fig 2.1) at the Aquatic Animal 13 
Nutrition and Health Research Aquarium, Plymouth University. The system is a closed 14 
freshwater recirculation system (RS) with a total holding capacity of ~6,000 l. The 15 
experimental set-up comprised of 18 x 150 l square fibreglass tanks, each provided with 16 
recirculated aerated water at a rate of ~450 l h
-1
. An automated 12 h light: 12 h dark 17 
photoperiod was maintained throughout both trials. The system received a constant 30 l h
-1
 18 
flow of groundwater to maintain losses from evaporation and reduce the potential build-up of 19 
nitrogenous wastes. All system and water parameters were monitored and maintained to meet 20 
the requirements of tilapia. Biological filtration was provided by a submerged filter bed. All 21 
nitrogenous wastes were monitored weekly using an automated discrete analyser (DR 2800, 22 
HACH) and cuvettes for ammonia, nitrite and nitrate (LCK 304, 341 and 340, respectively). 23 
The build-up of these compounds (as well as background probiotic levels) was prevented by 24 
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weekly water changes (~20% of system volume). Acceptable levels were considered to be < 25 
0.1mg l
-1
, < 1.0 mg l
-1
 and <50 mg l
-1
 for ammonia, nitrite and nitrate, respectively. Regular 26 
water changes also aided to minimise the build-up of background probiotic levels. Prior to 27 
water entering the biological filter, plastic brushes trapped and removed any solid waste; 28 
these were rinsed weekly to prevent the build-up of solid waste.  29 
System pH, dissolved oxygen (DO) and temperature were monitored daily (HQ40d, 30 
HACH). Temperature was kept at 28 ± 1 °C by an inline thermostatically controlled inline 31 
heater (Elecro) and pH was maintained at 6.8 ± 1. To maintain the appropriate pH, sodium 32 
bicarbonate (NaHCO3) was added to buffer the system water. DO was maintained > 6 mg l
-1
 33 
saturation by a supply of compressed air delivered to each individual tank via air stones and 34 
perforated pipes to the sump water.  35 
 36 
 37 
Figure 2.1: System A located at Plymouth University. Water circulates between 38 
experimental tanks (A), through mechanical (B) and biological (C) filtration and is held in the 39 
sump (D) before returning to experimental tanks.  40 
C B 
A 
D 
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2.2 Experimental fish 41 
Three separate batches of tilapia (Oreochromis niloticus) were obtained to conduct 42 
three trials. For trial’s I and II, fish were sourced from Fishgen Ltd. and for Trial III, fish 43 
were sourced from Manit Farm, Thailand. Upon arrival, water quality parameters (DO, pH, 44 
temperature and ammonia) were taken and a gradual water change took place using water 45 
from the holding system. After an hour, fish were transferred to fibreglass tanks and allowed 46 
to recover in darkness for 12 hr before light levels were slowly increased to full light intensity. 47 
Fish were fed a commercial feed with a pellet size suitable for the size of fry ad libitum for a 48 
minimum of six weeks of acclimation until random distribution into tanks for experimental 49 
trials. Grading (± 1.5% biomass) and provisional distribution into experimental tanks 50 
occurred 3-4 days prior to the experimental start date in order to reduce stress. Prior to fish 51 
sampling (apart from weighing) all tilapia were euthanized by overdose (300 mg l
-1
) of 52 
tricaine methane sulfonate (MS222; Pharmaq, Fordingbridge, UK). Once fish had lost 53 
equilibrium they were concussed, followed by destruction of the brain. 54 
 55 
2.3 Feed and weighing 56 
For trial’s I and II, iso-nitrogenous and iso-lipidic diets were formulated using 57 
Feedsoft Professional
®
 to meet the known requirements of tilapia (NRC 2011). Dry 58 
ingredients were mixed in small batches to ensure a homogenous mix before adding the oil 59 
and warm water in a Hobart food mixer (Hobart Food Equipment, Australia) to form a 60 
consistency suitable for cold press extrusion (PTM P6 extruder, Plymouth, UK). The 61 
lyophilised probiotic powder was added, at the levels described in the respective chapters, at 62 
the expense of corn starch. Diets were dried for 24 hours in an air convection oven set to 63 
44°C, broken up by hand to form suitably sized pellets and kept in air tight refrigerated 64 
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containers prior to use. Probiotic viability was checked using selective media (de Man, 65 
Rogosa and Sharpe (MRS) media, Bacillus selective agar and Slanetz and Bartley (S & B) 66 
media for Lactobacillus/Pediococcus, Bacillus and Enterococcus spp., respectively) by 67 
spread plating 10-fold serial dilutions and calculating the colony forming units (CFU) by 68 
counting statistically viable plates (i.e. 20-200 colonies). Control diets were also plated out on 69 
each medium to ensure they were void of probiotic contamination. Fresh diets were produced 70 
at the trial midpoint to ensure high probiotic viability. Specific dietary information can be 71 
found in each experimental chapter. 72 
All fish were weighed at day zero and fed relative to percentage biomass per day in 73 
four equal rations at ~0830, 1130, 1430 and 1730. Daily feed was adjusted on a weekly basis 74 
by batch weighing following a 24 hr starvation period. Feed input was adjusted accordingly 75 
in the event of any mortality.  76 
 77 
2.4 AOAC protocols for proximate analysis 78 
In each trial, diets and, where indicated, fish carcasses were analysed for proximate 79 
analysis for the determination of moisture, ash, protein, lipid and gross energy according to 80 
AOAC (1995) protocols. Unless specified samples were analysed in triplicate. 81 
 82 
2.4.1 Moisture 83 
For the determination of moisture content, samples were weighed into metal dishes 84 
(for diet samples) or aluminium foil trays (fish carcasses) and left uncovered in a drying oven 85 
set to 105°C for 72 hours, or until a constant weight was achieved. Samples were transferred 86 
to a desiccator to cool and re-weighed. The difference in weight accounted for the loss of 87 
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moisture, calculated by ((WW – DW)/ WW)*100, where WW is wet weight (g) and DW is 88 
dry weight (g). 89 
 90 
2.4.2 Ash 91 
For the determination of ash (total inorganic or mineral) content, samples (~ 500mg) 92 
were weighed into pre-weighed porcelain crucibles and placed in a muffle furnace at 550°C 93 
for 8 hours until a light grey ash results, or until a constant weight was achieved. Samples 94 
were cooled in a desiccator and re-weighed. The difference in weight accounted for the loss 95 
of organic material, calculated by ((SR – CW)/ SW)*100, where SR is sample residue 96 
(including crucible weight, g), CW is crucible weight (g) and SW is the original sample 97 
weight (g) 98 
 99 
2.4.3 Protein 100 
For the determination of protein content, the Kjeldahl method was used. Samples (~ 101 
200mg) were weighed in triplicate and transferred to Kjeldahl tubes. Two blank (empty) 102 
tubes were processed alongside to account for any influence the reagents may have on the 103 
procedure. Two samples of acetanilide standard were used (theoretical nitrogen content = 104 
10.36%) which corrected for the efficiency of nitrogen extraction. Additionally, two samples 105 
of casein were used to validate nitrogen and protein content. Catalyst tablets were added to 106 
each tube and 10ml of 0.1M sulphuric acid was added. Tubes were transferred to the 107 
Kjehldahl digestion block where they were heated to 105°C for 15 min, 225°C for 60 min and 108 
380°C for 45 min. Samples were then distilled and titrated using the Vadopest 40 automatic 109 
distillation unit (Gerhadt Laboratory Instruments, Bonn, Germany). Total nitrogen was 110 
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determined by ((ST – BT)* 0.2* 1.4007)/ SW where ST is the sample titre (ml), BT is the 111 
blank titre (ml), SW is sample weight (mg), 0.2 is the acid molarity and 1.4007 is the 112 
molecular weight of nitrogen. The efficiency was corrected for using results from acetanilide 113 
samples and crude protein was calculated by TN*6.25 where TN is total nitrogen and 6.25 is 114 
the conversion factor. 115 
 116 
2.4.4 Lipid 117 
For the determination of lipid content, samples (~ 3g) were weighed into extraction 118 
thimbles, plugged with cotton wool and placed into a beaker, along with anti-bumping 119 
granules. One hundred and forty millilitres of petroleum ether was added and the beakers 120 
placed on the Soxtherm unit (Gerhadt Laboratory Instruments, Bonn, Germany), heated to 121 
150°C for 30 minutes, rinsed for 45 minutes and left to evaporate. Beakers were left in a 122 
fume hood for at least an hour until all traces of solvent had dissolved and the beaker was re- 123 
weighed. The increase in beaker weight accounted for the extracted lipid, calculated by (LW/ 124 
SW)*100 where LW is lipid weight (determined from weight increase of beaker, g) and SW 125 
is the original sample weight (g).  126 
 127 
2.4.5 Gross energy 128 
For the determination of gross energy, samples (~ 1g) were analysed in duplicate 129 
using a bomb calorimeter (Parr 1356, Parr Instruments Co, USA). Samples were crafted into 130 
pellets and placed inside a stainless steel container and filled with 30 bar (435 PSI) of oxygen. 131 
The sample was electronically ignited through a wired connection inside the decomposition 132 
vessel and burned. The heat created by the combustion process was transferred to the 133 
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surrounding water jacket where it was detected. This information was then converted into the 134 
energy value of the sample. 135 
 136 
2.5  Growth performance and nutrient utilisation 137 
Growth performance and feed utilisation were assessed by final weight (FW), net 138 
weight gain (NWG), percentage increase (%I), feed intake (FI), specific growth rate (SGR), 139 
feed conversion ratio (FCR), protein efficiency ratio (PER) and survival. Calculations were 140 
carried out using the formulae: NWG = FW - IW; %I = ((100/ IW)*FW) - 100; SGR = 100 141 
((ln FW - ln IW)/T); FCR = FI/WG and PER = WG/PI, where FW = final weight (g), IW = 142 
initial weight (g), T = duration of feeding (days), FI = feed intake, WG = wet weight gain (g) 143 
and PI = protein ingested. 144 
 145 
2.6 Fish dissection 146 
Fish were dissected under aseptic conditions. After ensuring fish were healthy by 147 
means of an external examination, the entire outside of the fish was wiped down with 70% 148 
ethanol. A single cut was made with a sterile scalpel along the underside of the fish to open 149 
the peritoneal cavity. The entire gastrointestinal tract was carefully removed, trimmed of any 150 
lipid and the mid-intestine was identified by dividing the intestine into three equal portions. 151 
Digesta was isolated from the entire mid- intestine. Where mucosa samples were needed (as 152 
appropriate) the samples were taken from the most anterior part of the mid-intestine.  153 
 154 
 155 
___________________________________________________________________ Chapter 2 
 
70 
 
2.7  Histological appraisal 156 
2.7.1  Sample preparation and paraffin wax embedding 157 
Fish were sampled for histological appraisal of the mid-intestine. Tissue samples 158 
(approximately 5mm) were fixed in 10% buffered formalin and transferred to 70% ethanol 159 
after 48 hours. Samples were then dehydrated in a series of graded ethanol concentrations 160 
(Leica TP1020) prior to embedding. Samples were embedded in paraffin wax (Leica EG1150 161 
H) with two or three samples per wax block. 162 
 163 
2.7.2  Sectioning and staining 164 
Multiple sections (5µm thick) were cut from each wax block with a microtome 165 
(Leica), mounted onto glass slides and left to dry overnight. Sections were then cleared with 166 
histolene and rehydrated in a series of graded ethanol concentrations. Multiple sets of 167 
sections were stained with haematoxylin and eosin (H & E) or Alcian Blue-PAS (AB- PAS) 168 
and dehydrated once again. Sections were cleared in histolene and mounted with a cover slip 169 
and DPX mountant. Sections were examined and photographed using a Leica digital 170 
microimaging device (DMD108, Leica Microsystems) and analysed using Image J v1.46r 171 
(National Institute of Health, USA). Intraepithelial leucocytes (IEL’s) and goblet cells were 172 
quantified over a standardised distance of 100 µm from sections stained with H & E and AB- 173 
PAS, respectively. In both cases, typically 10 folds were measured per section and averaged. 174 
To measure perimeter ratio (arbitrary units, AU), the external and inside (lumen) perimeter of 175 
each section was measured and was calculated by LP/ EP where LP = lumen perimeter (µm) 176 
and EP = external perimeter (µm) (Fig 2.2). 177 
 178 
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Figure 2.2: Procedure for measuring intestinal perimeter ratio. Images of transverse cross 179 
sections are loaded into Image J (A), transformed to 8-bit (B) and the threshold function 180 
applied to obtain a black and white image (C). Image was adjusted to account for sectioning 181 
artefacts (D) and both the lumen and external perimeter measured (yellow).  182 
 183 
 184 
 185 
A 
D C 
B 
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2.8  Microbiological analyses 186 
2.8.1 Culture dependent analyses 187 
Samples were serially diluted with phosphate buffered saline (PBS) and 20μl was 188 
spotted onto duplicate MRS, S&B and Bacillus selective agar using the Miles and Misra 189 
method (Miles et al. 1938) to assess bacterial populations. Tryptone soya agar (TSA) was 190 
used to determine the total aerobic heterotrophic bacterial populations. Plates were incubated 191 
for 72 hours at 28°C and CFU were calculated by counting colonies from statistically viable 192 
plates (between 3-30 colonies). Representative subsets of probiotics were identified by using 193 
16S rRNA gene sequence analysis by using primers 27F (5’- AGA GTT TGA TCC TGG 194 
CTC AG -3’) and 1492R (5’- GGT TAC CTT GTT ACG ACT T -3’). DNA was obtained 195 
from the colonies as described in section 2.8.2. The following reagents were included in each 196 
PCR tube: 1 µl primer 27F and 1491R (50 pmol µl-1; Eurofins MWG, Germany), 25 µl 197 
MyTaq
TM
 Red Mix (Bioline), 20 µl DEPC treated water (Ambion) and 3 µl DNA template. 198 
Thermal cycling was conducted using a Techne TC-312 thermal cycler (Techne, 199 
Staffordshire, UK) under the following conditions: 94°C for 10 min, then 35 cycles at 94°C 200 
for 30 s, 53°C for 30 s and 72°C for 60 s. PCR products were checked on an agarose gel 201 
(section 2.9), cleaned (QIAquick PCR Purification Kit, Qiagen) and then sequenced by 202 
GATC-Biotech (Konstanz, Germany). The nucleotide sequence was submitted to a BLAST 203 
search to retrieve the closest known alignment identities for the partial 16S rRNA sequences. 204 
 205 
2.8.2 DNA extraction from individual colonies 206 
In order to obtain DNA from colonies, microLYSIS
®
 Plus (Microzone
µ
, Sussex, UK) 207 
was used as a DNA release buffer according to manufacturer’s instructions. One colony was 208 
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mixed with 20µl of microLYSIS
®
 and placed in a thermal cycler TC-512 (Techne, 209 
Staffordshire, UK) under the following conditions: 65°C for 15 min, 96°C for 2 min, 65°C 210 
for 4 min, 96°C for 1 min, 65°C for 1 min, 96°C for 30 s and a final hold at 10°C. Extracted 211 
DNA was used as a template for immediate PCR or stored at -20°C for later use.  212 
 213 
2.8.3 DNA extraction from intestinal samples 214 
DNA was extracted from digesta and mucosa samples using the QIAmp
®
 Stool Mini 215 
Kit (Qiagen) with some modifications to the manufacturer’s instructions. All centrifugation 216 
steps were performed at maximum speed (17,000 g) in a benchtop microcentrifuge and all 217 
reagents were molecular grade. To 100-200mg of sample, 500µl lysozyme (50 mg ml
-1
 in TE 218 
buffer) was added for 30 min at 37°C to enhance the lysis of Gram positive bacteria. Samples 219 
were homogenised and 700 µl of buffer ASL was added, vortexed for 1 min and heated for 5 220 
min at 90°C. Samples were vortexed again and centrifuged for 1 min. Eight hundred µl of the 221 
supernatant was transferred to a new microcentrifuge tube and half an Inhibitex tablet was 222 
added and immediately vortexed to remove PCR inhibitors. After leaving to stand for 1 min 223 
at room temperature samples were centrifuged for 3 min. The supernatant was transferred to a 224 
new microcentrifuge tube and then centrifuged again for a further 3 min. Three hundred and 225 
fifty µl of the supernatant was added to 15 µl of proteinase K (Qiagen) in a fresh 226 
microcentrifuge tube followed by 350 µl of buffer AL. Samples were mixed by inversion and 227 
incubated for 60 min at 56°C. Samples were cooled to room temperature before clean-up 228 
using the phenol- chloroform method. An equal amount (350 µl) of chloroform and phenol 229 
were added, mixed by inversion and centrifuged for 10 min. The supernatant (~650 µl) was 230 
mixed with an equal volume of chloroform in a new microcentrifuge tube and mixed by 231 
inversion before another 10 min centrifugation. The supernatant (~600 µl) was transferred to 232 
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a new microcentrifuge tube and 0.8 volumes (~480 µl) of ice cold isopropanol added and 233 
mixed by inversion. After 15 min standing at room temperature samples were centrifuged for 234 
10 min. The supernatant was discarded and the pellet washed twice with 500 µl of cold 70% 235 
ethanol. The pellet was left to air dry for 5 min and suspended overnight in 30 µl of water. 236 
Samples were checked for quality and quantity of DNA with a Nanodrop 2000 (Thermo 237 
Scientific, Wilmington, USA) and the integrity was checked using a 1.5% agarose gel 238 
(described in section 2.9). Samples were either used immediately for downstream procedures 239 
or stored at -20°C until further use.  240 
 241 
2.8.4 DGGE 242 
PCR amplification of the 16S rRNA V3 region was conducted using the reverse 243 
primer P2 (5'- ATT ACC GCG GCT GCT GG -3') and the forward primer P3 (5'-244 
CGCCCGCCGCGCGCGGCGGGCGGGGCGGGGGCACGGGGGGCCTACGGGAGGCA245 
GCAG-3') (Muyzer et al. 1993). The following reagents were included in each PCR tube: 1 246 
µl primer P2 and P3 (50 pmol µl-1; Eurofins MWG, Germany), 15 µl MyTaqTM Red Mix 247 
(Bioline), 11 µl DEPC treated water (Ambion) and 2 µl DNA template. Thermal cycling was 248 
conducted using a TC-512 thermal cycler (Techne, Staffordshire, UK) under the following 249 
conditions: 94°C for 10 min, then 35 cycles at 94°C for 30 s, 53°C for 30 s and 72°C for 60 s. 250 
DGGE was performed using a DCode Universal Mutation Detection System (Bio-Rad 251 
laboratories, Italy). Nineteen µl of PCR product from each sample was run on a 10% 252 
polyacrylamide gel (16 cm × 16 cm × 1 mm) with a denaturing gradient of 40–60% (where 253 
100% denaturant is 7 M urea and 40% formamide). The gel was run at 65 V for 16.5 h at 254 
60 °C in 1 × TAE buffer (66 mM Tris, 5 mM Na acetate, 1 mM EDTA). Visualization of the 255 
DGGE bands was achieved with SYBR Gold staining (Molecular Probes, Eugene, OR, USA). 256 
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The gel was scanned in a Bio-Rad universal hood II (Bio-Rad laboratories, Italy) and 257 
optimized for analyses by enhancing contrast and greyscale. Bands of interest were identified 258 
based on high peak intensities and/ or the co-migration of known probiotic bands. DNA was 259 
eluted from excised bands into 20µl of molecular grade water and stored at 4°C. This served 260 
as a template for PCR using the same primers and thermal cycling conditions minus the –GC 261 
clamp for sequence analysis. PCR products were cleaned (QIAquick PCR Purification Kit; 262 
Qiagen) and sequenced by GATC-Biotech (Konstanz, Germany). The nucleotide sequences 263 
were submitted to a BLAST search to retrieve the closest known alignment identities for the 264 
partial 16S rRNA sequences. 265 
 266 
2.8.5 High-throughput sequencing 267 
PCR amplification of the 16S rRNA V1-V2 region was conducted using primers 268 
338R (5'- GCW GCC WCC CGT AGG WGT -3') and 27F (5'- AGA GTT TGA TCM TGG 269 
CTC AG -3'). The following reagents were included in each PCR tube: 0.5 µl primer 338R 270 
and 27F (50 pmol µl-1; Eurofins MWG, Germany), 15 µl MyTaqTM Red Mix (Bioline), 19.5 271 
µl DEPC treated water (Ambion) and 4 µl DNA template (diluted 1/10 in molecular grade 272 
water). Thermal cycling was conducted using a TC-512 thermal cycler (Techne, Staffordshire, 273 
UK) under the following conditions: initial denaturation at 94°C for 7 min, then 10 cycles at 274 
94°C for 30 s, touchdown of 1°C per cycle from 62 -53°C for 30 s and 72°C for 30 s. A 275 
further 20 cycles were performed at 94°C for 30 s, 53°C for 30 s and 72°C for 30 s before a 276 
final extension for 7 min at 72°C. PCR products were purified (QIAquick PCR Purification 277 
Kit; Qiagen) and quantified using a Qubit
®
 2.0 Fluorometer (Invitrogen). Prior to sequencing 278 
the amplicons were assessed for fragment concentration using an Ion Library Quantitation Kit 279 
(Life Technologies
TM
, USA), then concentrations were adjusted to 26 pM. Amplicons were 280 
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attached to Ion Sphere Particles using Ion PGM Template OT2 400 kit (Life Technologies
TM
, 281 
USA) according to the manufacturer’s instructions. Multiplexed sequencing was conducted 282 
using Ion Xpress Barcode Adapters and a 318
TM
 chip (Life Technologies
TM
, USA) on an Ion 283 
Torrent Personal Genome Machine (Life Technologies
TM
, USA). Sequences were binned by 284 
sample and filtered within the PGM software to remove low quality reads. Data were then 285 
exported as FastQ files. 286 
All phylogenetic analyses were performed after the removal of low quality scores (Q 287 
< 20) with FASTX-Toolkit (Hannon Laboratory, USA). Sequences were concatenated and 288 
sorted by sequence similarity into a single fasta file, denoised and analysed using the QIIME 289 
1.8.0 pipeline (Caporaso et al. 2010b). The USEARCH quality filter pipeline (Edgar 2010) 290 
was used to filter out putative chimeras and noisy sequences and carry out operational 291 
taxonomic unity (OTU) picking on the remaining sequences. The taxonomic affiliation of 292 
each OTU was determined based on the Greengenes database (DeSantis et al. 2006) using the 293 
RDP classifier (Wang et al. 2007) clustering the sequences at 95% similarity with a 0.80 294 
confidence threshold and a minimum sequence length of 300 base pairs. Non-chimeric 295 
OTU’s were identified with a minimum pairwise identity of 95% and representative 296 
sequences from the OTU’s were aligned using PyNAST (Caporaso et al. 2010a). Single 297 
representative sequences belonging to probiotic genera, for both probiotic and control 298 
treatments (if applicable), were further identified using the NCBI nucleotide collection 299 
database BLAST. 300 
To estimate bacterial diversity, the number of OTUs present in the samples was 301 
determined and a rarefaction analysis was performed by plotting the number of observed 302 
OTUs against the number of sequences. Additionally, Good’s coverage, Shannon-Wiener 303 
(diversity) and Chao1 (richness) indices were calculated. The similarities between the 304 
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microbiota compositions of the intestinal samples were compared using weighted principal 305 
coordinate analysis (PCoA) and unweighted pair group method with arithmetic mean 306 
(UPGMA). 307 
 308 
2.9  Agarose gel electrophoresis 309 
Prior to downstream procedures, for quality control, all DNA extractions and PCR 310 
products were run on a 1.5% agarose gel. RNA samples were run on a 1% agarose gel. 311 
Agarose was mixed with 1 x tris acetate- EDTA (TAE) buffer and dissolved using a 312 
microwave. After cooling the TAE/ agarose mix to 50°C, SYBR Safe DNA stain was added 313 
(1 µl per 10 ml of molten agarose gel). Unless otherwise specified gels were poured and ran 314 
in an electrophoresis tank for 40 min at 90 V. Typically 5 µl of sample and 5 µl of Hyper 315 
ladder IV (Bioline, London, UK) were used and ran alongside positive and negative controls 316 
to check the amplicon length, as well as any possible contamination.  317 
 318 
2.10  Haemato-immunology  319 
Blood was taken from the caudal vein using a 25 gauge needle and a 1 ml syringe. 320 
Whole blood was collected in a 1.5 ml microcentrifuge tube where it was used for 321 
downstream procedures. Whole blood was left at 4°C overnight and then centrifuged at 3, 322 
600 g for 10 minutes. Serum was removed and stored at -80°C until use.  323 
 324 
 325 
 326 
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2.10.1  Haematocrit 327 
Whole blood haematocrit levels were determined by the microhaematocrit method. 328 
Whole blood was collected in heparinised capillary tubes and subsequently centrifuged at 10, 329 
500 g for 5 minutes (Centurion haematocrit centrifuge). Haematocrit was measured as 330 
percentage packed cell volume (% PCV) using a Hawksley haematocrit reader.  331 
 332 
2.10.2  Haemoglobin 333 
The colorimetric determination of blood haemoglobin was determined using 334 
Drabkin’s cyanide- ferricyanide solution. Five µl of whole blood was mixed with 1 ml of 335 
Drabkin’s reagent (1: 200). Each sample was transferred to a cuvette and measured using a 336 
spectrophotometer at 540 nm. Drabkin’s solution (with no blood) was used to blank the 337 
spectrophotometer. The sample haemoglobin levels were determined from a standard curve 338 
of lyophilised haemoglobin porcine powder and calculated using the formula HC = ((OD540 – 339 
0.0002)/ 6.6137) x 200 where HC = haemoglobin concentration (g dl
-1
), OD540 = absorbance 340 
of sample at 540 nm, 0.0002 = y- intercept of standard curve, 6.6137 = slope of standard 341 
curve and 200 = dilution factor.  342 
In addition to calculating the haematocrit and haemoglobin, the mean corpuscular 343 
haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC) and mean 344 
corpuscular volume (MCV) was calculated according to the following formulae: MCH (pg)= 345 
(HB*10)/RBC, MCHC (g dl
-1
) = (HB*100)/HT and MCV (fL) = (HT*10)/RBC where HB = 346 
haemoglobin concentration (g dl
-1
), RBC = red blood cells (10
6
) and HT = haematocrit 347 
(%PCV).  348 
 349 
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2.10.3 Blood cell counts 350 
Twenty µl of whole blood was added to 980 µl of Dacie’s solution (1/50 dilution; 1 351 
ml formaldehyde, 3.13g trisodium citrate, 0.1 g brilliant cresyl blue and made up to 100 ml 352 
with distilled water) and gently mixed to disperse the blood cells. Ten µl of sample was 353 
placed on a Neubauer haemocytometer in order to enumerate erythrocytes and leucocytes. 354 
 355 
2.10.4  Serum lysozyme activity 356 
Serum lysozyme activity was analysed using the turbidometric method, based on the 357 
lysis on Micrococcus lysodeikticus. Briefly, 10 µl of serum was added to 190 µl of 0.04 M 358 
sodium phosphate buffer (pH 6.2) containing lyophilised M. lysodeikticus at 0.2 mg ml
-1
. 359 
Reactions were carried out on a 96- well plate in triplicate. Columns 11 and 12 contained 360 
200µl of sodium phosphate buffer/ M. lysodeikticus mix (no serum) as a background control. 361 
The reduction in absorbance at 540 nm was measured at one and six minutes in a microplate 362 
reader (VersaMax
TM
, Molecular Devices) at 25°C. A unit of lysozyme activity was defined as 363 
a decrease in absorbance of 0.001 per minute.  364 
 365 
2.11 Gene expression 366 
 Gene expression samples were immediately immersed in RNALater at a ratio of 1:4 367 
and stored at -80°C until use. Total RNA was extracted using TRIzol (Invitrogen) according 368 
to the manufacturer’s protocol. Briefly, tissue was placed in 1 ml Trizol reagent, vortexed for 369 
30 s and left to stand at room temperature to ensure the complete dissociation of the 370 
nucleotide complexes. Two hundred µl of chloroform was added, vortexed for 15 s and left to 371 
stand at room temperature for 10 min. Samples were then centrifuged at 12,000 g for 15 min. 372 
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The aqueous supernatant was removed and 500 µl of isopropanol was added, mixed by 373 
pipetting and left to stand for 10 min. Samples were then centrifuged at 14,000 g for 15 min. 374 
This isopropanol step was repeated twice to ensure the maximum amount of RNA was 375 
precipitated. The supernatant was removed and the pellet washed by adding 1 ml of 70% 376 
ethanol. Samples were gently mixed by pipetting and then centrifuged at 10,000 g for 10 377 
minutes. This 70% ethanol step was repeated twice to ensure all impurities were removed. 378 
The ethanol was removed and pellets left to stand for 5 min before the addition of 30 µl of 379 
nuclease free water. All centrifugation steps were conducted at 4°C. RNA concentration and 380 
purity was measured spectophotometrically (NanoDrop Technologies) and RNA integrity 381 
was checked by running each sample on a 1% agarose gel (Section 2.9). Any samples with 382 
DNA contamination (as indicated by a smear) were cleaned using RNeasy MiniElute Cleanup 383 
Kit (Qiagen). RNA samples were subsequently stored at -80°C until use.  384 
A total concentration of 1 µg of RNA was used for cDNA synthesis using iScript 385 
cDNA Synthesis Kit (BioRad) according to manufacturer’s instructions. Primer efficiencies 386 
were determined using serial 1/10 dilutions of pooled cDNA and resulting plots of Ct versus 387 
the logarithmic cDNA input, using the equation E = 10(
-1/slope
). Duplicate PCR reactions (total 388 
reaction volume = 7.5 µl) were set on a 384-well plate and each reaction consisted of 2 µl of 389 
cDNA (1/10 dilution), 3.75 µl of 2X concentrated SYBR Green Supermix (Biorad), 0.225 µl 390 
of each forward and reverse primers (0.3 µM) and 1.3 µl of DEPC treated water (Ambion). 391 
All quality control measures and RT-reactions were carried out according to the MIQE 392 
guidelines (Bustin et al. 2009). The thermal profile for all reactions were 10 min at 95°C and 393 
then 40 cycles of 15s at 95°C and 60s at 60°C. Fluorescence monitoring occurred at the end 394 
of each cycle and melt curve analyses were performed in all cases to check for a single peak. 395 
GAPDH, β-actin and EF1-α were all assessed as reference genes in order to standardise the 396 
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results by eliminating variation in mRNA and cDNA quantity and quality. Reference genes 397 
were imported into GeNorm to assess the optimal number, and choices of reference genes. 398 
 399 
2.12  Statistical analyses 400 
All statistical analyses were carried out using Statgraphics Centurion XVI (Warrenton, 401 
VA, USA). All data are presented as mean ± standard deviation. All data were checked for 402 
normality and equality of variance using Kolmogorov- Smirnov and Bartlett’s test, 403 
respectively. Typically a one way analysis of variance (ANOVA) and post hoc Tukey’s 404 
honest significant difference (HSD) were used for the analysis where normal assumptions 405 
were met. Where data violated these conditions after log transformation, a Kruskal- Wallis 406 
test was used. Differences between treatments were then determined using a Mann-Whitney 407 
U-test. All percentage data were transformed using arcsine function prior to statistical 408 
analysis. In all cases significance was accepted at P < 0.05. DGGE banding patterns were 409 
transformed into presence/ absence matrices based on band peak intensities (Quantity One
®
 410 
version 4.6.3, Bio-Rad Laboratories, CA, USA). Band intensities were measured (Quantity 411 
One
®
 1-D Analysis Software, Bio-Rad Laboratories Ltd., Hertfordshire, UK) and ecological 412 
parameters (number of OTU’s, species richness, evenness and diversity) were analysed using 413 
Primer V6 software (PRIMER-E Ltd, Ivybridge, UK). Margalef species richness (d), Pielous 414 
evenness (J’) and Shannon’s diversity index (H’) were used to assess species richness, 415 
evenness and diversity respectively as determined by the following formulae: d = (N-1)/ 416 
log(n), J’ = H’/ log(N) and H’ = -Ʃ (pi (ln pi) where N = the total number of OTU’s,  n = total 417 
number of individuals (total intensity units) and pi = the proportion of the total number of 418 
individuals in the ith species. High-throughput sequencing data were uploaded to Stamp 419 
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v2.0.8 and t-test/ ANOVA with post hoc Tukey’s HSD were used to distinguish differences at 420 
each taxonomic level. 421 
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Chapter 3. Effect of monospecies and multispecies probiotic 1 
supplementation on growth performance, intestinal microbiota and health 2 
in tilapia, Oreochromis niloticus 3 
 4 
Abstract 5 
The intestinal microbiota, intestinal morphology, health status and growth 6 
performance of tilapia (O. niloticus) were investigated. Tilapia (55.03 ± 0.44g) were fed 7 
either a control diet (CON) or a probiotic diet containing B. subtilis (BS-5), Lactobacillus 8 
reuteri (LR-5), P. acidilactici (PA-5) singularly or as a multispecies probiotic (with the 9 
addition of E. faecium; AQ-5) for eight weeks. Culture dependent analyses revealed higher 10 
levels of allochthonous and autochthonous lactic acid bacteria, enterococci and Bacillus spp. 11 
in the corresponding probiotic treatment in all cases except for LR-5. After eight weeks, the 12 
compositional dissimilarity of the microbial profiles in treatment CON was significantly 13 
different to all probiotic treatments. Equally microbial communities in AQ-5 replicates were 14 
significantly dissimilar to those of LR-5 and PA-5. High-throughput sequencing revealed that 15 
the AQ-5 treatment significantly reduced the number of operational taxonomic units and 16 
species richness when compared to CON. Significantly higher proportions of reads belonging 17 
to Proteobacteria and Cyanobacteria were detected in the CON group whereas AQ-5 fish 18 
displayed a significantly higher abundance of reads assigned to the Firmicutes (which 19 
accounted for >99% of reads). Bacillus, Cetobacterium and Mycobacterium were the 20 
dominant genera in the digesta of control fish whereas Bacillus, Enterococcus and 21 
Pediococcus were the largest constituents in AQ-5 fish. After four weeks significantly higher 22 
goblet cells were observed in the mid-intestine of tilapia in AQ-5 when compared with 23 
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groups BS-5 and LR-5. AQ-5 acted to recruit a larger abundance of intra-epithelial leucocytes 24 
when compared with treatments CON and LR-5. The supplementation of AQ-5 in tilapia 25 
diets also led to higher microvilli density and a higher absorptive surface area index when 26 
compared with CON. These data suggest that both mono- and multispecies probiotics can 27 
modulate the intestinal microbiota, but the multispecies probiotic showed higher efficacy 28 
when modulating the intestinal morphology and mucosal barrier function in tilapia. 29 
 30 
3.1 Introduction 31 
Considering that a probiotic can exert its benefits via the modulation of the 32 
microbiome, there is a paucity of comprehensive data detailing these changes in fish. This is 33 
essential information given that the intestinal microbiomes of fish are diverse and complex 34 
communities (Romero et al. 2014). As with mammals, the intestinal microbiota of fish have 35 
important functions in host metabolism, mucosal development and maturation, nutrition, 36 
immunity and disease resistance (Rawls et al. 2004; Bates et al. 2006; Round and Mazmanian 37 
2009).  38 
It has been shown in higher vertebrates that multispecies probiotic mixes may have an 39 
advantage over monospecies probiotics (Timmerman et al. 2004). This is particularly true if 40 
the probiotic species have complimentary modes of action, thus providing synergism and 41 
conferring multiple benefits to the host. Evidence suggests that this may also be true for fish. 42 
After individual challenge trials with A. hydrophila and Ps. fluorescens, Aly et al. (2008) 43 
reported higher survival after one month in tilapia fed a dietary formulation containing B. 44 
subtilis and L. acidophilus, compared to a control diet, or diets containing the probiotic 45 
strains individually. The authors also observed that the viability of L. acidophilus in feed was 46 
significantly enhanced when mixed with B. subtilis. This suggests that diets containing more 47 
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than one probiotic may have the potential for prolonged shelf life, an important consideration 48 
for industrial scale up. 49 
Most research concerning probiotic supplementation in tilapia has focused on growth 50 
and immunostimulation with less attention on intestinal microbiology. Of the 187 finfish 51 
probiotic studies discussed in recent reviews (Carnevali et al. 2014; Lauzon et al. 2014; 52 
Merrifield and Carnevali 2014), only 74 (40%) investigated aspects of the gut microbiota. In 53 
tilapia only 26% (8 from 31) of the studies investigated the intestinal microbiota. These 54 
studies primarily used culture based approaches to enumerate probiont levels, and to a lesser 55 
extent total cultivable communities. More recently DGGE has been used to assess the impact 56 
of a limited number of probiotics on the tilapia intestinal microecology (Zhou et al. 2009; 57 
Ferguson et al. 2010; Liu et al. 2013). This limited understanding of the changes in the gut 58 
microbiota prevents a full depiction of the mechanisms of action of probiotics in fish, and 59 
ultimately prevents the optimisation of probiotic application strategies. 60 
Therefore the focus of this study was to assess the effects of monospecies and 61 
multispecies probiotic supplementation on the gastrointestinal (GI) microbiota of tilapia using 62 
a multidisciplinary approach, including high-throughput sequencing. In addition, the impact 63 
of the probiotic on the host intestinal morphology, growth performance and haemato-64 
immunology were assessed. 65 
 66 
3.2 Materials and methods 67 
3.2.1 Experimental design and diet preparation 68 
Six-hundred and eighty tilapia were randomly distributed to 17 150L fibreglass tanks 69 
(40 fish per tank; average weight = 55.03 ± 0.44g). Five diets were formulated and pelleted as 70 
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described in Section 2.3 (Tables 3.1 and 3.2). Experimental treatments were as follows: 71 
control (basal diet; n = 4), B. subtilis (basal diet + B. subtilis; n = 3), L. reuteri (basal diet + L. 72 
reuteri; n = 3), P. acidilactici (basal diet + P. acidilactici; n = 3) and Aquastar
®
 Growout 73 
(basal diet + Aquastar
®
 Growout; n = 4). All probiotics were supplied as a lyophilised 74 
product and added to the dry ingredients at 5 g kg
-1
 at the expense of corn starch. All diets 75 
were assessed for proximate composition as described in section 2.4 (Table 3.2). The 76 
probiotic trial was conducted for eight weeks followed by an 18 day post cessation of 77 
probiotic feed to assess probiont persistence in the intestine.  78 
 79 
3.2.2 Growth performance and carcass composition 80 
Prior to the start of the trial, twelve fish were pooled into four samples to assess initial 81 
proximate carcass composition as described in section 2.4. At the end of the experimental 82 
period two fish per tank were pooled into a single sample (thus n = 4 for CON and AQ-5 and 83 
n = 3 for BS-5, LR-5 and PA-5) to assess final proximate carcass composition. Growth 84 
performance and feed utilisation were assessed by means of final weight, weight gain, feed 85 
intake, protein efficiency ratio (PER), feed conversion ratio (FCR), specific growth rate 86 
(SGR), percentage increase and survival as described in section 2.5. Additionally, condition 87 
factor was assessed after four and eight weeks of experimental feeding by the formula 88 
(100*FW)/FL
3
 where FW = final weight (g) and FL = final length (cm).  89 
 90 
3.2.3 Intestinal microbiological analyses 91 
At weeks four and eight, two fish per tank were euthanized, dissected and digesta and 92 
intestinal mucosa isolated as described in section 2.6. 93 
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3.2.4 Culture dependent analyses 94 
Digesta from the mid-intestine was isolated and pooled by tank (thus n = 4 for CON 95 
and AQ-5 and n = 3 for BS-5, LR-5 and PA-5) to assess allochthonous populations. Mucosa 96 
samples were removed aseptically, washed with sterile PBS, homogenised and processed on 97 
an individual fish basis (thus n = 8 for CON and AQ-5 and n = 6 for BS-5, LR-5 and PA-5) to 98 
assess autochthonous bacterial populations. Culture dependent analyses were carried out 99 
according to section 2.8.1 to assess allochthonous and autochthonous bacterial populations. In 100 
addition to being spotted onto TSA, MRS, S+B and Bacillus selective agar, samples were 101 
also spotted onto Aeromonas selective agar to enumerate aeromonads.  102 
 103 
Table 3.1: Codes assigned to dietary treatments. 104 
Code Dietary treatment 
CON Control (basal diet) 
BS-5 Basal diet supplemented with B. subtilis at 5g kg
-1
 
LR-5 Basal diet supplemented with L. reuteri at 5g kg
-1
 
PA-5 Basal diet supplemented with P. acidilactici at 5g kg
-1
 
AQ-5 Basal diet supplemented with AquaStar
®
 Growout at 5g kg
-1
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Table 3.2: Dietary formulation and proximate composition (%). 105 
 CON BS-5 LR-5 PA-5 AQ-5 
Fishmeal
a 
 5.00 5.00 5.00 5.00 5.00 
Soyabean meal
b 
 37.26 37.26 37.26 37.26 37.26 
Corn Starch
c
  24.28 23.78 23.78 23.78 23.78 
Lysamine pea protein
d 
 5.00 5.00 5.00 5.00 5.00 
Glutalys
d 
 10.00 10.00 10.00 10.00 10.00 
Wheat bran
e
 10.00 10.00 10.00 10.00 10.00 
Fish oil 4.50 4.50 4.50 4.50 4.50 
Corn oil  2.95 2.95 2.95 2.95 2.95 
Vitamin & mineral premix
f
  0.50 0.50 0.50 0.50 0.50 
CMC-binder
c
  0.50 0.50 0.50 0.50 0.50 
B. subtilis
g
  0.00 0.50  0.00 0.00 0.00 
L. reuteri
g
 0.00 0.00 0.50 0.00 0.00 
P. acidilactici
g
 0.00 0.00 0.00 0.50 0.00 
AquaStar
®
 Growout
g
 0.00 0.00 0.00 0.00 0.50 
Proximate composition (% as fed basis) 
Dry matter 92.89 93.48 91.98 92.78 92.10 
Protein 35.74 36.61 35.59 35.82 35.88 
Lipid 10.06 9.63 9.74 9.63 9.82 
Ash 4.19 4.36 4.19 4.18 4.22 
Energy (MJ kg
-1
) 20.06  19.81 19.63 19.95 20.00 
a Herring meal LT92 – United Fish Products Ltd., Aberdeen, UK.  
b 
Biomar (48% protein), Denmark.  
c 
Sigma- Aldrich Ltd., UK.  
d 
Roquette Frêres, France. 
e
 Natural wheat bran, Holland & Barrett, UK.   
f 
Premier nutrition vitamin/mineral premix contains: 121 g kg
-1
 calcium, 
Vit A 1.0 μg kg-1, Vit D3 0.1 μg kg-1, Vit E (as alpha tocopherol acetate) 
7.0 g kg
-1
, Copper (as cupric sulphate) 250 mg kg
-1
, Magnesium 15.6 g kg
-
1
, Phosphorous 5.2 g kg
-1
.  
g 
Biomin Holding GmbH, Industriestrasse 21, 3130 Herzogenburg, Austria. 
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3.2.5 Culture independent analyses 108 
DNA was extracted from digesta samples using the QIAamp Stool Mini Kit (Qiagen) 109 
as described in section 2.8.3. DGGE was carried out on all digesta samples (thus n = 4 for 110 
CON and AQ-5 and n = 3 for BS-5, LR-5 and PA-5) to assess allochthonous bacterial 111 
communities as described in section 2.8.4. Additionally, high-throughput sequencing was 112 
conducted on replicates from CON and AQ-5 treatments (n = 4) as described in section 2.8.5 113 
to assess allochthonous microbial populations.  114 
 115 
3.2.6 Persistence of the probiotics after reverting to non-supplemented diet 116 
After reverting the AQ-5 treated fish to the control diet at the end of the trial (eight 117 
weeks), two fish per tank from treatment AQ-5 (n = 4) were sampled on days 3, 6, 9 and 18 118 
post cessation of AquaStar
®
 Growout feeding to assess probiotic persistence within the 119 
intestine by DGGE analysis as described in section 2.8.4. Presumptive probiotic bands were 120 
excised for sequence analysis as described in section 2.8.4. 121 
 122 
3.2.7 Intestinal histology 123 
At weeks four and eight, two fish per tank (thus n = 8 for CON and AQ-5 and n = 6 124 
for BS-5, LR-5 and PA-5) were sampled for histological appraisal of the mid-intestine as 125 
described in section 2.7. In addition to the perimeter ratio, the abundances of IEL’s and 126 
goblet cells, the mucosal fold length was calculated by measuring each mucosal fold within a 127 
section and calculating the average.  128 
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After eight weeks, the mid-intestines from two fish per tank from CON and AQ-5 129 
treatments (n = 8) were sampled for scanning electron microscopy (SEM) and transmission 130 
electron microscopy (TEM). Intestinal samples (ca. 2mm
2
) were washed in 1% S-131 
carboxymethyl-L-cysteine for 30 s (SEM only) to remove any mucus before fixation in 2.5% 132 
glutaraldehyde in sodium cacodylate buffer (0.1M pH 7.2). Fixative was removed from SEM 133 
samples and rinsed twice with 0.1M sodium cacodylate buffer each for 15 min. Samples were 134 
then dehydrated in increasing ethanol concentrations (30%, 50%, 70%, 90%) for 15 min each 135 
followed by 100% ethanol twice for a further 15 min each. Samples were critically point 136 
dried with ethanol as the intermediate fluid and CO2 as the transition fluid (Emitech K850, 137 
Kent, UK). Dried samples were mounted onto aluminium stubs and gold sputter coated 138 
(Emitech K550, Kent, UK). Samples were screened with a JSM 6610 LV (Jeol, Tokyo, Japan) 139 
SEM.  140 
TEM samples were rinsed twice with sodium cacodylate buffer (0.1M pH 7.2) for 15 141 
min each in order to remove the fixative. Samples were secondary fixed for 1 hr with osmium 142 
tetroxide (OsO4) and then rinsed again with sodium cacodylate buffer (0.1M pH 7.2) to 143 
remove residual OsO4. Samples were dehydrated in increasing ethanol concentrations (30%, 144 
50%, 70%, 90%) each for 15 min and then twice in 100% ethanol for 15 min each. Over the 145 
course of 72 hr the ethanol was replaced with resin by means of decreasing the ethanol: resin 146 
ratio by submersion in 30% resin (70% ethanol) for 24 hr, 50% resin (50% ethanol) for a 147 
minimum of 5 hr, 70% resin (30% ethanol) for a minimum of 5 hr and finally 100% resin for 148 
24 hr. Samples were placed in beem capsules and polymerisation of the resin occurred 149 
overnight at 70°C. Blocks were trimmed and semi-thin sections (0.5 µm) were cut with a 150 
glass knife and stained with methylene blue for initial examination under a light microscope. 151 
Ultrathin sections (~90 nm) were cut with a diamond knife and placed on copper grids. 152 
Sections were stained with saturated uranyl acetate solution for 30 min, rinsed with distilled 153 
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water and post-stained with Reynold lead citrate for 30 min. Stained sections were screened 154 
with a JEN 1400 (Jeol, Tokyo, Japan) TEM.  155 
All electron micrographs were analysed with Image J 1.46r (National Institute of 156 
Health, USA) to determine microvilli length and density. SEM micrographs were taken at x 157 
20,000 magnification. Micrographs were converted to 8-bit and then the foreground was 158 
differentiated from the background (space between microvilli) by the threshold function. The 159 
ratio of white/ black (i.e. foreground/ background) was calculated to give a microvilli density 160 
measure (arbitrary units; AU). Typically, 10 representative micrographs were analysed per 161 
sample. In order to measure microvilli length, 10 random well orientated microvilli 162 
(magnification x 20,000) were measured per micrograph, with typically 10 images analysed 163 
per sample.  164 
An absorptive surface area index (ASI) was calculated according to the following: 165 
ASI = microvilli length (µm) x microvilli density (AU) x intestinal perimeter ratio (AU). 166 
 167 
3.2.8 Haemato-immunological analyses 168 
Blood sampling was conducted after four and eight weeks of experimental feeding. 169 
Haematocrit, haemoglobin, MCV, MCH, MCHC, blood cell counts and lysozyme (n = 8 for 170 
CON and AQ-5 and n = 6 for BS-5, LR-5 and PA-5) was investigated as described in section 171 
2.10.  172 
 173 
3.2.9 Statistical analyses 174 
Statistical analyses were carried out as described in section 2.12.  175 
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3.3 Results 176 
3.3.1 Growth performance and carcass composition 177 
Growth performance was assessed after eight weeks of feeding experimental diets by 178 
means of final weight, weight gain, feed intake, PER, FCR, SGR, percentage increase, 179 
condition factor and survival (Table 3.3). Tilapia in all groups showed excellent survival (> 180 
99%) and good appetites resulting in positive growth performance. There were no significant 181 
differences in final weight, weight gain, percentage increase or feed intake between any of 182 
the treatments (P > 0.05). SGR’s also remained unaffected (P > 0.05) by dietary treatment, 183 
ranging from 1.27 in BS-5 and AQ-5 to 1.35 in CON and LR-5. Furthermore there were no 184 
significant differences in feed utilisation parameters, FCR and PER (P > 0.05). The condition 185 
factor remained unaffected by treatments at both four and eight weeks of experimental 186 
feeding (P > 0.05). There were no significant differences observed in moisture, ash, lipid or 187 
protein content between dietary treatments (Table 3.4). 188 
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Table 3.3: Growth performance of tilapia after eight weeks of feeding experimental diets. 189 
 CON BS-5 LR-5 PA-5 AQ-5 
Initial weight (g fish
-1
) 55.04 ± 1.29 54.63 ± 0.94 55.02 ± 0.78 55.83 ± 0.52 54.61 ± 0.93 
Average weight (g fish
-1
 ) 103.93 ± 3.96 99.42 ± 0.94 104.07 ± 5.48 102.09 ± 6.76 99.43 ± 8.41 
Weight gain (g fish
-1
) 48.89 ± 2.93 44.79 ± 1.88 49.05 ± 4.76 46.26 ± 6.46 44.82 ± 7.97 
Feed intake (g fish
-1
) 70.13 ± 2.38 68.70 ± 0.92 70.44 ± 1.96 69.76 ± 2.16 68.10 ± 2.52 
PER 0.91 ± 0.05 0.78 ± 0.06 0.90 ± 0.11 0.84 ± 0.15 0.82 ± 0.18 
FCR (g g
-1
) 1.44 ± 0.04 1.58 ± 0.08 1.47 ± 0.12 1.51 ± 0.15 1.57 ± 0.25 
SGR (% day
-1
) 1.35 ± 0.05 1.27 ± 0.06 1.35 ± 0.09 1.28 ± 0.13 1.27 ± 0.17 
Percentage increase (%) 188.79 ± 4.17 182.06 ± 4.87 189.06 ± 7.59 182.80 ± 11.10 181.99 ± 14.04 
Condition factor (week 4) 1.91 ± 0.07 1.91 ± 0.11 1.90 ± 0.13 1.93 ± 0.03 1.90 ± 0.16 
Condition factor (week 8) 2.02 ± 0.10 1.99 ± 0.09 2.13 ± 0.29 1.94 ± 0.06 1.98 ± 0.20 
Survival (%) 100 ± 0.00 99.17 ± 1.18 99.17 ± 1.18 100.00 ± 0.00 100.00 ± 0.00 
 190 
Table 3.4: Proximate carcass composition (%) of tilapia of tilapia prior to ‘Day 0’ and after eight weeks of feeding experimental diets.  191 
 Initial fish CON BS-5 LR-5 PA-5 AQ-5 
Moisture 70.74 ± 1.32 66.66 ± 0.91
 
67.05 ± 1.34
 
66.24 ± 0.60 68.43 ± 1.74
 
65.72 ± 0.45
 
Ash*  14.54 ± 1.07 11.46 ± 0.84 11.88 ± 0.87 11.61 ± 0.82 12.14 ± 0.97 11.75 ± 0.43 
Lipid*  28.67 ± 1.92 34.15 ± 2.59 30.42 ± 3.38 32.43 ± 2.64 29.48 ± 2.83 32.88 ± 1.52 
Protein*  53.63 ± 1.81 53.09 ± 1.77 54.03 ± 3.00 52.10 ± 1.25 53.90 ± 2.49 53.38 ± 2.03 
* Parameters reported as percentage of dry weight matter.  192 
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3.3.2 Culture dependent analyses 193 
The effect of dietary probiotics on the allochthonous and autochthonous intestinal 194 
bacteria was determined using culture based methods at weeks four and eight. TVC, LAB, 195 
Bacillus spp., enterococci and Aeromonas spp. counts were enumerated on TSA, MRS, 196 
Bacillus spp., S & B and Aeromonas spp. selective media, respectively (Table 3.5). No 197 
significant differences were observed in TVC levels between the treatments at either time 198 
points, with allochthonous levels ranging between log 6-8 CFU g
-1
 and autochthonous levels 199 
slightly lower, between log 5-7 CFU g
-1
. There were no differences between allochthonous or 200 
autochthonous Aeromonas levels at either time point. 201 
After feeding experimental diets, there was significantly higher allochthonous LAB 202 
counts in treatments PA-5 and AQ-5 when compared with CON and LR-5 (week four) and 203 
also BS-5 after eight weeks. After four weeks the lowest autochthonous LAB levels were 204 
observed in the CON fed fish, these were significantly lower than all probiotic treatments. At 205 
both time points the administration of B. subtilis in the diets caused a significantly higher 206 
abundance of autochthonous LAB in the intestine of tilapia when compared to CON and LR-207 
5 groups. At week four significantly higher autochthonous LAB levels were found in PA-5, 208 
but in both cases there was no significant differences between this treatment and AQ-5.  209 
At week eight, significantly higher allochthonous Bacillus levels were present in AQ-210 
5 and BS-5 fed fish when compared to CON, LR-5 and PA-5. Autochthonous Bacillus were 211 
not detected in CON, LR-5 or PA-5. Significantly higher levels were present in treatments 212 
BS-5 and AQ-5 when compared to the remaining three treatments, but there were no 213 
differences between these two groups.  214 
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After four weeks of feeding experimental diets, both allochthonous and 215 
autochthonous enterococci were not detected in BS-5, LR-5 or PA-5. Despite detectable 216 
levels being present in the digesta of the CON fed fish this was not significantly different 217 
between the monospecies probiotic groups due to their presence in only one out of four 218 
replicates. In both cases, there was a significantly higher abundance of enterococci in AQ-5 219 
when compared to all other treatments. After eight weeks, enterococci were not detected in 220 
CON, PA-5 (allochthonous) and LR-5 (autochthonous). Both allochthonous and 221 
autochthonous levels were significantly higher in the AQ-5 treatment when compared to all 222 
other treatments.  223 
Subsets of these isolates were confirmed as the probiotics administered by 16S rRNA 224 
sequence analysis and by migration to the same position as known B. subtilis, E. faecium, L. 225 
reuteri and P. acidilactici samples in a DGGE. 226 
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Table 3.5: TVC (log CFU g
-1
) of allochthonous (D) and autochthonous (M) heterotrophic aerobic bacteria, LAB, Bacillus spp., enterococci, and 227 
Aeromonas spp. in the GI tract of tilapia fed experimental diets after four and eight weeks of feeding experimental diets. 228 
 Week Region CON BS-5 LR-5 PA-5 AQ-5 
TVC 4 D 5.81 ± 2.22 7.72 ± 0.24 7.50 ± 0.15 7.71 ± 0.36 8.17 ± 0.67 
  M 5.85 ± 1.02 6.64 ± 0.80 7.10 ± 1.23 6.37 ± 1.40 6.30 ± 0.48 
 8 D 7.36 ± 0.61 6.31 ± 1.47 5.55 ± 1.89 6.64 ± 0.49 6.93 ± 0.53 
  M 4.93 ± 0.65 4.58 ± 0.66 4.40 ± 0.77 4.93 ± 0.76 4.78 ± 0.43 
LAB 4 D 3.34 ± 0.37
a 
4.20 ± 1.10
ab 
3.01 ± 0.44
a 
6.58 ± 1.37
b 
5.91 ± 0.98
b 
  M 2.80 ± 0.20
a
 4.39 ± 0.86
b
 3.09 ± 0.36
c
 4.84 ± 0.89
d 
4.64 ± 1.45
bcd
 
 8 D 3.10 ± 0.69
a 
3.07 ± 0.52
a
 3.22 ± 0.73
a 
6.62 ± 0.84
b
 6.41 ± 0.73
b 
  M n.d
a 
2.78 ± 0.18
b 
n.d
a 
4.66 ± 0.41
c 
4.43 ± 0.99
c 
Bacillus spp. 4 D * * * * * 
  M * * * * * 
 8 D 2.66 ± 0.77
a
 4.03 ± 1.55
ab
 3.47 ± 0.32
a 
2.51 ± 0.71
a 
6.39 ± 0.45
b 
  M n.d
a 
2.60 ± 1.33
b 
n.d
a 
n.d
a 
4.79 ± 1.15
b 
Enterococci 4 D 2.78 ± 0.13
a 
n.d
a 
n.d
a 
n.d
a 5.09 ± 1.51b 
  M n.d
a 
n.d
a 
n.d
a 
n.d
a 
5.09 ± 1.51
b 
 8 D n.d
a 
2.89 ± 0.16
b
 3.11 ± 0.59
b 
n.d
a 
6.28 ± 0.16
c 
  M n.d
a 
2.77 ± 0.15
b
 n.d
a 
n.d
a 
4.20 ± 0.92
c 
Aeromonas spp. 4 D 4.34 ± 1.32 4.94 ± 1.16 4.45 ± 0.34 5.22 ± 1.09 4.27 ± 1.57 
  M 3.03 ± 0.53 3.56 ± 0.99 3.88 ± 1.61 4.05 ± 0.87 3.67 ± 0.93 
 8 D 6.89 ± 0.37 6.95 ± 0.26 6.38 ± 0.17 6.51 ± 0.48 6.07 ± 0.31 
  M 4.63 ± 0.92 4.51 ± 0.67 4.22 ± 0.53 4.55 ± 0.72 3.79 ± 0.75 
n.d. = not detected 229 
a, b
 Different superscripts indicate a significant difference (P < 0.05) 230 
* no data available due to overgrowth on the plates.  231 
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3.3.3 DGGE 232 
The influence of dietary probiotics on the intestinal microbial diversity in tilapia was 233 
investigated using DGGE at weeks four and eight. At both time points, DGGE analysis 234 
revealed complex microbial communities in both treatments with samples containing 21-32 235 
OTU’s (Figs 3.1 and 3.2). Bands of interest were isolated from DGGE fingerprints at both 236 
time points and sequencing results confirmed the presence of each four probiotic species in 237 
the respective treatments (Tables 3.6 and 3.7). Table 3.8 displays the microbial ecological 238 
parameters derived from the DGGE fingerprints from fish fed experimental diets for four 239 
weeks. There were no differences in number of OTU’s present, species richness and diversity 240 
or SIMPER analyses (P > 0.05). Furthermore, ANOSIM indicated no significant pairwise 241 
dissimilarity’s between dietary treatments. Similarly, the number of OTU’s, species richness 242 
and diversity and SIMPER analyses remained unaffected after eight weeks of probiotic 243 
supplementation (P > 0.05; Table 3.9). However, after eight weeks, ANOSIM revealed a 244 
significant dissimilarity between the intestinal microbiota from fish in CON when compared 245 
with BS-5, LR-5, PA-5 and AQ-5 (dissimilarity = 39.37, 40.64, 39.65 and 52.09 respectively; 246 
P = 0.03). The intestinal microbiota from AQ-5 was also significantly dissimilar to that of 247 
LR-5 and PA5 (dissimilarity = 45.83 and 52.59 respectively; P = 0.03) and approaching 248 
significance when compared to that of BS-5 (dissimilarity = 46.37; P = 0.06). There were no 249 
further differences between the other pairwise comparisons (Table 3.9).   250 
 251 
 252 
 253 
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 254 
Figure 3.1: Dendrogram representing the relatedness of the microbial communities in the 255 
digesta of tilapia after four weeks of feeding with experimental diets. DGGE fingerprints 256 
below represent amplified products from the V3 region of the samples which correspond to 257 
those used in the dendrogram. Band numbers correspond to those in Table 3.6. 258 
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 259 
Figure 3.2: Dendrogram representing the relatedness of the microbial communities in the 260 
digesta of tilapia after eight weeks of feeding with experimental diets. DGGE fingerprints 261 
below represent amplified products from the V3 region of the samples which correspond to 262 
those used in the dendrogram. Band numbers correspond to those in Table 3.7. 263 
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Table 3.6: Excised bands from DGGE after four weeks (Fig 3.1) of feeding experimental 264 
diets with their closest known alignment identities retrieved from NCBI-BLAST searches.  265 
Band Closest relative Identity (%) Treatments/ replicates 
present 
1 Lactobacillus aviarius 99 CON(3/3) 
 PA-5 (2/2) 
 BS-5 (3/3) 
 LR-5 (3/3) 
 AQ-5 (3/3) 
2 Enterococcus faecium 100 CON(2/3) 
 PA-5 (0/2) 
 BS-5 (1/3) 
 LR-5 (3/3) 
 AQ-5 (3/3) 
3 Lactobacillus sakei 98 CON(3/3) 
 PA-5 (2/2) 
 BS-5 (3/3) 
 LR-5 (3/3) 
 AQ-5 (3/3) 
4 Pediococcus acidilactici 92 CON(3/3) 
 PA-5 (2/2) 
 BS-5 (1/3) 
 LR-5 (3/3) 
 AQ-5 (3/3) 
5 Lactobacillus frumenti  100 CON(3/3) 
 PA-5 (2/2) 
 BS-5 (3/3) 
 LR-5 (3/3) 
 AQ-5 (3/3) 
6 Lactobacillus reuteri 95 CON(1/3) 
 PA-5 (0/2) 
 BS-5 (2/3) 
 LR-5 (3/3) 
 AQ-5 (1/3) 
7 Bacillus subtilis 100 CON(3/3) 
 PA-5 (2/2) 
 BS-5 (3/3) 
 LR-5 (2/3) 
 AQ-5 (3/3) 
8 Mycobacterium sp. 100 CON(3/3) 
 PA-5 (0/2) 
 BS-5 (3/3) 
 LR-5 (3/3) 
 AQ-5 (3/3) 
 266 
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Table 3.7: Excised bands from DGGE after eight weeks (Fig 3.2) of feeding experimental 267 
diets with their closest known alignment identities retrieved from NCBI-BLAST searches.  268 
Band Closest relative Identity (%) Treatments/ 
replicates present 
9 Lactobacillus aviarius 100 CON(4/4) 
 PA-5 (3/3) 
 BS-5 (3/3) 
 LR-5 (3/3) 
 AQ-5 (4/4) 
10 Enterococcus faecium 100 CON(3/4) 
 PA-5 (1/3) 
 BS-5 (2/3) 
 LR-5 (3/3) 
 AQ-5 (4/4) 
11 Lactobacillus crispatus 98 CON(4/4) 
 PA-5 (2/3) 
 BS-5 (2/3) 
 LR-5 (2/3) 
 AQ-5 (0/4) 
12 Pediococcus acidilactici 99 CON(0/4) 
 PA-5 (3/3) 
 BS-5 (0/3) 
 LR-5 (0/3) 
 AQ-5 (2/4) 
13 Pseudomonas stutzeri 93 CON(4/4) 
 PA-5 (3/3) 
 BS-5 (3/3) 
 LR-5 (3/3) 
 AQ-5 (3/4) 
14 Lactobacillus reuteri 97 CON(3/4) 
 PA-5 (1/3) 
 BS-5 (1/3) 
 LR-5 (3/3) 
 AQ-5 (3/4) 
15 Bacillus subtilis 100 CON(0/4) 
 PA-5 (0/3) 
 BS-5 (2/3) 
 LR-5 (3/3) 
 AQ-5 (4/4) 
16 Lactobacillus rhamnosus 94 CON(4/4) 
 PA-5 (2/3) 
 BS-5 (3/3) 
 LR-5 (3/3) 
 AQ-5 (0/4) 
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Table 3.8: Microbial community analysis of the intestinal allochthonous bacterial populations of tilapia from DGGE fingerprints after four 269 
weeks of feeding experimental diets. 270 
 Microbial ecological parameters  Similarity (ANOSIM)  
 N Richness Diversity SIMPER (%)   R- value P- value Dissimilarity 
(%) 
CON 24.67 ± 4.19 7.37 ± 0.92 3.19 ± 0.18 63.39 ± 1.46      
BS-5 21.33 ± 2.49 6.64 ± 0.56 3.05 ± 0.12 69.92 ± 10.40      
LR-5 26.67 ± 2.49 7.81 ± 0.54 3.28 ± 0.09 76.50 ± 5.41      
PA-5 23.50 ± 7.50 7.07 ± 1.66 3.10 ± 0.33 59.57 ± 0.00      
AQ-5 28.33 ± 0.47 8.17 ± 0.10 3.34 ± 0.02 83.52 ± 5.81      
Pairwise comparisons  
CON vs BS-5       0.65 0.10 43.42 
CON vs LR-5       0.82 0.10 43.59 
CON vs PA-5       0.42 0.10 41.12 
CON vs AQ-5       0.69 0.10 42.08 
BS-5 vs LR-5       0.63 0.10 36.54 
BS-5 vs PA-5       0.83 0.10 50.21 
BS-5 vs AQ-5       0.67 0.10 35.47 
LR-5 vs PA-5       0.92 0.10 48.00 
LR-5 vs AQ-5       0.22 0.30 23.25 
PA-5 vs AQ-5       1.00 0.10 48.21 
N = number of operational taxonomic units; Richness = Margalef species richness; Diversity = Shannon’s diversity index; SIMPER = similarity 271 
percentage within group replicates. 272 
a, b
 Different superscripts indicate a significant difference (P < 0.05). 273 
 274 
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Table 3.9: Microbial community analysis of the intestinal allochthonous bacterial populations of tilapia from DGGE fingerprints after eight 275 
weeks of feeding experimental diets. 276 
 Microbial ecological parameters  Similarity (ANOSIM)  
 N Richness Diversity SIMPER (%)   R- value P- value Dissimilarity 
(%) 
CON 32.25 ± 2.38 8.99 ± 0.50 3.47 ± 0.07 77.44 ± 3.87      
BS-5 27.00 ± 3.74 7.88 ± 0.80 3.29 ± 0.14 65.79 ± 5.43      
LR-5 29.00 ± 3.27 8.31 ± 0.69 3.36 ± 0.11 73.49 ± 3.48      
PA-5 27.33 ± 3.30 7.95 ± 0.71 3.30 ± 0.12 60.27 ± 13.08      
AQ-5 29.00 ± 4.24 8.30 ± 0.90 3.36 ± 0.14 64.72 ± 12.00      
Pairwise comparisons  
CON vs BS-5       0.82 0.03 39.37 
CON vs LR-5       0.95 0.03 40.64 
CON vs PA-5       0.56 0.03 39.65 
CON vs AQ-5       0.98 0.03 52.09 
BS-5 vs LR-5       0.72 0.10 41.13 
BS-5 vs PA-5       0.09 0.30 38.93 
BS-5 vs AQ-5       0.65 0.06 46.37 
LR-5 vs PA-5       0.48 0.10 43.26 
LR-5 vs AQ-5       0.75 0.03 45.83 
PA-5 vs AQ-5       0.89 0.03 52.59 
N = number of operational taxonomic units; Richness = Margalef species richness; Diversity = Shannon’s diversity index; SIMPER = similarity 277 
percentage within group replicates. 278 
a, b
 Different superscripts indicate a significant difference (P < 0.05).  279 
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3.3.4 High-throughput sequencing 280 
Microbial communities from the digesta of tilapia in treatments CON and AQ-5 were 281 
further investigated using high-throughput sequencing analyses. A total of 1,609,610 282 
sequence reads were obtained from the Ion Torrent
®
 PGM; after removing low quality reads 283 
68,161 ± 2,701 and 38,444 ± 4,135 sequences were obtained for AQ-5 and CON groups, 284 
respectively and used for downstream analyses. Good’s coverage estimators for both 285 
treatments were >0.99 indicating that sufficient sequencing coverage was achieved and that 286 
the OTU’s detected in the samples are representative of the sampled population (Table 3.10).  287 
Rarefaction curves approached the saturation phase in both treatments at approx. 288 
30,000- 40,000 sequence reads, although the plateau was higher for those samples belonging 289 
to the control group (Fig 3.3a). Consequently there was a significantly higher number of 290 
OTUs and species richness (Chao1) in the control group when compared to probiotic fed fish 291 
(Table 3.10). The PCoA plot demonstrates a clear separation between each treatment (Fig 292 
3.3b) suggesting that there is clear dissimilarity between the intestine microbiota of fish fed 293 
control diets compared with fish fed the AQ-5 diet. This is supported by the UPGMA which 294 
shows clear differentiation between CON and AQ-5 replicates, with replicates clustering by 295 
treatment (Fig 3.3c). Fig 3.3d illustrates that 40 genera were present (i.e. accounting 296 
for >0.01% of the reads) in control samples which were not present in AQ-5 samples. 297 
Twenty-nine genera were common to samples in both CON and AQ-5 treatments.  298 
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Table 3.10: Number of raw reads, reads assigned to OTU’s, Goods coverage and diversity/ richness indices of allochthonous intestinal 299 
microbiota composition between CON and AQ-5 treatments after eight weeks of experimental feeding. 300 
Treatment Reads (pre 
trimming) 
Reads assigned 
(post trimming) 
Good’s Coverage Number of OTU’s Shannon’s 
diversity index 
Chao1 Index 
CON 244,815 ± 46,578 38,444 ± 4,135 1.00 ± 0.00 129.49 ± 10.44
a
 4.04 ± 0.71 136.08 ± 10.74
a 
AQ-5 157,588 ± 8518 68,161 ± 2,701 0.99 ± 0.00 90.16 ± 10.66
b
 3.87 ± 0.07 114.29 ± 9.87
b
 
a, b
 Different superscripts indicate a significant difference (P < 0.05). 301 
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 302 
Figure 3.3: Bacterial community composition and relatedness in the digesta of tilapia fed 303 
either a CON or AQ-5 diet for eight weeks. (a) Comparison of rarefaction curves between 304 
allochthonous intestinal microbiota composition between fish fed a control diet or probiotic 305 
diet after eight weeks of experimental feeding. (b) PCoA plots where data points represent 306 
samples from fish fed a control diet (blue circles) and probiotic diet (red squares). (c) 307 
UPMGA showing hierarchical clustering of intestinal microbiota from fish from each 308 
treatment. Bootstrap values are indicated by red branches (75- 100%). (d) Venn diagram 309 
showing the number of genera (accounting for >0.01% reads) assigned to control replicates, 310 
probiotic replicates and genera which are common in both treatments. 311 
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Fig 3.4 shows the major bacterial constituents in the digesta of fish fed either a CON 312 
or AQ-5 based diet at the phylum and genus levels. Firmicutes accounted for > 99% of 16S 313 
reads in probiotic fed fish. Firmicutes were also the dominant phyla in the digesta of CON 314 
fish although their presence was significantly lower (44.80% of reads; P = 0.01). 315 
Proteobacteria and Cyanobacteria reads were significantly higher in control samples (8.50% 316 
and 25.11%, respectively) than in the AQ-5 samples (0.36%; P = 0.03 and 0.18%; P = 0.05, 317 
respectively). Actinobacteria, Bacteroidetes, Fusobacteria, Nitrospirae, Spirochaetes and the 318 
phylum TM6 were also present in both treatments although their relative abundance was 319 
lower and not significantly different between treatments.  320 
The relative abundance of reads assigned to Enterococcus was significantly (P = < 321 
0.001) higher in AQ-5 fed fish when compared to CON fish (52.50% vs 1.35%, respectively). 322 
Reads belonging to Burkholderia, Leuconostoc, Acinetobacter, Legionella, Lactobacillus, 323 
Corynebacterium, Weisella, Sphingomonas, Rhodococcus and Hyphomicrobium were all 324 
significantly more abundant in the CON samples when compared to the AQ-5 fed fish (P < 325 
0.05). In the AQ-5 fed fish, after Enterococcus, the next most abundant genera were Bacillus 326 
(45.94%) and Pediococcus (0.44%). Lactobacillus reads accounted for 0.08% of sequences in 327 
probiotic samples. Bacillus (34%) also comprised a large component of the allochthonous 328 
microbiota in CON fish and low levels of Enterococcus (1.35%), Lactobacillus (1.04%) and 329 
Pediococcus (0.15%) sequence reads were also present. BLAST searches using single 330 
representative sequences belonging to each of these genera confirmed the presence of P. 331 
acidilactici, B. subtilis and L. reuteri in AQ-5 samples; however, these species were not 332 
present in the CON samples. In the CON fish the Bacillus spp. were identified as B. 333 
megaterium and B. aquimaris, Pediococcus spp. as P. pentasaceus and Lactobacillus reads 334 
were predominantly L. aviarius. Enterococcus reads in both treatment groups were identified 335 
as E. faecium. 336 
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Cetobacterium (accounting for 13.80% of the reads) and Mycobacterium (5.27%) were also 337 
present in the CON group; however they were found at lower levels in the AQ-5 treatment 338 
(0.02% and 0.31% respectively; P > 0.05). Streptococcus accounted for 0.48% of the reads in 339 
CON samples but was not detected in 3 out of 4 replicates of the AQ-5 treatment (present at 340 
0.01% in the fourth replicate). 341 
 342 
3.3.5 Persistence of probiotics after reverting to the control diet 343 
The persistence of each probiotic in the intestine of the AQ-5 fed fish was assessed by 344 
DGGE analysis on 3, 6, 9 and 18 days post reverting to the control diet (Fig 3.5). E. faecium 345 
was present six days after reverting to control diets, although bands were only visible in two 346 
of the four replicates. Bands representing amplicons from P. acidilactici, L. reuteri and B. 347 
subtilis all showed signs of decreasing intensity but were still present after 18 days of 348 
reverting to the control diet (Fig 3.5). Sequence analysis confirmed that these OTUs were the 349 
respective probiotic species. The number of OTU’s, species richness, species evenness and 350 
diversity of microbial communities were altered after reverting to the control diet; these 351 
parameters all followed the same pattern, initially decreasing from day 0 to day 6, before 352 
increasing at day 9 where they were at their highest post cessation of probiotic feeding, 353 
before decreasing again on day 18 (Fig 3.5). 354 
 355 
 356 
 357 
 358 
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 359 
Figure 3.4: Comparison of allochthonous intestinal microbiota composition between fish fed 360 
a CON or AQ-5 diet after eight weeks of experimental feeding. Heatmap shows bacterial 361 
OTU’s assigned at the phylum level and bars show OTU’s assigned at the genus level (> 362 
0.25 % of reads). Each sample represents pooled microbial communities of two fish.  363 
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 364 
Day 0 3 6 9 18 
Abundance
#
      
E. faecium 100 41.31 24.43 n.d n.d 
P. acidilactici
 
100 43.90 59.61 101.71 68.66 
L. reuteri 100 64.64 62.11 52.95 63.91 
B. subtilis 100 64.90 43.56 42.20 65.15 
N
1 
30.50 ± 3.50 17.00 ± 3.08 18.00 ± 3.54 24.00 ± 6.75 18.00 ± 1.00 
Richness
2 
2.82 ± 0.33 1.69 ± 0.29 1.76 ± 0.29 2.25 ± 0.55 1.79 ± 0.10 
Evenness
3 
0.98 ± 0.00 0.98 ± 0.00 0.99 ± 0.00 0.99 ± 0.01 0.98 ± 0.00 
Diversity
4 
3.34 ± 0.10 2.77 ± 0.17 2.83 ± 0.22 3.08 ± 0.24 2.84 ± 0.04 
#
 Values are expressed in terms of percentage relative abundance against the peak density at 365 
day 0. 366 
n.d = not detected 367 
Figure 3.5: DGGE fingerprints showing the persistence of the probiotic bacteria 368 
administered within the intestinal tract of tilapia, previously from the AQ-5 treatment, after 369 
reverting to the CON diet. Numbers above lanes indicate a pooled sample from two fish on 370 
the day post reverting to the basal diet. The table shows microbial diversity and percentage 371 
band intensity of E. faecium, P. acidilactici, L. reuteri and B. subtilis (relative to day 0) from 372 
DGGE fingerprints of the probiotic fed fish after reverting to the control diet. 373 
 374 
 375 
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3.3.6 Intestinal histology 376 
Light microscopy was used to examine the mid-intestine of tilapia after four and eight 377 
weeks of feeding experimental diets. Fish from all dietary treatments displayed an intact 378 
epithelial barrier with extensive mucosal folds extending into the lumen, with each fold 379 
consisting of simple lamina propria housing abundant IEL’s and numerous goblet cells (Fig 380 
3.6). At week four there were no differences in mucosal fold length, perimeter ratio or IEL 381 
abundance (Table 3.11). There were significantly higher numbers of goblet cells present in 382 
the epithelia of fish in treatment AQ-5 when compared with those in treatments BS-5 and 383 
LR-5 (P = <0.01) but were not different to treatments CON or PA-5. These differences in 384 
goblet cell abundance were not apparent after eight weeks. Equally there were no differences 385 
in mucosal fold length or perimeter ratio after eight weeks. IEL abundance was significantly 386 
elevated in the AQ-5 treatment (40.01 ± 4.46) when compared to treatments CON (32.68 ± 387 
4.81) and LR-5 (32.00 ± 3.03; P = 0.02). Treatments BS-5 and PA-5 were not significantly 388 
different from CON, AQ-5 or indeed each other (Table 3.11).  389 
After eight weeks, treatments CON and AQ-5 were analysed by SEM and TEM to 390 
assess microvilli density and length, respectively. Fish in both treatments appeared to have a 391 
healthy brush border with organised, closely packed microvilli showing no signs of 392 
intracellular gaps or necrotic enterocytes (Fig 3.7). The microvilli density in the intestine of 393 
the AQ-5 fed fish (4.58 ± 0.69) was significantly higher than the CON fed fish (3.49 ± 0.75; 394 
P < 0.05) (Table 3.11). Numerical increases (P = 0.08) in microvilli length (AQ-5 = 1.37 ± 395 
0.19µm vs. CON = 1.19 ± 0.14µm) and the perimeter ratio (P = 0.09), combined with a 396 
significant increase in microvilli density, resulted in a significantly (P = 0.01) higher 397 
absorptive surface area index (ASI) of the AQ-5 fed fish (40.84 ± 5.17) compared to those 398 
receiving the CON diet (22.07 ± 3.85) (Table 3.11).  399 
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 400 
Figure 3.6: Light micrographs of the mid intestine of tilapia fed CON (a & b), BS-5 (c & d), 401 
LR-5 (e & f), PA-5 (g & h) or AQ-5 (i & j) diet after eight weeks. Goblet cells (arrows) are 402 
filled with abundant acidic mucins in all treatments and abundant IELs (arrowheads) are 403 
present in the epithelia. Abbreviations used are E: enterocytes; LP: lamina propria, L: lumen. 404 
Light microscopy staining: a, c, e, g, i: H & E; b, d, f, h, j: Alcian-Blue-PAS. Scale bars = 405 
100µm. 406 
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Table 3.11: Histological data from the mid-intestine of tilapia after four and eight weeks of experimental feeding.  407 
 CON BS-5 LR-5 PA-5 AQ-5 
Week 4      
Mucosal fold length (µm) 265.53 ± 34.56 300.10 ± 56.67 264.96 ± 34.27 301.71 ± 55.15 284.27 ± 28.06 
Perimeter ratio (AU) 5.55 ± 0.46 6.42 ± 1.13 6.52 ± 1.02 6.47 ± 1.35 5.98 ± 1.20 
IEL’s (per 100 µm) 34.71 ± 3.39 31.92 ± 2.62 33.30 ± 2.78 34.81 ± 5.16 35.28 ± 2.27 
Goblet cells (per 100 µm) 5.65 ± 1.51
ab
 4.90 ± 0.61
a
 4.93 ± 0.65
a
 5.17 ± 0.46
ab
 6.88 ± 0.83
b
 
Week 8      
Mucosal fold length (µm) 270.38 ± 51.29 295.12 ± 28.22 262.70 ± 53.10 300.48 ± 41.96 282.04 ± 69.36 
Perimeter ratio (AU) 5.36 ± 1.24 5.87 ± 0.97 5.82 ± 1.04 6.70 ± 1.14 6.48 ± 0.74 
IEL’s (per 100 µm) 32.68 ± 4.81a 38.55 ± 5.87ab 32.00 ± 3.03a 35.25 ± 2.57ab 40.01 ± 4.46b 
Goblet cells (per 100 µm) 5.76 ± 0.41 5.65 ± 0.99 5.14 ± 0.68 5.19 ± 0.59 6.23 ± 1.44 
Microvilli length (µm) 1.19 ± 0.14 - - - 1.37 ± 0.19 
Microvilli density (AU) 3.49 ± 0.75
a
 - - - 4.58 ± 0.69
b
 
ASI* 22.07 ± 3.85
a
 - - - 40.84 ± 5.17
b 
a, b
 Different superscripts indicate a significant difference (P < 0.05). 408 
* absorptive surface index 409 
- no data collected 410 
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 411 
Figure 3.7: Scanning electron (a and c) and transmission electron (b and d) micrographs of 412 
the mid-intestine of Nile tilapia fed CON (a and b) or AQ-5 (c and d) diets at the end of the 413 
experimental period. Abbreviations used are L: lumen; TJ: tight junction; MV: microvilli. 414 
Scale bars = 1 µm (a and c), 2 µm (b and d). 415 
 416 
3.3.7 Haemato-immunological analyses 417 
Blood was taken from tilapia at weeks four and eight in order to assess haemato-418 
immunological parameters. There were no significant differences in haematocrit, 419 
haemoglobin, erythrocytes, leucocytes, MCV, MCH, MCHC or serum lysozyme activity after 420 
four weeks of feeding on the experimental diets (Table 3.12). After eight weeks MCV was 421 
2 µm 
2 µm 
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significantly higher in the CON fed fish when compared to LR-5, PA-5 and AQ-5 (P < 0.05). 422 
The MCV of fish in treatment BS-5 was not significantly different to that of any other 423 
treatment. Haematocrit, haemoglobin, RBC, WBC, MCH, MCHC and serum lysozyme 424 
activity remained unchanged by dietary treatment after eight weeks (Table 3.12).  425 
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Table 3.12: Haemato-immunological parameters in tilapia after four and eight weeks of feeding experimental diets.  426 
 CON BS-5 LR-5 PA-5 AQ-5 
Week 4      
Haematocrit (%PCV) 41.80 ± 3.19 40.67 ± 2.21 38.83 ± 2.73 38.33 ± 1.25 37.00 ± 2.10 
Haemoglobin (g dl
-1
) 9.66 ± 1.89 10.30 ± 0.90 9.45 ± 1.73 9.32 ± 1.07 8.86 ± 1.20 
RBC (10
6
 µl-1) 1.81 ± 0.72 1.20 ± 0.92 1.85 ± 0.88 1.75 ± 0.94 1.65 ± 0.83 
WBC (10
3
 µl-1) 28.78 ± 10.79 23.52 ± 16.52 25.67 ± 9.38 27.54 ± 9.79 29.63 ± 12.70 
MCV (fL) 379.16 ± 252.03 536.71 ± 272.91 327.06 ± 246.82 333.79 ± 249.60 364.64 ± 252.48 
MCH (pg) 76.66 ± 62.07 135.71 ± 76.75 85.52 ± 64.42 107.68 ± 114.13 84.83 ± 63.96 
MCHC (g dl
-1
) 25.94 ± 1.79 23.67 ± 4.22 26.12 ± 1.80 24.22 ± 3.66 24.24 ± 2.46 
Serum lysozyme activity (AU) 312.20 ± 52.25 301.18 ± 66.12 353.82 ± 32.61 316.19 ± 62.09 312.96 ± 72.93 
Week 8      
Haematocrit (%PCV) 37.50 ± 2.29 35.17 ± 4.10 36.33 ± 2.21 35.67 ± 1.70 37.20 ± 3.37 
Haemoglobin (g dl
-1
) 8.96 ± 1.17 8.88 ± 0.53 9.15 ± 1.27 8.14 ± 1.65 8.47 ± 1.66 
RBC (10
6
 µl-1) 1.55 ± 0.61 2.02 ± 0.68 2.06 ± 0.18 2.09 ± 0.39 2.21 ± 0.24 
WBC (10
3
 µl-1) 20.11 ± 7.80 23.05 ± 8.72 23.85 ± 7.85 19.81 ± 5.37 29.80 ± 6.21 
MCV (fL) 323.24 ± 178.34
a
 231.39 ± 141.72
ab
 165.13 ± 10.45
b
 191.84 ± 50.07
b
 174.14 ± 16.97
b
 
MCH (pg) 74.50 ± 48.00 54.66 ± 30.97 43.54 ± 3.19 39.74 ± 7.20 39.00 ± 9.05 
MCHC (g dl
-1
) 23.72 ± 3.51 24.15 ± 1.96 26.56 ± 3.41 20.91 ± 4.46 22.52 ± 3.88 
Serum lysozyme activity (AU) 207.26 ± 90.51 277.58 ± 58.96 286.82 ± 120.19 257.58 ± 96.67 239.12 ± 97.06 
a, b
 Different superscripts indicate a significant difference (P < 0.05).  427 
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3.4 Discussion 428 
The intestinal microbiomes of fish are complex communities which have been 429 
demonstrated to impact host health, mucosal development and differentiation, metabolism, 430 
nutrition and disease resistance (Rawls et al. 2004; Bates et al. 2006; Round and Mazmanian 431 
2009). These communities are sensitive to rearing environment, seasonal and dietary changes, 432 
including probiotic supplementation (Merrifield et al. 2010; Dimitroglou et al. 2011; Romero 433 
et al. 2014). The present literature available on the impact of probiotics on the intestinal 434 
microbiomes of fish has been investigated predominantly by culture dependent means or 435 
semi-quantitative techniques such as DGGE.  436 
The present study used a multidisciplinary approach consisting of culture based 437 
techniques, DGGE and high-throughput sequencing. Culture dependent approaches 438 
demonstrated that each probiotic treatment was able to modulate the allochthonous and 439 
autocthonous microbial populations within the intestine. Each probiotic was recovered in the 440 
intestine using culture methods with the exception of L. reuteri. However, this species was 441 
detected when using more sensitive culture independent techniques suggesting that this 442 
species may have low survivability during diet preparation or through the upper intestinal 443 
tract. Despite differences on selective agar, dietary treatment did not affect intestinal total 444 
viable counts. 445 
However, since only a fraction of the total intestinal microbiota of fish is cultivable 446 
under laboratory conditions (Zhou et al. 2014), and early estimates suggest up to 50% of the 447 
community in the tilapia intestine is non-cultivable (Sugita et al. 1981), culture independent 448 
methods were also utilised in the current investigation in order to provide a comprehensive 449 
overview of microbial communities. Here, DGGE revealed complex microbial communities 450 
in all treatments. Sequencing of excised bands confirmed the presence of B. subtilis, E. 451 
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faecium, L. reuteri and P. acidilactici in the corresponding treatments. At week eight, 452 
ANOSIM indicated that the intestinal microbiota of fish in the CON treatment was 453 
significantly dissimilar to all probiotic treatments illustrating that both the mono- and 454 
multispecies probiotics tested can modulate the intestinal microbiota of tilapia. 455 
The introduction of high-throughput sequencing technologies has increased our 456 
understanding of microbial diversity and function in complex environments, including the GI 457 
tract of fish (van Kessel et al. 2011; Roeselers et al. 2011; Desai et al. 2012; Wu et al. 2012; 458 
Boutin et al. 2013; Carda-Diéguez et al. 2013; Wu et al. 2013; Ingerslev et al. 2014; Zarkasi 459 
et al. 2014; Falcinelli et al. 2015; Lyons et al. 2015). At present, there is a paucity of 460 
information on the intestinal microbiome of tilapia using high-throughput sequencing; to the 461 
authors knowledge this is the first study utilising high-throughput sequencing to assess the 462 
intestinal microbial communities in tilapia. In the present study, sequence libraries for both 463 
treatments assessed (CON and AQ-5) displayed Good’s coverage estimations of >0.99, 464 
indicating that the intestinal microbiota had been fully sampled. Firmicutes accounted for > 465 
99% of 16S rRNA reads in the AQ-5 fish and although they accounted for a significantly 466 
smaller proportion of the reads in the control fed fish they remained the most abundant 467 
phylum present. Concomitantly, Proteobacteria and Cyanobacteria were significantly more 468 
abundant in the control fish along with other notable phyla present including Fusobacteria, 469 
Actinobacteria and Bacteroidetes. These phyla have all been detected in varying levels in 470 
omnivorous fish species (van Kessel et al. 2011; Roeselers et al. 2011; Wu et al. 2013) 471 
including tilapia (Zhou et al. 2009; Liu et al. 2013). BLAST searches using single 472 
representative sequences from Cyanobacteria revealed high similarity to nucleotide 473 
sequences from soybean chloroplasts. It is possible that at least some of these reads may have 474 
been artefacts derived from the diets as opposed to the presence of Cyanobacteria populations.  475 
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At the genera level, in AQ-5, the most abundant 16S rRNA reads belonged to 476 
Enterococcus and Bacillus followed by Pediococcus. At a lower level, Lactobacillus spp. was 477 
also detected. Confirming the DGGE analyses, the administered probiotic species, E. faecium, 478 
B. subtilis, P. acidilactici and L. reuteri, were identified in the high-throughput sequence 479 
libraries from the AQ-5 fed fish. In contrast, although these genera were present in the 480 
control fed fish, with the exception of E. faecium the probiotic species were not detected. E. 481 
faecium has routinely been detected as an indigenous constituent of the gut of a number of 482 
fish (Sun et al. 2009; Gopalakannan and Arul 2011; Desai et al. 2012; Sahnouni et al. 2012; 483 
Bourouni et al. 2012) and shellfish species (Cai et al. 1999) and its presence in the control 484 
tilapia in this experiment is indicative that this species is native to the tilapia intestine also. 485 
The relative abundance of a number of potential pathogens (Legionella spp., Mycobacterium 486 
spp. and Streptococcus spp.) was reduced, significantly in the case of Legionella, by the 487 
application of dietary AquaStar
®
 Growout. This topic warrants further investigation.  488 
Despite the numerous significant differences in OTU abundances detected, 29 of the 489 
69 (42%) genera detected in this study were common to both treatment groups. This may be 490 
suggestive of a core microbiome, which despite possible modulation in terms of abundance, 491 
persists within the intestine irrespective of the probiotic treatment. This would infer that 492 
members of these genera are well adapted to the selective pressures present in the tilapia 493 
intestinal tract. Similarly, other studies have identified a core microbiome in fish species, 494 
which appear to be present when individuals are reared in different locations, different 495 
conditions or fed different diets (Roeselers et al. 2011; Wong et al. 2013).  496 
Due to the absolute dominance (as a proportion of total number of reads) of the 497 
administered probiotics (i.e. Enterococcus and Bacillus), it is perhaps not surprising that the 498 
number of observed OTU’s and the Chao1 index were significantly lower in the probiotic 499 
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group. Despite these changes, the diversity, as indicated by Shannon- Wiener Index, was not 500 
significantly different between the two treatments. This suggests that the apparent reduction 501 
of other OTU’s may not necessarily be due to their absolute reduction in abundance, but 502 
possibly their relative decrease as a proportion of the total bacterial reads given the large 503 
number of probiotic 16S rRNA reads. Caution should be applied when interpreting high-504 
throughput sequence libraries as 16S rRNA copy numbers can differ amongst bacterial 505 
species (Fogel et al. 1999); this can lead to incorrect conclusions when discussing true 506 
bacterial diversity taxon abundance (Wintzingerode et al. 1997). For example, Bacillus and 507 
Enterococcus appear to be present at similar levels given the proportion of reads assigned to 508 
these genera in the probiotic fed fish, however, Bacillus strains have typically been reported 509 
to contain 10 copies of the 16S rRNA gene whereas Enterococcus spp. have frequently been 510 
reported to contain four copies (Fogel et al. 1999). Therefore estimating the abundance (i.e. 511 
number of cells) of each bacterial species, relative to other species, is problematic. 512 
The observed modulation of the intestinal microbiome in the present study influenced 513 
the host intestinal morphology. Histological analysis revealed an increased population of 514 
IEL’s in the mid-intestine of tilapia after eight weeks feeding in treatment diet AQ-5 when 515 
compared with CON and LR-5 groups. Similar results were obtained by Salinas et al. (2008) 516 
who discovered higher populations of acidophilic granulocytes and Ig
+
 populations in 517 
intestinal mucosa of gilthead sea bream, Sparus aurata, when supplementing diets with 518 
Lactobacillus delbrüeckii ssp. lactis and B. subtilis when compared to the control treatment, 519 
or each treatment containing the probiotics singularly. Other studies have also reported a 520 
larger abundance of intestinal IEL’s in tilapia fed monospecies probiotic applications of P. 521 
acidilactici (Standen et al. 2013) and L. rhamnosus (Pirarat et al. 2011). 522 
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Furthermore, after eight weeks microvilli density was significantly higher in the mid-523 
intestine of treatment AQ-5 when compared to treatment CON. Higher microvilli density 524 
may reduce the exposure of the tight junctions between enterocytes and this may help to 525 
provide a more effective barrier against potential pathogens. Further to this, increased 526 
microvilli density, combined with numerical improvements of microvilli length and perimeter 527 
ratio, significantly improved the absorptive surface area index in the AQ-5 fed fish. Here, no 528 
differences were observed in growth performance. As long as growth is not impaired, this 529 
result (i.e. no difference in growth performance) should be considered a positive outcome 530 
since the probiotics can manifest other benefits such as immune modulation or improvements 531 
in gut morphology which likely uses energy and resources. Further work is needed to 532 
optimise of dose and feeding regime to investigate whether the changes observed here could 533 
result in improved growth performance. 534 
After the eight week feeding trial, DGGE analysis was used to investigate the 535 
persistence of each of the probionts in the intestine after the cessation of probiotic feeding. 536 
All four probionts showed decreasing trends in abundance after AquaStar
®
 Growout 537 
supplementation had ceased but were still detected for a number of days post transition to the 538 
non-supplemented control diet. E. faecium was still detected for up to six days post reverting 539 
to the control diet. The remaining three probiotics were still present after 18 days of control 540 
feeding, demonstrating the temporal colonisation of the intestine of these species. Similarly, 541 
after the dietary supplementation of P. acidilactici for 32 days, P. acidilactici could be 542 
detected in the tilapia intestine for at least 17 days after cessation of probiotic feeding 543 
(Ferguson et al. 2010). The ability of other probiotics including Carnobacterium spp., 544 
Lactobacillus spp., Lactococcus spp., Leuconostoc spp. and Bacillus spp. to persist in the 545 
gastrointestinal tract of tilapia, salmonids and catfish has been investigated, demonstrating 546 
temporal colonisation lasting from < 3 days to > 3 weeks (Nikoskelainen et al. 2003; Kim 547 
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and Austin 2006; Balcázar et al. 2007; Ran et al. 2012; Ridha and Azad 2012). Thus it is 548 
evident the length of time a probiont may remain in the intestine of fish, after probiotic 549 
feeding has ceased, is dependent on the probiotic species, host species, environmental factors, 550 
dosage and duration of probiotic supplementation. 551 
In conclusion, all three microbiological methods used in the present study (culture 552 
based, DGGE and high-throughput sequencing) confirmed the probiotic presence in the 553 
intestine of the corresponding treatment. Survival through the upper GI tract is an essential 554 
requirement of any probiotic, since probiotic cells must survive the gastric process in order to 555 
exert their beneficial effect in the intestine. Furthermore, each probiotic, whether applied 556 
singularly or as a mix, was able to modulate the intestinal microbiota in tilapia. Under these 557 
conditions AquaStar
®
 Growout can stimulate the localised immune response through the 558 
recruitment of IEL’s (when compared to CON) and the higher abundance of goblet cells 559 
(when compared to BS-5 and LR-5) in the intestinal mucosa, which may result in better 560 
protection against localised pathogens. Intestinal translocation experiments and disease 561 
challenge studies are required to validate this hypothesis. Future work should focus on 562 
elucidating the mechanisms which underpin these localised immunological changes using a 563 
transcriptomic approach. Concomitantly with modulated microbiota and IEL levels, 564 
AquaStar
®
 Growout treatment enhanced intestinal morphology by elevating the absorptive 565 
surface area when compared to CON. In addition, the probiotics contained in the AquaStar
®
 566 
Growout product are able to remain in the gut after reverting to the basal diet suggesting 567 
these benefits may continue to persist after probiotic feeding has ceased. The benefits 568 
observed were not at the expense of growth performance which was not affected by dietary 569 
treatment.  570 
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Chapter 4. Dietary administration of a commercial mixed-species probiotic 1 
improves growth performance and modulates the intestinal immunity of 2 
tilapia, Oreochromis niloticus 3 
 4 
Abstract 5 
The growth performance, immunological status, intestinal morphology and 6 
microbiology of tilapia, Oreochromis niloticus, were investigated after dietary administration 7 
of the commercial probiotic AquaStar
®
 Growout. Tilapia (29.02 ± 0.33g) were split into five 8 
treatments; control (CON), 1.5g kg
-1
 probiotic (PRO-1.5), 3g kg
-1
 probiotic (PRO-3), pulsed 9 
probiotic feeding (PRO-PULSE) or an initial probiotic feed followed by control feeding 10 
(PRO-INI). After six weeks of experimental feeding, fish fed PRO-3 displayed significantly 11 
higher final weight, weight gain and SGR compared to the CON or PRO-INI treatments. 12 
After six weeks of supplementing the probiotic at 3g kg
-1
, an up-regulation of intestinal 13 
caspase-3, PCNA and HSP70 mRNA levels fed fish was observed when compared to the 14 
CON. Immuno-modulatory pathways were also affected; significantly higher expression of 15 
TLR2, pro-inflammatory genes TNFα and IL-1β, and anti-inflammatory genes IL-10 and 16 
TGFβ suggest that the probiotic may potentiate a higher state of mucosal tolerance and 17 
immuno-readiness. Histological appraisal revealed significantly higher numbers of 18 
intraepithelial leucocytes in the intestine of PRO-3 fed fish compared with treatments CON, 19 
PRO-PULSE and PRO-INI but not PRO-1.5 after six weeks. Additionally, fish receiving 20 
PRO-3 had a significantly higher abundance of goblet cells in their mid-intestine when 21 
compared with fish from all other treatments. Together, these data suggest that continuous 22 
provision of AquaStar
®
 Growout at 3g kg
-1
 for six weeks can improve tilapia growth and 23 
elevate the intestinal immunological status of the host.  24 
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4.1 Introduction 25 
Using high-throughput sequencing, it has previously been reported that AquaStar
®
 26 
Growout, supplemented through tilapia diets at 5 g kg
-1
, can result in the relative dominance 27 
of probiotic 16S rRNA reads (>99% of total reads; Chapter 3) in the tilapia intestine, but it is 28 
unclear what implications this has on localised host immunity. It is of paramount importance 29 
that aquaculture stocks are healthy and capable of mounting an effective immune response 30 
were the host to come into contact with a potential pathogen. The intestinal tract plays an 31 
important role in the mucosal barrier function. Not only does it serve as a physico-chemical 32 
barrier against invading pathogens, there are also tolerance mechanisms in place which allow 33 
the residence of commensal and mutualistic microbes (Foey and Picchietti 2014). Probiotics 34 
can have beneficial implications on the gut-associated lymphoid tissues (GALT). These 35 
benefits can manifest themselves within the intestine by means of reinforcing barrier defences 36 
by elevating populations of intra epithelial leucocytes and goblet cells as described in Chapter 37 
3, and also by inducing the expression of pro-inflammatory cytokines (e.g. TNFα and IL-1β), 38 
thus maintaining the capacity of recognising and responding to pathogens, and regulatory 39 
cytokines (e.g. TGFβ and IL-10) for the maintenance of mucosal tolerance (Pirarat et al. 2011; 40 
He et al. 2013; Liu et al. 2013; Ren et al. 2013; Standen et al. 2013; Villamil et al. 2014). 41 
These cytokines are the end products to complex molecular pathways which is initiated by 42 
TLR’s recognising their corresponding pathogen associated molecular pattern (PAMP) (Cerf-43 
Bensussan and Gaboriau-Routhiau 2010). Probiotic supplementation can up-regulate the 44 
expression of intestinal TLR3 in Atlantic salmon, Salmo salar, and intestinal TLR2 and 45 
TLR5 in grouper, Epinephelus coioides, with a corresponding induction of IL-1β, TNFα, IL-8 46 
and TGFβ expression (Abid et al. 2013; Sun et al. 2014).  47 
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The current investigation aimed to evaluate multiple doses and feeding regimes of 48 
AquaStar
®
 Growout, on intestinal immunity, growth performance, intestinal integrity and 49 
intestinal microbiology.  50 
 51 
4.2 Materials and methods 52 
4.2.1 Experimental design and dietary preparation 53 
Five hundred tilapia were randomly distributed to 10 150L fibreglass tanks (50 fish 54 
per tank; average weight = 29.02 ± 0.33g). Three diets were formulated and pelleted as 55 
described in section 2.3 (Table 4.1). Treatments were as follows; control (basal diet void of 56 
AquaStar
®
 Growout), low probiotic dose (basal diet supplemented with AquaStar
®
 Growout 57 
at 1.5g kg
-1
), high probiotic dose (basal diet supplemented with AquaStar
®
 Growout at 3 g kg
-
58 
1
), probiotic pulse feeding (alternating weekly between AquaStar
®
 Growout feeding at 1.5g 59 
kg
-1
 and the basal diet) and initial probiotic feeding (first two weeks AquaStar
®
 Growout 60 
feeding at 1.5g kg
-1
 followed by remainder of the trial on the basal diet). Fish were fed 61 
experimental diets for six weeks at a rate of 1- 5% biomass per day in four equal rations. All 62 
diets were assessed for proximate composition as described in section 2.4 (Table 4.1). Water 63 
quality parameters were monitored and maintained as described in section 2.1. Diet codes 64 
were assigned to each treatment for ease of analysis (Table 4.2). After four weeks, treatments 65 
were reduced from triplicate to duplicate (i.e. n = 2) in order to increase stocking densities 66 
and reduce tilapia aggression.  67 
 68 
 69 
 70 
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Table 4.1: Dietary formulation and proximate composition (%). 71 
 Basal 1.5g kg
-1 
3g kg
-1
 
Fishmeal
a 
 10.00 10.00 10.00 
Soyabean meal
b 
 33.89 33.89 33.89 
Corn Starch
c
  31.90 31.75 31.60 
Lysamine pea protein
d 
 5.00 5.00 5.00 
Glutalys
d 
 10.00 10.00 10.00 
Fish oil 3.75 3.75 3.75 
Corn oil  4.00 4.00 4.00 
Vitamin& mineral premix
f
  0.50 0.50 0.50 
CMC-binder
c
  0.50 0.50 0.50 
Methionine
c
 0.36 0.36 0.36 
AquaStar
®
 Growout
g 
 0.00 0.15 0.30 
Proximate composition (% as fed basis)  
Moisture  7.16 ± 0.03 5.89 ± 0.09 8.23 ± 0.19 
Crude protein  37.57 ± 0.16 38.08 ± 0.30 37.03 ± 0.13 
Lipid  10.09 ± 0.03 10.61 ± 0.24 10.41 ± 0.09 
Ash  4.29 ± 0.04 4.25 ± 0.07 4.20 ± 0.01 
Energy (MJ kg
-1
) 19.72 ± 0.05 19.57 ± 0.40 18.97 ± 0.19 
a 
Herring meal LT92 – United Fish Products Ltd., Aberdeen, UK.  72 
b 
Hamlet HP100, Denmark.  73 
c 
Sigma- Aldrich Ltd., UK.  74 
d 
Roquette Frêres, France. 75 
e
 Natural wheat bran, Holland & Barrett, UK.   76 
f 
Premier nutrition vitamin/mineral premix contains: 121 g kg
-1
 calcium, Vit A 1.0 μg kg-1, 77 
Vit D3 0.1 μg kg-1, Vit E (as alpha tocopherol acetate) 7.0 g kg-1, Copper (as cupric sulphate) 78 
250 mg kg
-1
, Magnesium 15.6 g kg
-1
, Phosphorous 5.2 g kg
-1
.  79 
g 
Biomin Holding GmbH, Industriestrasse 21, 3130 Herzogenburg, Austria. 80 
 81 
4.2.2 Growth performance and carcass composition 82 
Prior to the start of the trial, nine fish were pooled into three samples to assess initial 83 
proximate carcass composition as described in section 2.4. At the end of the experimental 84 
period four fish per tank were pooled into two samples (n = 4) to assess final proximate 85 
carcass composition. Growth performance and feed utilisation were assessed by final weight, 86 
weight gain, feed intake, SGR, FCR and PER as described in section 2.5. 87 
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Table 4.2: Codes assigned to dietary treatments. 88 
Dietary code Diet 
CON Continuous feeding of basal diet (without probiotic) 
PRO-1.5 Continuous feeding of the basal diet supplemented with AquaStar
®
 
Growout at 1.5g kg
-1
 
PRO-3 Continuous feeding of the basal diet supplemented with AquaStar
®
 
Growout at 3g kg
-1
 
PRO-PULSE Alternating weekly between AquaStar
®
 Growout feeding at 1.5g kg
-1
 
and the basal diet 
PRO-INI Initial two weeks AquaStar
®
 Growout feeding at 1.5g kg
-1
 followed by 
remainder of the trial on the basal diet 
 89 
4.2.3 RT-PCR 90 
The mid-intestine was sampled from two fish per tank after three weeks (n = 6) and 91 
four fish per tank after six weeks (n = 8) to assess gene expression of caspase-3, PCNA, 92 
HSP70, TLR2, TGFβ, IL-10, TNFα and IL-1β as described in section 2.11. Primer sequences 93 
and efficiencies are reported in Table 4.3. Cycle threshold (Ct) values were imported into the 94 
relative expression software tool (REST
©
) (Pfaffl et al. 2002) where experimental treatments 95 
were each compared to the control. Data were reported as fold change.  96 
 97 
4.2.4 Intestinal histology 98 
Two fish per tank were sampled at weeks three (n = 6) and six (n = 8) to asses 99 
perimeter ratio, IEL and goblet cell abundance as described in section 2.7.  100 
 101 
4.2.5 Culture dependent analyses 102 
Digesta was isolated and pooled from two fish per tank after three weeks (n = 3). 103 
After six weeks, digesta was removed from four fish per tank and pooled into two samples 104 
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(thus n = 4) to assess allochthonous level of LAB, enterococci, Bacillus and TVC. Samples 105 
were processed as described in section 2.8.1.  106 
 107 
4.2.6 DGGE 108 
DNA was extracted using the QIAamp Stool Mini Kit (Qiagen) as described in 109 
section 2.8.3. DGGE was carried out on all digesta samples from week three (n = 3) and week 110 
six (n = 4) to assess allochthonous bacterial communities as described in section 2.8.4.  111 
 112 
4.2.7 Haemato-immunological analyses 113 
 Blood samples were taken to assess haematocrit and haemoglobin after six weeks (n = 114 
10). Furthermore serum was collected to assess serum lysozyme activity (n = 20). All 115 
sampling and analyses was carried out according to section 2.10. 116 
 117 
4.2.8 Statistical analyses 118 
Statistical analyses were carried out as described in section 2.12.  119 
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Table 4.3: Primer sequences for RT-PCR 120 
Gene Forward 5’ - 3’ Reverse 5’ – 3’ Amplicon 
size 
Tm 
(°C) 
E-
value 
GenBank number 
β-actin TGACCTCACAGACTACCTCATG TGATGTCACGCACGATTTCC 89 58.8 2.1 KJ126772.1 
GAPDH CCGATGTGTCAGTGGTGGAT GCCTTCTTGACGGCTTCCTT 82 59.4 2.0 JN381952.1 
EF1α TGATCTACAAGTGCGGAGGAA GGAGCCCTTTCCCATCTCA 80 58.4 2.0 AB075952.1 
Caspase-
3 
GGCTCTTCGTCTGCTTCTGT GGGAAATCGAGGCGGTATCT 80 59.4 2.1 GQ421464.1 
PCNA CCCTGGTGGTGGAGTACAAG AGAAGCCTCCTCATCGATCTTC 80 60.9 2.0 XM_003451046.2 
HSP70 ACCCAGACCTTCACCACCTA GTCCTTGGTCATGGCTCTCT 84 59.4 2.0 FJ213839.1 
TLR2 GCAGTGCCTTGAGTCTTGATC ACCGTGGAGATCGAGAACCT 101 59.6 2.1 XM_005460165 
TNFα CCAGAAGCACTAAAGGCGAAGA CCTTGGCTTTGCTGCTGATC 82 59.9 2.0 AY428948.1 
IL-1β TGGTGACTCTCCTGGTCTGA GCACAACTTTATCGGCTTCCA 86 58.7 2.1 XM_005457887.1 
TGFβ GTTTGAACTTCGGCGGTACTG TCCTGCTCATAGTCCCAGAGA 80 59.8 2.1 XM_003459454.2 
IL-10 CTGCTAGATCAGTCCGTCGAA GCAGAACCGTGTCCAGGTAA 94 59.6 2.1 XM_003441366.2 
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4.3 Results 121 
4.3.1 Growth performance and carcass composition 122 
Growth performance was assessed by means of routine growth and feed utilisation 123 
parameters after six weeks of feeding experimental feeding (Table 4.4). Tilapia fed the PRO-124 
3 diet displayed the best growth performance. In this treatment the final weight, weight gain 125 
and SGR were significantly higher when compared to either CON or PRO-INI (P = 0.019, 126 
0.014 and 0.021 respectively). However, they did not significantly differ from treatments 127 
PRO-1.5 or PRO-PULSE. No differences in feed intake, PER or FCR were observed between 128 
any treatment. There were no significant differences in proximal composition between 129 
carcass moisture, ash, lipid, protein or energy (Table 4.5). 130 
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Table 4.4: Growth performance of tilapia after six weeks of feeding experimental diets. 131 
 CON PRO-1.5 PRO-3 PRO-PULSE PRO-INI 
Initial weight (g fish
-1
) 29.42 ± 0.37 28.66 ± 0.25 29.10 ± 0.59 28.94 ± 0.03 29.42 ± 0.08 
Average weight (g fish
-1
 ) 68.20 ± 0.63
a
 68.83 ± 0.39
ab
 71.74 ± 0.83
b
 68.81 ± 0.04
ab
 67.57 ± 1.34
a
 
Weight gain (g fish
-1
) 38.78 ± 0.10
a
 40.17 ± 0.13
ab
 42.64 ± 0.23
b
 39.87 ± 0.06
ab
 38.15 ± 1.42
a
 
Feed intake (g fish
-1
) 53.46 ± 1.23 55.39 ± 0.57 56.42 ± 0.70 55.42 ± 0.05 54.91 ± 0.04 
PER 1.47 ± 0.15 1.47 ± 0.02 1.59 ± 0.02 1.44 ± 0.00 1.34 ± 0.10 
FCR (g g
-1
) 1.38 ± 0.07 1.38 ± 0.01 1.33 ± 0.01 1.39 ± 0.00 1.44 ± 0.06 
SGR (% day
-1
) 2.48 ± 0.06
a
 2.58 ± 0.01
ab
 2.66 ± 0.02
b
 2.55 ± 0.01
ab
 2.45 ± 0.06
a
 
* Parameters reported as percentage of dry weight matter.
 
132 
a, b
 Different superscripts indicate a significant difference (P < 0.05).  133 
 134 
Table 4.5: Proximate carcass composition (%) of tilapia of tilapia prior to ‘Day 0’ and after six weeks of feeding experimental diets.  135 
 Initial fish CON PRO-1.5 PRO-3 PRO-PULSE PRO-INI 
Moisture 77.41 ± 0.32 68.75 ± 0.44
 
68.97 ± 0.78
 
69.41 ± 0.89 69.81 ± 1.14
 
68.72 ± 0.59
 
Ash*  16.64 ± 0.43 9.88 ± 0.37 10.17 ± 0.49
 
9.67 ± 0.31
 
10.52 ± 0.74
 
10.20 ± 0.08
 
Lipid*  18.95 ± 0.87 34.68 ± 0.53
 
32.42 ± 0.78
 
34.94 ± 1.79
 
32.67 ± 1.68
 
33.78 ± 0.73
 
Protein*  58.19 ± 0.20
 
52.03 ± 0.42
 
53.41 ± 0.52
 
52.48 ± 1.50
 
54.43 ± 1.32
 
52.90 ± 1.38
 
Energy* - 24.67 ± 0.15 24.39 ± 0.45 24.72 ± 0.46 24.56 ± 0.36 25.05 ± 0.16 
* Parameters reported as percentage of dry weight matter. 136 
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4.3.2 RT-PCR 137 
Relative intestinal gene expression of caspase-3, PCNA, HSP70, TLR2, TNFα, IL-1β, 138 
IL-10 and TGFβ were analysed. The largest fold change was observed in caspase-3 mRNA 139 
levels after six weeks of experimental feeding which were up-regulated approximately seven 140 
fold in PRO-3 when compared to the control group (P = 0.001; Fig 4.1). The gene expression 141 
of PCNA and HSP70 were six and three and half times higher in PRO-3 respectively, when 142 
compared to the control treatment after six weeks of supplementation (P = < 0.001 and 0.028 143 
respectively). Caspase-3, PCNA and HSP70 gene expression levels did not differ between 144 
any experimental treatments when compared to the control treatment at week three (Fig 4.1). 145 
TLR2, pro- and anti-inflammatory gene expression analyses after three weeks did not 146 
reveal any significant differences between the experimental treatments when compared to the 147 
control treatment (Fig 4.2). After six weeks, changes in immunity gene expression were 148 
revealed (Fig 4.2). TLR2 was significantly up-regulated more than four fold in PRO-3 when 149 
compared to the control treatment (P = 0.004). The pro-inflammatory cytokines TNFα and 150 
IL-1β were up-regulated approximately three and five times, respectively, in the intestine of 151 
the PRO-3 fed fish compared to the CON fed fish (P = 0.028 and 0.003 respectively). 152 
Furthermore, tolerogenic cytokines IL-10 and TGFβ were also up-regulated by approximately 153 
five and six fold respectively in PRO-3 when compared to the control treatment (P = 0.005 154 
and 0.003 respectively). There were no significant changes in gene expression between PRO-155 
1.5, PR0-PULSE and PRO-INI when compared to the control treatment with any of the 156 
investigated genes of interest (P > 0.05). 157 
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 158 
Figure 4.1: Relative mid-intestinal gene expression of caspase-3 and PCNA and HSP70 after 159 
three and six weeks of feeding experimental diets. Values are reported in fold change when 160 
compared against the expression in the control treatment (set to 1.0). Asterisks highlight 161 
significant differences (P < 0.05) when compared to the control treatment within the same 162 
sampling period. 163 
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 164 
Figure 4.2: Relative gene expression of intestinal TLR2 (a) pro-inflammatory cytokines 165 
TNFα and IL-1β (b) and anti-inflammatory cytokines IL-10 and TGFβ (c) after three and six 166 
weeks of feeding experimental diets. Values are reported in fold change when compared 167 
against the expression in the control treatment (set to 1.0). Asterisks highlight significant 168 
differences (P < 0.05) when compared to the control treatment within the same sampling 169 
period. 170 
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4.2.3 Intestinal histology 171 
At week three and six, light microscopy was used to examine the perimeter ratio, IEL 172 
and goblet cell levels from the mid-intestine (Table 4.6). At both time points fish from all 173 
dietary treatments had an intact epithelial barrier with extensive mucosal folds, abundant 174 
IEL’s and numerous goblet cells. After three weeks of feeding experimental diets, perimeter 175 
ratio, IEL and goblet cell abundance remained unaffected by dietary regime (P = 0.771, 0.246 176 
and 0.477 respectively). After six weeks, tilapia in different treatments showed altered 177 
perimeter ratios (P = 0.007). The highest perimeter ratio was recorded in PRO-INI which was 178 
significantly higher than PRO-1.5 but not CON, PRO-3 or PRO-PULSE. Perimeter ratio in 179 
PRO-3 was also significantly higher when compared to the lower probiotic dose, PRO-1.5. 180 
However, perimeter ratio remained unchanged between treatments PRO-1.5, CON, and PRO-181 
PULSE. After six weeks, IEL and goblet cell abundance remained unchanged by dietary 182 
treatment in groups CON, PRO-1.5, PRO-PULSE and PRO-INI. However, IEL levels were 183 
significantly elevated in PRO-3 when compared to treatments CON, PRO-PULSE and PRO-184 
INI (P = 0.003) but not PRO1.5. PRO-3 also contained significantly larger populations of 185 
goblet cell when compared to all other treatments after six weeks (P < 0.001). No differences 186 
were observed in IEL or goblet cell abundance after three weeks (Table 4.6).  187 
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Table 4.6: Histological data from the mid-intestine of tilapia after three and six weeks of experimental feeding.   188 
 CON PRO-1.5 PRO-3 PRO-PULSE PRO-INI 
Week 3      
Perimeter ratio (AU) 2.94 ± 0.92 3.34 ± 0.60 3.10 ± 0.70 3.40 ± 0.88 3.58 ± 0.93 
IEL’s (per 100 µm) 31.06 ± 3.54 34.63 ± 4.42 36.55 ± 2.99 32.55 ± 2.76 32.91 ± 5.25 
Goblet cells (per 100 µm) 4.22 ± 0.93 4.43 ± 0.88 4.37 ± 0.72 3.83 ± 0.54 3.66 ± 0.89 
Week 6      
Perimeter ratio (AU) 2.57 ± 0.58
ab
 2.03 ± 0.29
a
 3.16 ± 0.86
b
 2.94 ± 0.47
ab
 3.68 ± 0.72
b
 
IEL’s (per 100 µm) 34.04 ± 4.41a 37.39 ± 3.60ab 41.63 ± 2.66b 34.85 ± 2.99a 31.95 ± 1.61a 
Goblet cells (per 100 µm) 4.96 ± 1.53
a
 4.95 ± 0.91
a
 8.56 ± 0.82
b
 5.18 ± 0.64
a
 5.58 ± 1.33
a
 
a, b
 Different superscripts indicate a significant difference (P < 0.05).  189 
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4.2.4 Culture dependent analyses 190 
The effect of AquaStar
®
 Growout treatments on the allochthonous aerobic 191 
heterotrophic bacteria was determined using culture based methods at week three and six 192 
(Table 4.7). No significant differences were observed in TVC levels between the treatments 193 
at either time point with allochthonous levels approximately log 6-7 CFU g
-1
 for each 194 
treatment (week three P = 0.349 and week six P = 0.993).  195 
After three weeks of feeding experimental diets, there were significantly higher 196 
intestinal LAB in PRO-3 when compared to CON, PRO-PULSE and PRO-INI (P = 0.001) 197 
but no different to PRO-1.5. LAB were only detected in two out of three replicates in PRO-198 
1.5 and not detected at all in CON, PRO-PULSE and PRO-INI replicates. Thus there were no 199 
significant differences between these four treatments. Levels of enterococci showed a similar 200 
pattern. The abundance of allochthonous enterococci was greatest in PRO-3 and PRO-1.5. 201 
Enterococci were not detected in treatments CON or PRO-INI and in just one out of three 202 
replicates in PRO-PULSE. Consequently, enterococci levels were significantly higher in 203 
PRO-3 and PRO-1.5 when compared to those detected in other treatments (P = <0.001), but 204 
not different from each other. Bacillus levels remained unchanged between dietary regimes 205 
(P = 0.727; Table 4.7). 206 
After six weeks, highest LAB levels were observed in the digesta of PRO-3, these 207 
were significantly higher than CON and PRO-INI (P = 0.006) but not PRO-1.5 or PRO-208 
PULSE. Similarly, PRO-3 resulted in the highest Bacillus levels which were significantly 209 
higher than those found in PRO-PULSE but not in other treatments (P = 0.026). LAB and 210 
Bacillus populations were no different in treatments CON, PRO-1.5, PRO-PULSE and PRO-211 
INI. Furthermore, enterococci levels were significantly higher in PRO-3 when compared to 212 
CON, PRO-PULSE and PRO-INI. Despite being numerically higher, they were no different 213 
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to enterococci levels recovered in PRO-1.5 digesta (Table 4.7). Representative subsets of 214 
probiotics were confirmed by using 16S rRNA gene sequence analysis. 215 
 216 
Table 4.7: Allochthonous TVC, LAB, enterococci and Bacillus spp. (log CFU g
-1
) in the 217 
intestinal tract of tilapia after three and six weeks of experimental feeding. 218 
 CON PRO-1.5 PRO-3 PRO-PULSE PRO-INI 
Week 3      
TVC 6.29 ± 0.19 6.01 ± 0.53 7.07 ± 0.53 6.15 ± 0.18 6.77 ± 0.53 
LAB n.d
a 
2.93 ± 1.92
ab
 6.18 ± 0.99
b 
n.d
a 
n.d
a 
Bacillus spp. 4.77 ± 0.22 5.00 ± 0.21
 
5.89 ± 1.42
 
4.84 ± 0.19 4.95 ± 0.18 
Enterococci n.d
a 
3.98 ± 0.59
b 
5.83 ± 0.98
b 
1.16 ± 1.21
a 
n.d
a 
Week 6      
TVC 5.89 ± 0.59 5.92 ± 0.27 5.94 ± 0.28 6.01 ± 0.53 6.05 ± 0.51 
LAB 1.08 ± 1.34
a
 3.30 ± 1.86
ab
 5.39 ± 0.83
b
 2.45 ± 2.18
ab
 n.d
a
 
Bacillus spp. 4.30 ± 0.25
ab 
4.57 ± 0.22
ab
 5.18 ± 0.58
b
 3.87 ± 0.43
a 
4.10 ± 0.45
ab 
Enterococci n.d
a
 3.13 ± 1.72
bc
 5.03 ± 0.99
c
 0.94 ± 1.12
ab
 n.d
a
 
n.d = not detected 219 
a, b
 Different superscripts indicate a significant difference (P < 0.05). 220 
 221 
4.2.5 DGGE 222 
The influence of probiotic treatment on the allochthonous intestinal microbial 223 
diversity in tilapia was investigated using DGGE after three and six weeks. Suspected 224 
probiotic bands were identified by migration to the same position as known B. subtilis, E. 225 
faecium, L. reuteri and P. acidilactici samples. Presumed probiotic bands were isolated from 226 
DGGE gels and sequencing confirmed the presence of all four probiotic species from 227 
probiotic fingerprints. Tables 4.8 and 4.9 display the microbial ecological parameters derived 228 
from the DGGE fingerprints after three and six weeks, respectively.  229 
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Table 4.8: Microbial community analysis of the intestinal allochthonous bacterial populations of tilapia from DGGE fingerprints after three weeks 230 
of feeding experimental diets. 231 
 Microbial ecological parameters  Similarity (ANOSIM)  
 N Richness Diversity SIMPER (%)   R- value P- value Dissimilarity (%) 
CON 15.67 ± 1.89 5.32 ± 0.46 2.74 ± 0.13 78.82 ± 5.69      
PRO-1.5 16.00 ± 6.53 5.34 ± 1.58 2.68 ± 0.45 65.56 ± 12.27      
PRO-3 16.00 ± 2.16 5.40 ± 0.52 2.76 ± 0.14 74.84 ± 7.30      
PRO-PULSE 24.00 ± 2.45 7.23 ± 0.54 3.17 ± 0.10 91.65 ± 2.95      
PRO-INI 16.67 ± 1.25 5.57 ± 0.30 2.81 ± 0.08 79.83 ± 4.44      
Pairwise comparisons  
CON vs PRO-1.5       0.57 0.10 38.86 
CON vs PRO-3       0.65 0.10 33.18 
CON vs PRO-PULSE       1.00 0.10 33.94 
CON vs PRO-INI       0.78 0.10 30.52 
PRO-1.5 vs PRO-3       -0.11 0.70 25.12 
PRO-1.5 vs PRO-PULSE  0.35 0.20 30.46 
PRO-1.5 vs PRO-INI       0.22 0.10 32.33 
PRO-3 vs PRO-PULSE       0.56 0.10 26.79 
PRO-3 vs PRO-INI       0.19 0.10 24.92 
PRO-PULSE vs PRO-INI  0.78 0.10 25.07 
N = number of operational taxonomic units; Richness = Margalef species richness; Diversity = Shannon’s diversity index; SIMPER = similarity 232 
percentage within group replicates. 233 
a, b
 Different superscripts indicate a significant difference (P < 0.05).  234 
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Table 4.9: Microbial community analysis of the intestinal allochthonous bacterial populations of tilapia from DGGE fingerprints after six weeks 235 
of feeding experimental diets. 236 
 Microbial ecological parameters  Similarity (ANOSIM)  
 N Richness Diversity SIMPER (%)   R- value P- value Dissimilarity (%) 
CON 17.75 ± 1.64 5.82 ± 0.39 2.87 ± 0.10 84.14 ± 7.35
a
      
PRO-1.5 15.25 ± 4.87 5.19 ± 1.19 2.67 ± 0.34 62.54 ± 15.42
b
      
PRO-3 13.00 ± 1.00 4.68 ± 0.25 2.56 ± 0.08 78.36 ± 8.88
ab
      
PRO-PULSE 19.25 ± 2.49 6.16 ± 0.57 2.95 ± 1.13 82.42 ± 4.37
a
      
PRO-INI 15.00 ± 1.41 5.17 ± 0.34 2.70 ± 0.09 72.81 ± 12.24
ab
      
Pairwise comparisons  
CON vs PRO-1.5       0.27 0.09 35.11 
CON vs PRO-3       1.00 0.03 53.35 
CON vs PRO-PULSE       0.37 0.06 20.84 
CON vs PRO-INI       0.17 0.11 23.64 
PRO-1.5 vs PRO-3       0.15 0.23 34.54 
PRO-1.5 vs PRO-PULSE    0.47 0.03 40.33 
PRO-1.5 vs PRO-INI       0.44 0.06 42.48 
PRO-3 vs PRO-PULSE       1.00 0.03 58.25 
PRO-3 vs PRO-INI       0.98 0.03 58.10 
PRO-PULSE vs PRO-INI   0.08 0.37 22.14 
N = number of operational taxonomic units; Richness = Margalef species richness; Diversity = Shannon’s diversity index; SIMPER = similarity 237 
percentage within group replicates. 238 
a, b
 Different superscripts indicate a significant difference (P < 0.05).  239 
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At week three, numerically PRO-PULSE displayed highest values with regards to 240 
number of OTU’s, species richness and diversity indices observed in allochthonous intestinal 241 
microbial communities (Table 4.8). However, these differences were not significant (P = 242 
0.147, 0.169 and 0.278 respectively). Replicates within all treatments showed a high 243 
similarity percentage (SIMPER) and no differences were detected between treatments (P = 244 
0.055). Similarly, no differences were observed when pair wise comparisons were assessed 245 
by means of ANOSIM. Replicates from CON, PRO-PULSE and PRO-INI showed tight 246 
clustering indicating a high similarity (Fig 4.3). Apart from one replicate from PRO-3, both 247 
the continuously supplemented probiotic groups (PRO-1.5 and PRO-3) showed a looser 248 
clustering effect, indicating their similarity to each other along with their dissimilarity to 249 
treatments CON, PRO-PULSE and PRO-INI. 250 
After six weeks, PRO-PULSE again demonstrated the highest values with respect to 251 
number of OTU’s, species richness or diversity indices. However, there were no significant 252 
differences between treatments (P = 0.083, 0.086 and 0.102 respectively; Table 4.9). 253 
Replicates from CON and PRO-PULSE showed the highest similarity percentage (SIMPER), 254 
this was significantly higher than replicates in PRO-1.5 but not those in PRO-3 or PRO-INI. 255 
Apart from PRO-1.5, all other treatments revealed no differences with regards to SIMPER 256 
analyses. ANOSIM revealed that the microbial communities within PRO-3 was significantly 257 
dissimilar to CON, PRO-PULSE and PRO-INI (53.35%, 58.25% and 58.10% dissimilar, 258 
respectively; P = 0.03) but not PRO-1.5 (34.54% dissimilar; P = 0.23). Additionally, the 259 
microbial community within PRO-1.5 was significantly dissimilar to the microbial 260 
community within the intestine of PRO-PULSE (40.33% dissimilar; P = 0.03; Table 4.9). 261 
This can be visualised in Fig 4.4 where there is a loose clustering effect of the communities 262 
from replicates assigned to each treatment. Replicates from treatments CON, PRO-PULSE 263 
and PRO-INI showed loose clustering although there was a certain amount of overlap 264 
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between these three treatments. Two out of four replicates from PRO-1.5 showed high 265 
similarity to those from PRO-3, whereas the remaining two replicates are more similar to the 266 
other treatments (Fig 4.4).  267 
  268 
4.2.6 Haemato-immunological analyses 269 
 Blood samples were assessed for haematocrit, haemoglobin and serum lysozyme 270 
activity after six weeks of feeding experimental diets (Table 4.10). Both haematocrit or 271 
haemoglobin values were within the expected range for tilapia but they were not affected by 272 
dietary regime. However, differences were observed in serum lysozyme. Serum lysozyme 273 
activity was significantly lower in PRO-1.5 when compared with activity in CON and PRO-274 
PULSE but not when compared with PRO-3 or PRO-INI (P = 0.034). Activity did not differ 275 
between treatments CON, PRO-3, PRO-PULSE or PRO-INI.  276 
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 277 
Figure 4.3: Dendrogram representing the relatedness of the microbial communities in the 278 
digesta of tilapia after three weeks of feeding with experimental diets. DGGE fingerprints 279 
below represent amplified products from the V3 region of the samples which correspond to 280 
those used in the dendrogram. 281 
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 282 
Figure 4.4: Dendrogram representing the relatedness of the microbial communities in the 283 
digesta of tilapia after six weeks of feeding with experimental diets. DGGE fingerprints 284 
below represent amplified products from the V3 region of the samples which correspond to 285 
those used in the dendrogram.  286 
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Table 4.10: Haemato-immunological data from tilapia after six weeks of experimental feeding. 287 
 CON PRO-1.5 PRO-3 PRO-PULSE PRO-INI 
Haematocrit (%PCV) 37.30 ± 2.45 39.60 ± 3.29 37.80 ± 2.86 38.00 ± 1.58 38.11 ± 3.18 
Haemoglobin (g dl
-1
) 7.24 ± 1.70 8.32 ± 1.09 8.12 ± 0.83 7.62 ± 1.87 8.42 ± 0.83 
Serum lysozyme 
activity (AU) 
335.50 ± 40.30
a
  295.43 ± 55.75
b
 344.04 ± 100.71
ab 
345.85 ± 43.80
a 
308.80 ± 60.57
ab 
a, b
 Different superscripts indicate a significant difference (P < 0.05).  288 
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4.4 Discussion 289 
The administration of AquaStar
®
 Growout at 3g kg
-1
 for six weeks resulted in 290 
improved growth performance when compared to treatments CON or PRO-INI.  Aquastar
®
 291 
Hatchery has previously been reported to improve growth performance of rainbow trout 292 
(Giannenas et al. 2015). Although there is no data regarding the growth promoting effects of 293 
AquaStar
®
 Growout in tilapia, Bacillus spp., Enterococcus spp. and Lactobacillus spp., either 294 
singularly or in combination with other species have been reported to improve tilapia growth 295 
(Lara-Flores et al. 2003; El-Haroun et al. 2006; Wang et al. 2008; Apún-Molina et al. 2009; 296 
Mehrim 2009; Essa et al. 2010; Zhou et al. 2010; Jatobá et al. 2011; Abumourad et al. 2013; 297 
Ayyat et al. 2014). The mechanisms which underpin these improvements are only partly 298 
described. Previous work on tilapia suggests that Aquastar
®
 Growout may improve the 299 
potential for growth by increasing absorptive surface area (Chapter 3). Probiotics may also be 300 
important in the production of digestive enzymes. Essa et al. reported elevated intestinal 301 
amylase, protease and lipase activities in tilapia supplemented with B. subtilis and/ or L. 302 
rhamnosus and elevated intestinal protease activity in fish supplemented with S. cerevisae 303 
(Essa et al. 2010). Probiotics have also shown antagonism to a number of pathogens (Aly et 304 
al. 2008). It could be hypothesised that probiotics are capable of exerting a similar growth 305 
promoting mechanism as antibiotic growth promoters, through the inhibition of sub-clinical 306 
infections.  307 
Heat shock proteins have important roles in protein metabolism, protein folding, 308 
protein chaperoning, mediating the repair and degradation of damaged proteins and are also 309 
involved in generating an immune response (Norouzitallab et al. 2015). Furthermore it has 310 
also been proposed that heat shock proteins play important roles in the long term adaptation 311 
of animals to their environments through genetic mechanisms (Basu et al. 2002). Fish 312 
exhibiting higher HSP70 expression may therefore be more able to generate an efficient 313 
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immune response and also be more tolerant to a wider range of environmental conditions. 314 
Many authors have reported lower expression of HSP70 after probiotic administration in fish 315 
(Avella et al. 2010a; Avella et al. 2010b; Avella et al. 2011) including tilapia (He et al. 2013). 316 
In the present study gene expression analyses were used to elucidate the effect of the 317 
probiotic treatment on the mid-intestine at the molecular level. After six weeks, intestinal 318 
HSP70 gene expression was significantly higher in PRO-3 when compared to the control. 319 
Using an ex vivo approach, Ren et al. (2013) demonstrated that exposure to Aeromonas 320 
hydrophila did not cause an upregulation of HSP70 in the anterior or posterior intestine of 321 
tilapia. Conversely, the addition of L. plantarum, as well as a mix of A. hydrophila and L. 322 
plantarum to the intestinal sac caused an upregulation of HSP70 (Ren et al. 2013). Similar 323 
results were reported by Liu et al. (2013) after the supplementation of hybrid tilapia diets 324 
with two Lactobacillus species. From their studies it was also evident that there appears to be 325 
a dosage, as well as temporal effect. For example, after 10 days intestinal HSP70 was 326 
significantly up-regulated, down-regulated after 20 days and not different after 35 days when 327 
compared to the control treatment.  328 
After six weeks, caspase-3 and PCNA gene expression were both significantly up-329 
regulated in PRO-3 when compared with the control group. Caspase-3 is part of the cysteine-330 
aspartic acid protease family where it is activated by initiator caspases-8 or 9 resulting in 331 
programmed cell death (apoptosis). On the other hand, PCNA (proliferating cell nuclear 332 
antigen) is a marker for cell proliferation and is crucial for cellular and DNA replication. 333 
Organised apoptosis is essential for the health of the host since it results in the elimination of 334 
dangerous or damaged cells without causing an inflammatory response or tissue damage 335 
(Voll et al. 1997). Since the GI tract is one of the key sites of interaction with the external 336 
environment (Ringø et al. 2007) the intestine could be exposed to a number of opportunistic 337 
pathogens or chemical contaminants, especially in aquaculture where high stocking densities 338 
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and water quality can be an issue. Therefore, both an elevated proliferative and apoptotic 339 
capacity is likely to be beneficial to the host.  340 
The gut associated lymphoid tissue (GALT) in fish differs from their mammalian 341 
counterparts since fish lack Peyer’s patches and mesenteric lymph nodes. Teleosts possess a 342 
more diffusely organised GALT which provides a physical, chemical and cellular barrier to 343 
pathogenic invasion (Foey and Picchietti 2014). Similar to mammalian models, immune and 344 
epithelial cells within the GALT of fish express pattern recognition receptors (PRR’s) 345 
including toll-like receptors (TLR’s), which are sensitive to a number of pathogen associated 346 
molecular patterns (PAMP’s). Upon ligation, a cascade effect is initiated through a series of 347 
adaptor proteins and transcription factors resulting in the transcription of important immune 348 
molecules such as cytokines, chemokines and defensins (Foey and Picchietti 2014). 349 
TLR2 gene expression was up-regulated after six weeks in PRO-3 when compared 350 
with the control treatment. TLR2 is ligated by lipoteichoic acid (LTA), which is a major 351 
constituent in the cell wall of Gram- positive bacteria (Takeuchi et al. 1999), such as those 352 
present in AquaStar
®
 Growout. This up-regulation, induced by Gram positive probiotics 353 
might be of particular importance because tilapia are susceptible to a number of Gram-354 
positive infections, in particular St. iniae and St. agalactiae. Indeed, TLR2 was up-regulated 355 
in Mrigal carp (Cirrhinus mrigala) following Streptococcus uberis infection as well as A. 356 
hydrophila infection (Basu et al. 2012), another destructive pathogen in tilapia culture. It has 357 
been demonstrated that TLR’s may have important roles to play in the probiotic modulation 358 
of the innate immune system in other fish species (Abid et al. 2013; Sun et al. 2014). Sun et 359 
al. (2014) reported an upregulation in both TLR2 and TLR5 in grouper after Psychrobacter 360 
sp. supplementation. Furthermore, authors demonstrated a higher expression of pro-361 
inflammatory genes IL-1β and IL-8, and anti-inflammatory gene TGFβ after probiotic 362 
supplementation. The present study also reports higher gene expression of both pro-363 
___________________________________________________________________ Chapter 4 
 
149 
 
inflammatory cytokines (TNFα and IL-1β) and anti-inflammatory cytokines (IL-10 and TGFβ) 364 
after probiotic administration at 3g kg
-1
 for six weeks when compared to the control treatment. 365 
Importantly, despite the up-regulation of pro-inflammatory cytokines, there was no evidence 366 
of inflammation from histology examinations. It is possible that this was balanced by the up-367 
regulation of anti-inflammatory cytokine gene expressions. Other authors have reported 368 
higher expression of pro-inflammatory cytokines in tilapia after probiotic feeding (Pirarat et 369 
al. 2011; He et al. 2013; Liu et al. 2013; Ren et al. 2013; Standen et al. 2013; Villamil et al. 370 
2014). It is postulated that the induction of pro-inflammatory cytokines improves immune 371 
readiness of the host. In support of this, disease resistance studies in tilapia have 372 
demonstrated that probiotics are able to increase the expression of TNFα and IL-1β which 373 
may have contributed to significantly lower mortality when exposed to A. hydrophila (Liu et 374 
al. 2013; Villamil et al. 2014).  375 
This study also demonstrated that the probiotics also have anti-inflammatory 376 
signalling effects, by inducing the up-regulation of TGFβ and IL-10. Naturally, anti-377 
inflammatory cytokines will have an immune-suppressive effect on the host; this could be 378 
indicative of a tolerance mechanism where the host does not interpret the probiotic as a threat. 379 
This has been demonstrated in other studies where TGFβ was up-regulated after probiotic 380 
administration (He et al. 2013; Liu et al. 2013). To the authors knowledge this is the first 381 
study to demonstrate probiotic modulation of IL-10 in the intestine of tilapia after probiotic 382 
feeding. However, similar results have been reported in rainbow trout after L. plantarum 383 
supplementation (Perez-Sanchez et al. 2011). 384 
Histological analyses revealed a significantly larger population of IEL’s in the mid 385 
intestine of tilapia after six weeks in PRO-3 when compared to treatments CON, PRO-386 
PULSE or PRO-INI. Similar results have been obtained in other studies using tilapia fed diets 387 
supplemented with either P. acidilactici (Standen et al. 2013), L. rhamnosus (Pirarat et al. 388 
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2011) or AquaStar
®
 Growout (Chapter 3). Probiotic administration has led to increased IEL 389 
abundance in other commercially important fish species including European sea bass  and 390 
gilthead sea bream (Salinas et al. 2008; Picchietti et al. 2009). Whilst the type of IEL cannot 391 
be eluded to in this study, Picchietti et al. (2009) characterised elevated T-cells and 392 
acidophilic granulocytes in the posterior intestine of European sea bass. Likewise, Salinas et 393 
al. (2008) reported higher levels of acidophilic granulocytes and Ig
+
 cells in the posterior 394 
intestine of gilthead sea bream when fed a mixed probiotic (Lactobacillus delbrüeckii ssp 395 
lactis + B. subtilis). These data suggest that probiotics not only act upon the innate immune 396 
system in fish, but may have important roles to play through adaptive immunity mechanisms 397 
too.  398 
Whilst all fish displayed abundant goblet cells within the intestine, there were 399 
significantly larger populations in the mid-intestine of tilapia in PRO-3 when compared to all 400 
other treatments after six weeks of probiotic supplementation. Intestinal mucus is vital to the 401 
defensive barrier, both physically and chemically, since it functions to trap and remove 402 
pathogens, preventing their attachment to the epithelia. In addition to mucin components 403 
(mucopolysaccharides) and glycoproteins, mucus also contains a number of secretory factors 404 
with a wide range of functions including pathogen antagonism (Ellis 2001; Whyte 2007). 405 
Applications of L. rhamnosus and P. acidilactici have also been reported to increase the 406 
number of goblet cells in tilapia (Pirarat et al. 2006; Standen et al. 2013). It remains to be 407 
seen however whether probiotics can modulate the compositional components within 408 
intestinal mucus. 409 
This study was successful in recovering each probiotic species from tilapia digesta, a 410 
requirement which is important for potential probiotic candidates. Furthermore, probiotic 411 
supplementation was capable of modulating the composition of intestinal microbiota. This 412 
confirms results obtained in Chapter 3 where the effect of dietary AquaStar Growout
®
 on the 413 
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intestinal microbiota in tilapia was demonstrated using high-throughput sequencing. Probiotic 414 
modulation of intestinal microbiota has also been achieved after dietary supplementation by B. 415 
subtilis, P. acidilactici, B. amyloliquefaciens, E. faecium,  Lactobacillus sp. L. plantarum, L. 416 
brevis, L. acidophilus and S. cerevisae as well as multi-species applications (Shelby et al. 417 
2006; Ferguson et al. 2010; Ridha and Azad 2012; He et al. 2013; Liu et al. 2013; Standen et 418 
al. 2013; Iwashita et al. 2015).  419 
In conclusion, under the current experimental conditions, the continuous 420 
supplementation of AquaStar
®
 Growout at 3g kg
-1
 can improve growth performance and 421 
elevate the intestinal immunological status in tilapia. The probiotic may act to augment 422 
mucosal tolerance mechanisms whilst creating a state of immune readiness, improved barrier 423 
function through the increased number of goblet cells and IEL’s in the intestine, which may 424 
ultimately retard pathogen infection and translocation. Future work should focus on 425 
investigating the temporal effect of AquaStar
®
 Growout on the localised immune response, as 426 
well as investigating the systemic immune response. Furthermore, it is important to study the 427 
molecular pathways which link TLR’s with cytokines, as this could provide important 428 
information regarding probiotic mechanisms of action.  429 
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Chapter 5. Dietary supplementation of AquaStar
®
 Growout elicits both a 1 
localised and systemic immune response in tilapia, Oreochromis niloticus 2 
 3 
Abstract 4 
The immunological status, intestinal morphology, intestinal microbiology and growth 5 
performance of tilapia, O. niloticus, were investigated after dietary administration of the 6 
commercial probiotic AquaStar
®
 Growout. Tilapia (41.43 ± 0.18g) were split into three 7 
treatments; control (CON), continuous probiotic feeding (PRO-3) and pulsed probiotic 8 
feeding (PRO-PULSE) and fed for five weeks. At weekly intervals samples of intestine and 9 
head-kidney (HK) were taken to assess the gene expression of TLR2, MYD88, NFκB and 10 
inflammatory cytokines. TLR2, TNFα, IL-1β, TGFβ and IL-10 were all up-regulated by 11 
probiotic treatments. The gene expression of MYD88 was not affected by dietary treatment in 12 
the intestine, but was up-regulated in probiotic treatments in the HK. Furthermore, the gene 13 
expression of intestinal NFκB was significantly down-regulated in both probiotic treatments 14 
when compared to the control. However, no differences were observed with NFκB mRNA 15 
levels in the HK indicating that cytokines are activated by different molecular pathways 16 
depending on the organ. The extent of the up/down-regulation in the genes of interest was 17 
dependent on the probiotic treatment (i.e. continuous or pulsed), the duration of feeding (i.e. 18 
two, three, four or five weeks) and the tissue investigated (i.e. intestine or HK). Histological 19 
appraisal revealed that after five weeks, tilapia in PRO-3 demonstrated a significantly larger 20 
abundance of intraepithelial leucocytes (IELs) and goblet cells when compared to CON. 21 
Within whole blood of fish, there were significantly higher circulating leucocytes in PRO-3 22 
when compared with CON. Together these results demonstrate that AquaStar
®
 Growout can 23 
improve the barrier function as well as the localised and systemic immune response. These 24 
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improvements may provide the host with greater protection when challenged with a potential 25 
pathogen. High-throughput sequencing revealed that dietary treatment had little effect on the 26 
microbial communities within the intestine. This highlights that microbial modulation is not 27 
always necessary when bringing benefits to immune responses. Importantly, all the 28 
improvements described were at no detriment to growth performance which remained 29 
unaffected by probiotic supplementation. 30 
 31 
5.1 Introduction 32 
Probiotics have been successful in protecting tilapia from a number of pathogens 33 
including A. hydrophila, Ed. tarda, Fl. columnare, Pr. vulgaris, Ps. fluorescens, St. iniae and 34 
St. agalactiae (Pirarat et al. 2006; Aly et al. 2008a; Mohamed and Ahmed Refat 2011; 35 
Abdel-Tawwab 2012; Ng et al. 2014; Villamil et al. 2014; Iwashita et al. 2015; Ridha and 36 
Azad 2015). The mechanisms behind elevated protection are unclear and likely differ 37 
depending on probiotic application. Probiotics may limit pathogenic invasion via the 38 
production of inhibitory substances (Apún-Molina et al. 2009; Abumourad et al. 2013; 39 
Villamil et al. 2014), or by reducing the available receptor sites or nutrients which are needed 40 
by pathogens (Verschuere et al. 2000; Ren et al. 2013). It has also been shown that the 41 
administration of inactivated bacteria can also bring immune benefits to the host (Taoka et al. 42 
2006). Considering inactivated bacteria could not compete for adhesion sites or nutrients, nor 43 
could they produce inhibitory substances, it is clear that probiotics can activate and modulate 44 
the mucosal immune system. The dietary supplementation of L. rhamnosus, P. acidilactici 45 
and AquaStar
®
 Growout have previously been reported to reinforce the intestinal barrier 46 
defence in tilapia by means of increasing IELs and goblet cells (Pirarat et al. 2011; Standen et 47 
al. 2013; Chapters 3 and 4).  48 
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There is a paucity of information detailing the molecular interactions between 49 
probiotics and mucosal immunity in fish. The recognition of microbes in the intestine is 50 
mediated by PRRs, including TLRs. TLRs recognise a broad range of microbe/pathogen 51 
associated molecular patterns (MAMPs/PAMPs) and are expressed according to location of 52 
MAMP/PAMP exposure. Teleosts express multiple TLRs including 1, 2, 3, 4, 5, 5S, 7, 8, 9, 53 
13, 14, 18, 19, 20, 21, 22 and 23 which recognise and respond to both bacterial and viral 54 
ligands (Rebl et al. 2010). Once bound, adaptor proteins, such as myeloid differentiation 55 
factor 88 (MYD88) are recruited. This induces the activation of transcription factors such as 56 
nuclear factor-kappa B (NFκB) which results in the production of cytokines and antimicrobial 57 
proteins (Zhu et al. 2013). In a recent study, Sun et al. (2014) demonstrated that grouper fed 58 
viable Psychrobacter sp. resulted in an up-regulation of intestinal TLR2, TLR5, MYD88 and 59 
cytokines IL-1β, TGFβ and IL-8. Furthermore, Chapter 4 reported that supplementing tilapia 60 
diets with AquaStar
®
 Growout at 3 g kg
-1
 resulted in an up-regulation of intestinal gene 61 
expression of TLR2 and a corresponding up-regulation in cytokines TNFα, IL-1β, TGFβ an 62 
IL-10.  63 
As well as improvements to localised immunity as highlighted in Chapters 3 and 4, 64 
probiotic supplementation can improve the systemic immunity in tilapia. These benefits can 65 
manifest themselves via modifications to blood constituents (such as serum lysozyme activity, 66 
circulating leucocytes etc.) or through the gene expression of cytokines in other immuno-67 
important organs such as the HK and spleen (Taoka et al. 2006; Aly et al. 2008b; Mehrim 68 
2009; Ali et al. 2010; Pirarat et al. 2011; Ridha and Azad 2012; Liu et al. 2013; Villamil et al. 69 
2014; Ridha and Azad 2015).  70 
The aim of this trial was to assess the temporal effects of probiotics on both the 71 
localised and systemic immune system through the analysis of intestinal and HK gene 72 
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expression, haemato-immunology and histology. Intestinal microbiology and growth 73 
performance were also investigated.  74 
 75 
5.2 Materials and methods 76 
5.2.1 Experimental design and dietary preparation 77 
Four hundred and fifty tilapia were randomly distributed to nine 500L concrete tanks 78 
(50 fish per tank; average weight = 41.43 ± 0.18g) which were supplied by freshwater 79 
sourced from the local river system, on a flow-through basis (Fig 5.1). Commercial diets (No. 80 
461; 32% protein, 5% lipid) were obtained from INTEQC Feed Co. Ltd., Thailand. The 81 
commercial diet was ground in a blender to form a fine powder, sieved to remove large 82 
particles and weighed into 1kg batches. AquaStar
®
 Growout was added to the ground diet at 83 
3g kg
-1
 (Table 5.1). The diet was mixed thoroughly to ensure a homogenous mix and warm 84 
water was added to form a consistency suitable for cold press extrusion. Once extruded, diets 85 
were placed in aluminium trays and dried in an air convection oven for 24 hours. The basal 86 
diet served as the control diet and was prepared in the same manner, without the addition of 87 
probiotic. Diets were analysed for proximate composition as described in section 2.4 (Table 88 
5.1). Treatments were as follows; control (basal diet void of AquaStar
®
 Growout), continuous 89 
probiotic feeding (continuous feeding of the basal diet supplemented with AquaStar
®
 90 
Growout at 3g kg
-1
) and probiotic pulse feeding (alternating weekly between AquaStar
®
 91 
Growout feeding at 3g kg
-1
 and the basal diet). Diet codes were assigned for ease of analysis 92 
(Table 5.2). Fish were fed experimental diets for five weeks at a rate of 2.5- 5% biomass per 93 
day in four equal rations and sampling took place at weekly intervals (two, three, four and 94 
five weeks). Water quality parameters were monitored and maintained as described in section 95 
2.1 with the exception of water temperature which was approximately 31 ± 1°C.  96 
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 97 
Figure 5.1: Flow through system where tilapia were held during trial III. The experimental 98 
system consisted of concrete tanks with a capacity of 500L. Water originated from the local 99 
river system and was monitored daily (pH, DO and temperature) and weekly (nitrogen waste) 100 
to ensure conditions were appropriate for tilapia.  101 
 102 
5.2.2 Growth performance 103 
Growth performance and feed utilisation were assessed by final weight, weight gain, feed 104 
intake, SGR, FCR and PER as described in section 2.5. 105 
 106 
Table 5.1: Dietary formulation and proximate composition (%). 107 
 Basal 3g kg
-1 
Commercial feed
a 
100.00 99.70 
AquaStar
®
 Growout
b 
 0.00 0.30 
Proximate composition (% as fed basis) 
Moisture  6.80 ± 0.11 6.84 ± 0.02 
Crude protein  33.97 ± 0.51 34.16 ± 0.20 
Lipid  6.06 ± 0.60 6.87 ± 0.22 
Ash  13.32 ± 0.04 13.26 ± 0.01 
Fibre 3.36 ± 0.12 3.58 ± 0.14 
Energy (MJ kg
-1
) 18.08 ± 0.31 17.77 ± 0.06 
a 
No. 461, INTEQC Feed Co Ltd., Thailand 108 
b
 Biomin Holding GmbH, Industriestrasse 21, 3130 Herzogenburg, Austria. 109 
 110 
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Table 5.2: Codes assigned to dietary treatments. 111 
Dietary code Diet 
CON Continuous feeding of basal diet (without probiotic) 
PRO-3 Continuous feeding of the basal diet supplemented with AquaStar
®
 
Growout at 3g kg
-1
 
PRO-PULSE Alternating weekly between AquaStar
®
 Growout feeding at 3g kg
-1
 and 
the basal diet 
 112 
5.2.3 RT-PCR 113 
At each sampling point, the mid-intestine and HK were isolated from three fish per 114 
tank (n = 9). Samples were stored separately in RNALater and kept at -20°C until 115 
transportation. Upon arrival in Plymouth, samples were immediately transferred to -80°C.  116 
Both organs were assessed for the gene expression of TLR2, MYD88, NFκB, TNFα, IL-1β 117 
TGFβ and IL-10. HK samples were processed as described in section 2.11. RNA was 118 
extracted from intestinal samples in the same manner as described in section 2.11. RT-PCR 119 
of intestinal samples were performed using the SYBR Green method in an iQ5 iCycler 120 
thermal cycler (Bio-Rad) and duplicate PCR reactions were set on a 96 well plate. Each 121 
reaction contained 1 µl of diluted (1/20 in molecular grade water) cDNA, 5 µl of 2X 122 
concentrated iQ
TM
 SYBR Green Supermix (Bio-Rad), 0.3 µM of forward and 0.3 µM of 123 
reverse primer. The thermal profile for all reactions was 3 min at 95°C, and then 45 cycles of 124 
20 s at 95°C, 20 s at 60°C and 20 s at 72°C. All quality control steps occurred as described in 125 
section 2.11. Primer sequences and efficiencies for intestinal and HK samples are displayed 126 
in Tables 5.3 and 5.4, respectively. The data obtained for both tissues (HK and intestine) 127 
were analysed using the iQ5 optical system software version 2.0 (Bio-Rad).  128 
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Table 5.3: Primer sequences for RT-PCR of intestinal samples. 129 
Gene Forward 5’ - 3’ Reverse 5’ – 3’ Amplicon 
size 
Tm 
(°C) 
E-
value 
GenBank number 
β-actin GGGTCAGAAAGACAGCTACGTT CTCAGCTCGTTGTAGAAGGTGT 144 56.7 1.94 XM_003443127.2 
TLR2 GCAGTGCCTTGAGTCTTGATC ACCGTGGAGATCGAGAACCT 101 59.6 1.92 XM_005460165 
MYD88 AGCTCGAAGTAAACGCCTGAT ACAAATGGTGAGGAAGCGTAAA 85 57.2 1.91 KJ130039 
NFκB CACTCGTCCGACTGCTCTAG TCTCCTCCAGCTCCCGATAC 82 61.4 1.98 XM_005462791.1 
TNFα TTCAGGGTGATCTGCGG CCCAGGTAAATGGCGTTGTA 197 54.9 1.91 NM_001279533.1 
IL-1β TGGTGACTCTCCTGGTCTGA GCACAACTTTATCGGCTTCCA 86 58.7 1.97 XM_005457887.1 
TGFβ TGCCAAGGTGCTTAACAGGT ATCCCCGACGTTACTCCGTA 118 57.3 1.94 XM_003459454.2 
IL-10 CTTCTCAGACCGTCCTCCTG AGGAGTCTTCGACGGACTGA 216 57.0 1.94 XM_003441366.2 
 130 
Table 5.4: Primer sequences for RT-PCR of HK samples. 131 
Gene Forward 5’ - 3’ Reverse 5’ – 3’ Amplicon 
size 
Tm 
(°C) 
E-
value 
GenBank number 
β-actin TGACCTCACAGACTACCTCATG TGATGTCACGCACGATTTCC 89 58.8 2.03 KJ126772.1 
GAPDH CCGATGTGTCAGTGGTGGAT GCCTTCTTGACGGCTTCCTT 82 59.4 1.98 JN381952.1 
EF1α TGATCTACAAGTGCGGAGGAA GGAGCCCTTTCCCATCTCA 80 58.4 2.00 AB075952.1 
TLR2 GCAGTGCCTTGAGTCTTGATC ACCGTGGAGATCGAGAACCT 101 59.6 1.99 XM_005460165 
MYD88 AGCTCGAAGTAAACGCCTGAT ACAAATGGTGAGGAAGCGTAAA 85 57.2 2.05 KJ130039 
NFκB CACTCGTCCGACTGCTCTAG TCTCCTCCAGCTCCCGATAC 82 61.4 1.67 XM_005462791.1 
TNFα CCAGAAGCACTAAAGGCGAAGA CCTTGGCTTTGCTGCTGATC 82 59.9 1.99 AY428948.1 
IL-1β TGGTGACTCTCCTGGTCTGA GCACAACTTTATCGGCTTCCA 86 58.7 1.92 XM_005457887.1 
TGFβ GTTTGAACTTCGGCGGTACTG TCCTGCTCATAGTCCCAGAGA 80 59.8 1.89 XM_003459454.2 
IL-10 CTGCTAGATCAGTCCGTCGAA GCAGAACCGTGTCCAGGTAA 94 59.6 1.99 XM_003441366.2 
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5.2.4 Intestinal histology 132 
At each sampling point, three fish per tank (n = 9) were sampled to asses perimeter 133 
ratio, IEL and goblet cell abundance as described in section 2.7.  134 
 135 
5.2.5 Haemato-immunological analyses 136 
 At each sampling point, blood samples were taken to assess haematocrit, haemoglobin, 137 
blood cell counts, MCV, MCH and MCHC (n = 9). Serum was collected to assess serum 138 
lysozyme activity (n = 15). All sampling and analyses was carried out according to section 139 
2.10. Furthermore leucocyte differential counts were conducted to determine the proportions 140 
of circulating white blood cells (n = 9). For this, a blood smear was prepared by the addition 141 
of 5 µl of whole blood onto a clean slide. A second slide was used to smear the blood sample 142 
down the length of the slide in order to achieve a monofilm layer of cells. Blood smears were 143 
left to dry, fixed in methanol for 15 min and stained using May Grünwald stain (diluted 1:1 144 
with Sorensen’s buffer, pH 6.8). Slides were then rinsed in Sorensen’s buffer and counter 145 
stained with Giemsa satin (diluted 1:9 with Sorensen’s buffer, pH 6.8). After a final rinse in 146 
buffer, slides were left to dry and cover slips were added using DPX mountant. All blood 147 
smears were examined under 400 x magnification. One hundred white blood cells were 148 
counted to quantify the proportions of lymphocytes, monocytes and granulocytes (Fig 5.2).  149 
 150 
5.2.6 High-throughput sequencing 151 
After four and five weeks, digesta was isolated from the mid-intestine of tilapia from 152 
two fish per tank (n = 6). All microbiology samples were stored and transported to Plymouth 153 
University in 100% molecular grade ethanol. DNA was extracted using the QIAamp Stool 154 
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Mini Kit (Qiagen) as described in section 2.8.3 with an extra half hour for the lysozyme pre-155 
treatment. High-throughput sequencing was used to assess allochthonous bacterial 156 
communities as described in section 2.8.5. 157 
 158 
5.2.7 Statistical analyses 159 
Statistical analyses were carried out as described in section 2.12.  160 
 161 
  
  
Figure 5.2: Characterisation of tilapia leucocyte sub-populations stained with May Grünwald 162 
and Giemsa: (a) lymphocyte, (b) monocyte, (c) granulocyte (neutrophil) and (d) granulocyte 163 
(eosinophil).  164 
 165 
a b 
c d 
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5.3 Results 166 
5.3.1 Growth performance 167 
 Growth performance was assessed by means of final weight, weight gain, feed intake, 168 
PER, FCR and SGR (Table 5.5). Fish in all treatments showed excellent growth 169 
characteristics with 100% survival in each treatment. No differences were observed between 170 
treatments in any parameter measured.  171 
 172 
Table 5.5: Growth performance of tilapia after five weeks of feeding experimental diets. 173 
 CON PRO-3 PRO-PULSE 
Initial weight (g fish
-1
) 41.43 ± 0.09 41.21 ± 0.12 41.65 ± 0.23 
Average weight (g fish
-1
 ) 103.86 ± 2.48 106.72 ± 1.51 107.92 ± 2.69 
Weight gain (g fish
-1
) 62.42 ± 2.49 65.51 ± 1.44 66.27 ± 2.60 
Feed intake (g fish
-1
) 65.08 ± 0.31 66.37 ± 1.35 66.56 ± 1.13 
PER 3.19 ± 0.25 3.21 ± 0.13 3.27 ± 0.03 
FCR (g g
-1
) 0.99 ± 0.04 0.99 ± 0.02 0.98 ± 0.00 
SGR (% day
-1
) 3.06 ± 0.02 3.17 ± 0.04 3.17 ± 0.08 
Survival 100 ± 0.00 100 ± 0.00 100 ± 0.00 
  174 
 175 
5.3.2 RT-PCR 176 
 Relative intestinal gene expression of TLR2, MYD88 and NFκB were analysed at 177 
each time point. After two and five weeks of experimental feeding, the intestinal gene 178 
expression of TLR2 was significantly higher in PRO-3 when compared with both CON and 179 
PRO-PULSE. At these time points, there was no difference in gene expression levels between 180 
CON and PRO-PULSE treatments. After three and four weeks of experimental feeding, 181 
TLR2 expression was significantly higher in PRO-PULSE when compared with CON, but 182 
significantly lower than PRO-3, where gene expression was highest (Fig 5.3a). The intestinal 183 
gene expression of MYD88 was not affected by dietary treatment (Fig 5.3b). Initially, after 184 
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two weeks of experimental feeding, intestinal gene expression of NFκB was similar in all 185 
treatments. By week three the abundance of NFκB mRNA had significantly reduced in both 186 
probiotic treatments, PRO-3 and PRO-PULSE, when compared with CON. At week three 187 
there was no difference between PRO-3 and PRO-PULSE. After four and five weeks, similar 188 
results were observed with regards to the gene expression of intestinal NFκB. At both of 189 
these time points the expression was significantly higher in the CON fed fish when compared 190 
to both PRO-3 and PRO-PULSE, but PRO-PULSE samples demonstrated significantly 191 
higher expression than PRO-3 samples (Fig 5.3c).  192 
 The relative intestinal expression of cytokines TNFα, IL-1β, IL-10 and TGFβ were 193 
also analysed at weeks two, three, four and five. At each time point the gene expression of 194 
TNFα was significantly higher in PRO-3 fed fish when compared with PRO-PULSE. In each 195 
case, expression levels observed in PRO-PULSE samples were significantly higher than CON 196 
samples which had the lowest mRNA levels (Fig 5.4a). With the exception of week two, 197 
similar results were observed with regards to intestinal gene expression of IL-1β (Fig 5.4b). 198 
The highest expression levels were observed in PRO-3 samples, these were significantly 199 
higher than those of the PRO-PULSE which in turn had significantly higher expression levels 200 
when compared to CON. At week two there were no differences in IL-1β expression between 201 
dietary treatments.  202 
 After two weeks of experimental feeding, the abundance of TGFβ mRNA was 203 
significantly higher in treatment PRO-3 when compared to both PRO-PULSE and CON. 204 
There were no differences in expression levels between PRO-PULSE and PRO-3. After three 205 
and four weeks, TGFβ expression levels remained unaffected by dietary treatment. After five 206 
weeks, both probiotic treatments, PRO-3 and PRO-PULSE, resulted in significantly lower 207 
levels of TGFβ mRNA levels when compared with CON but expression was not different 208 
between PRO-3 and PRO-PULSE (Fig 5.4c). At each time point the intestinal expression of 209 
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IL-10 was highest in PRO-3. At week two, gene expression was significantly higher in PRO-210 
3 when compared to both CON and PRO-PULSE; no differences were observed between 211 
these treatments however. After weeks three, four and five, IL-10 gene expression was 212 
significantly higher in PRO-3 samples when compared to PRO-PULSE, which in turn 213 
displayed significantly higher expression levels than those in CON (Fig 5.4d). 214 
 215 
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 216 
Figure 5.3: Effects of dietary treatment on the relative gene expression of intestinal TLR2 (a), 217 
MYD88 (b) and NFκB (c) after different feeding periods. Values are presented as means ± 218 
standard deviation. Different superscripts within each time point indicate a significant 219 
difference (P < 0.05). 220 
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 221 
Figure 5.4: Effects of dietary treatment on the relative gene expression of intestinal TNFα (a), IL-1β (b), TGFβ (c) and IL-10 (d) after different 222 
feeding periods. Values are presented as means ± standard deviation. Different superscripts within each time point indicate a significant difference 223 
(P < 0.05).  224 
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To evaluate whether dietary probiotics can affect systemic immunity, the gene 225 
expression of TLR2, MYD88, NFκB, TNFα, IL-1β, TGFβ and IL-10 were assessed in HK 226 
tissues. The dietary supplementation of probiotics did not result in any changes to the HK 227 
TLR2, MYD88, NFκB or cytokine gene expression until week five. Furthermore no obvious 228 
patterns emerged. After five weeks, the continuous supplementation of AquaStar Growout
®
 229 
(PRO-3) significantly increased the HK gene expression of both TLR2 and MYD88 when 230 
compared to CON. The relative HK gene expression of TLR2 in PRO-PULSE treated fish did 231 
not differ from that of either PRO-3 or CON treatments (Fig 5.5a). In the case of MYD88, the 232 
elevated expression in PRO-3 was not statistically different to that of PRO-PULSE, but 233 
expression levels were significantly higher in PRO-PULSE when compared to that of the 234 
CON samples (Fig 5.5b). The relative abundance of NFκB in the HK was not affected by 235 
dietary treatment at any time point assessed (Fig 5.5c). 236 
The relative expression of TNFα was significantly up-regulated in treatments PRO-3 237 
and PRO-PULSE when compared to CON. Despite the highest expression being observed in 238 
PRO-3, there were no significant differences between the two probiotic treatments with 239 
regards to TNFα gene expression (Fig 5.6a). The HK expression of pro-inflammatory gene 240 
IL-1β was also significantly higher in PRO-3 when compared with CON but not PRO-241 
PULSE. PRO-PULSE revealed numerically higher expression of IL-1β than that of CON but 242 
there were no significant differences between the two treatments (Fig 5.6b). The HK of fish 243 
belonging to PRO-3 revealed a significant up-regulation of TGFβ and IL-10 when compared 244 
to CON. In both cases the expression of TGFβ and IL-10 in PRO-PULSE did not differ from 245 
either PRO-3 or CON treatments (Figs 5.6c and 5.6d, respectively). 246 
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 247 
Figure 5.5: Effects of dietary treatment on the relative gene expression of HK TLR2 (a), 248 
MYD88 (b) and NFκB (c) after different feeding periods. Values are presented as means ± 249 
standard deviation. Different superscripts, within each time point, indicate a significant 250 
difference (P < 0.05). 251 
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 252 
Figure 5.6: Effects of dietary treatment on the relative gene expression of HK TNFα (a), IL-1β (b), TGFβ (c) and IL-10 (d) after different feeding 253 
periods. Values are presented as means ± standard deviation. Different superscripts, within each time point, indicate a significant difference (P < 254 
0.05).  255 
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5.3.3 Intestinal histology 256 
At each sampling time point, a histological appraisal of the mid-intestine of tilapia 257 
was conducted by the measurement of the perimeter ratio, IEL and goblet cell numbers 258 
(Table 5.6). With the exception of week four, the perimeter ratio was highest in the probiotic 259 
treatments when compared with the control, however, no statistical difference was observed 260 
at any time point. The abundance of IELs and goblet cells were not affected by dietary 261 
treatment from weeks two to four. In probiotic treatments, IELs showed an increasing 262 
abundance through the investigation and after five weeks there were significantly higher 263 
populations of IELs in treatment PRO-3 (40.95 ± 7.04 per 100 µm) when compared to CON 264 
(29.50 ± 4.59 per 100 µm), but were not different to PRO-PULSE (33.43 ± 6.98 per 100 µm). 265 
CON and PRO-PULSE treatments did not differ from each other with regards to IEL 266 
abundance. The same patterns were observed with respect to the abundance of goblet cells 267 
residing in the mid-intestine of tilapia. In probiotic treatments, the number of goblet cells 268 
showed a gradual increase as the trial progressed until week five where they were 269 
significantly more abundant in PRO-3 (7.55 ± 2.49 per 100 µm) when compared to CON 270 
(4.77 ± 1.46 per 100 µm) but not PRO-PULSE (5.70 ± 2.05 per 100 µm). CON and PRO-271 
PULSE treatments did not differ from each other with regards to goblet cell abundance. 272 
 273 
 274 
 275 
 276 
 277 
 278 
 279 
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Table 5.6: Histological data from the mid-intestine of tilapia after two, three, four and five 280 
weeks of experimental feeding.   281 
 CON PRO-3 PRO-PULSE 
Week 2    
Perimeter ratio (AU) 2.68 ± 0.50 3.25 ± 1.08 2.90 ± 0.54 
IEL’s (per 100 µm) 30.22 ± 2.52 31.17 ± 3.74 29.93 ± 3.58 
Goblet cells (per 100 µm) 3.79 ± 0.53 4.06 ± 0.67 4.38 ± 0.63 
Week 3    
Perimeter ratio (AU) 2.70 ± 0.71 2.97 ± 0.88 3.33 ± 0.96 
IEL’s (per 100 µm) 31.43 ± 2.95 29.84 ± 1.76 31.23 ± 3.56 
Goblet cells (per 100 µm) 4.59 ± 0.43 5.07 ± 0.82 5.16 ± 0.54 
Week 4    
Perimeter ratio (AU) 3.70 ± 1.02 3.52 ± 0.73 3.38 ± 0.46 
IEL’s (per 100 µm) 30.60 ± 3.00 34.82 ± 2.66 33.37 ± 4.93 
Goblet cells (per 100 µm) 3.71 ± 0.98 5.14 ± 1.17 4.52 ± 1.32 
Week 5    
Perimeter ratio (AU) 3.28 ± 0.53 3.49 ± 1.27 3.52 ± 0.65 
IEL’s (per 100 µm) 29.50 ± 4.59a 40.95 ± 7.04b 33.43 ± 6.98ab 
Goblet cells (per 100 µm) 4.77 ± 1.46
a
 7.55 ± 2.49
b
 5.70 ± 2.05
ab
 
a, b
 Different superscripts indicate a significant difference (P < 0.05). 282 
 283 
5.3.4 Haemato-immunological analyses 284 
 At each sampling time point, the haemato-immunological status of tilapia was 285 
assessed by the measurement of haematocrit, haemoglobin, erythrocyte and leucocyte counts, 286 
MCV, MCH, MCHC and serum lysozyme activity (Table 5.7). After two weeks of 287 
experimental feeding, the haemoglobin concentration was significantly higher in PRO-288 
PULSE fed fish (11.67 ± 1.38 g dl
-1
) when compared with CON fed fish (9.30 ± 1.32 g dl
-1
), 289 
but it was not different to PRO-3 (10.70 ± 0.96 g dl
-1
). As a result of this, MCHC was also 290 
significantly higher in the PRO-PULSE treatment (30.37 ± 3.57 g dl
-1
)
 
when compared to 291 
both CON and PRO-3 treatments (22.60 ± 2.57 and 25.78 ± 1.65 g dl
-1
). Haematocrit, 292 
erythrocyte levels, leucocyte levels, MCV, MCH and serum lysozyme activity remained 293 
unaffected by dietary treatment after two weeks.  294 
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Table 5.7: Haemato-immunological data from tilapia after experimental feeding at each 295 
sampling point. 296 
 CON PRO-3 PRO-PULSE 
Week 2    
Haematocrit (%PCV) 41.11 ± 3.03 41.56 ± 3.17 38.78 ± 4.98 
Haemoglobin (g dl
-1
) 9.30 ± 1.32
a 
10.70 ± 0.96
ab
 11.67 ± 1.38
b
 
RBC (10
6
 µl-1) 1.26 ± 0.42 1.40 ± 0.43 1.55 ± 0.32 
WBC (10
3
 µl-1) 10.71 ± 0.66 10.38 ± 0.95 10.65 ± 1.16 
MCV (fL) 379.48 ± 174.70 324.29 ± 103.01 259.18 ± 53.39 
MCH (pg) 86.69 ± 45.30 83.06 ± 24.93 78.42 ± 18.38 
MCHC (g dl
-1
) 22.60 ± 2.57
a 
25.78 ± 1.65
a
 30.37 ± 3.57
b
 
Serum lysozyme 
activity (AU) 
356.08 ± 79.25 365.82 ± 100.27 385.38 ± 84.27 
Week 3    
Haematocrit (%PCV) 40.67 ± 3.46
ab
 43.78 ± 2.25
b
 40.00 ± 2.11
a
 
Haemoglobin (g dl
-1
) 11.69 ± 1.55 13.27 ± 1.55 12.62 ± 1.29 
RBC (10
6
 µl-1) 1.47 ± 0.52 1.41 ± 0.32 1.27 ± 0.25 
WBC (10
3
 µl-1) 12.67 ± 1.92 12.17 ± 0.64 12.00 ± 1.93 
MCV (fL) 311.72 ± 103.55 326.91 ± 81.60 329.70 ± 75.98 
MCH (pg) 93.53 ± 43.42 98.86 ± 26.08 103.77 ± 24.29 
MCHC (g dl
-1
) 28.91 ± 4.36 30.23 ± 2.47 31.53 ± 2.52 
Serum lysozyme 
activity (AU) 
389.95 ± 95.82 420.51 ± 100.08 409.92 ± 77.36 
Week 4    
Haematocrit (%PCV) 41.67 ± 2.67 39.67 ± 3.68 39.00 ± 3.06 
Haemoglobin (g dl
-1
) 12.48 ± 2.69 11.70 ± 1.57 11.06 ± 1.53 
RBC (10
6
 µl-1) 1.44 ± 0.38
a
 1.24 ± 0.22
ab 
0.95 ± 0.18
b
 
WBC (10
3
 µl-1) 14.06 ± 5.37 15.46 ± 2.33 10.90 ± 1.05 
MCV (fL) 314.46 ± 93.36
a
 329.66 ± 61.31
ab
 426.64 ± 89.97
b 
MCH (pg) 95.14 ± 36.90 97.03 ± 19.87 122.37 ± 33.79 
MCHC (g dl
-1
) 29.87 ± 5.41 29.63 ± 3.88 28.58 ± 4.87 
Serum lysozyme 
activity (AU) 
406.62 ± 102.15 438.07 ± 105.57 474.57 ± 80.59 
Week 5    
Haematocrit (%PCV) 42.25 ± 2.05 43.43 ± 3.70 45.00 ± 3.43 
Haemoglobin (g dl
-1
) 11.43 ± 2.10 10.14 ± 2.39 10.59 ± 1.05 
RBC (10
6
 µl-1) 1.09 ± 0.39 1.17 ± 0.21 0.92 ± 0.18 
WBC (10
3
 µl-1) 10.29 ± 3.43
a
 16.62 ± 3.96
b
 12.79 ± 3.66
ab
 
MCV (fL) 432.01 ± 148.66 379.24 ± 82.32 530.37 ± 121.31 
MCH (pg) 113.63 ± 28.17 91.51 ± 32.42 120.25 ± 27.88 
MCHC (g dl
-1
) 26.78 ± 5.62 21.50 ± 1.75 23.86 ± 2.87 
Serum lysozyme 
activity (AU) 
290.68 ± 85.74 345.54 ± 65.73 282.43 ± 91.53 
a, b
 Different superscripts indicate a significant difference (P < 0.05).  297 
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After three weeks of experimental feeding, only haematocrit presented a statistical 298 
difference. Haematocrit was significantly higher in PRO-3 treatment (43.78 ± 2.25 %PCV) 299 
when compared with PRO-PULSE (40.00 ± 2.11 %PCV), but was not different to the CON 300 
fed fish (40.67 ± 3.46 %PCV). Haemoglobin, erythrocyte and leucocyte levels, MCV, MCH, 301 
MCHC and serum lysozyme activity remained unaffected by dietary treatment after three 302 
weeks.  303 
After four weeks erythrocytes were significantly more abundant in CON fed fish 304 
(1.44 ± 0.38 x10
6
 µl-1) when compared with PRO-PULSE (0.95 ± 0.18 x106 µl-1) but was not 305 
different to PRO-3 (1.24 ± 0.22 x10
6
 µl-1). Consequently, MCV was significantly lower in 306 
CON (314.46 ± 93.36 pg) when compared with PRO-PULSE (426.64 ± 89.97 pg) but was 307 
not different to PRO-3 (329.66 ± 61.31 pg). Haematocrit, haemoglobin, leucocyte levels, 308 
MCH, MCHC and serum lysozyme activity remained unaffected by dietary treatment after 309 
four weeks.  310 
After five weeks, leucocyte levels were significantly higher in PRO-3 (16.62 ± 3.96 311 
x10
3
 µl-1) when compared with CON (10.29 ± 3.43 x103 µl-1), but were not different to PRO-312 
PULSE (12.79 ± 3.66 x10
3
 µl-1). Haematocrit, haemoglobin, erythrocyte levels, MCV, MCH, 313 
MCHC and serum lysozyme activity remained unaffected by dietary treatment after five 314 
weeks of experimental feeding.  315 
With the exception of week three, where samples were damaged during transportation, 316 
the abundance of leucocyte sub-populations (lymphocytes, monocytes and granulocytes) 317 
were also investigated at each time point (Table 5.8). No significant differences were 318 
observed in the proportions of circulating lymphocytes, monocytes or granulocytes after two 319 
and four weeks of experimental feeding. After five weeks, blood from PRO-3 treated fish had 320 
significantly higher proportions of circulating monocytes (14.17 ± 4.54%) when compared to 321 
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fish in PRO-PULSE (7.83 ± 3.44%). The proportion of granulocytes was significantly higher 322 
in blood from CON (2.17 ± 1.17%) samples when compared to PRO-PULSE (0.67 ± 0.75%). 323 
 324 
Table 5.8: Circulatory leucocyte proportions of tilapia fed experimental diets at each 325 
sampling point. 326 
 CON PRO-3 PRO-PULSE 
Week 2    
Lymphocytes 84.00 ± 4.90 82.50 ± 5.25 86.67 ± 4.68 
Monocytes 11.17 ± 5.05 14.83 ± 4.37 11.17 ± 3.89 
Granulocytes 4.83 ± 1.57 2.67 ± 2.56 2.17 ± 1.21 
Week 3    
Lymphocytes -* -* -* 
Monocytes -* -* -* 
Granulocytes -* -* -* 
Week 4    
Lymphocytes 87.83 ± 5.76 87.83 ± 2.41 93.00 ± 2.52 
Monocytes 10.00 ± 4.08 10.50 ± 2.57 6.17 ± 2.34 
Granulocytes 2.17 ± 1.95 1.67 ± 1.70 0.83 ± 0.90 
Week 5    
Lymphocytes 88.67 ± 4.97 84.67 ± 3.68 91.50 ± 3.95 
Monocytes 9.17 ± 3.67
ab
 14.17 ± 4.54
b
 7.83 ± 3.44
a 
Granulocytes 2.17 ± 1.17
a
 1.17 ± 0.75
ab
 0.67 ± 0.75
b
 
* No data available due to sample damage during transportation 327 
a, b
 Different superscripts indicate a significant difference (P < 0.05). 328 
 329 
5.3.5 High-throughput sequencing 330 
Microbial communities from the digesta of tilapia were investigated after four and 331 
five weeks using high-throughput sequencing analyses. A total of 1,288,759 and 1,715,037 332 
sequence reads were obtained from the Ion Torrent
®
 PGM after four and five weeks, 333 
respectively (Table 5.9). After removing low quality reads, 19,821 ± 2,997, 18,351 ± 6,145 334 
and 23,470 ± 3,528 sequences were obtained after four weeks, and after five weeks, 11,969 ± 335 
3,513, 15,016 ± 13,429 and 14,696 ± 1,671 sequences were obtained for CON, PRO-3 and 336 
PRO-PULSE groups, respectively. These sequences were used for downstream analyses. 337 
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Good’s coverage estimators for all treatments were 1.00 at both time points indicating that 338 
sufficient sequencing coverage was achieved and that the OTU’s detected in the samples 339 
were representative of the microbial community.  340 
After four weeks, the numbers of OTU’s detected were significantly lower in PRO-341 
PULSE when compared to CON and PRO-3. There were no differences between CON and 342 
PRO-3. Both diversity and species richness (as indicated by Shannon and Chao1 indices, 343 
respectively) were lowest in the PRO-PULSE treatment. Diversity was significantly lower in 344 
this treatment when compared with PRO-3 but not CON. However, the diversity of microbial 345 
communities remained the same in PRO-3 and CON. Species richness was significantly 346 
lower in PRO-PULSE when compared to CON but was not different to PRO-3. No 347 
differences were observed in species richness between the two probiotic treatment, PRO-3 348 
and PRO-PULSE (Table 5.9).  349 
After five weeks, allochthonous microbial communities from the PRO-PULSE fed 350 
fish revealed numerically the highest number of observed species, diversity and species 351 
richness indices. However, there were no statistical differences in each parameter between 352 
experimental treatments (Table 5.9). 353 
 354 
 355 
 356 
 357 
 358 
 359 
 360 
 361 
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Table 5.9: Number of raw reads, reads assigned to OTU’s, Goods coverage and diversity/ 362 
richness indices of allochthonous intestinal microbiota after four and five weeks of 363 
experimental feeding. 364 
 CON PRO-3 PRO-PULSE 
Week 4    
Reads (pre trimming) 69,908 ± 7,646 65,784 ± 24,087 79,102 ± 13,440 
Reads assigned (post trimming) 19,821 ± 2,997 18,351 ± 6,145 23,470 ± 3,528 
Good’s Coverage 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 
Number of OTU’s 59.50 ± 1.84a 62.42 ± 3.88a 54.31 ± 2.91b 
Shannon’s diversity index 3.48 ± 0.30ab 3.62 ± 0.16a 3.23 ±  0.07b 
Chao1 Index 67.04 ± 2.84
a
 70.24 ± 5.02
ab 
60.56 ± 4.39
b
 
Week 5    
Reads (pre trimming) 69,685 ± 17,362 61,986 ± 15,527 72,387 ± 7,829 
Reads assigned (post trimming) 11,969 ± 3,513 15,016 ± 13,429 14,696 ± 1,671 
Good’s Coverage 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 
Number of OTU’s 42.57 ± 5.12 43.45 ± 4.15 45.88 ± 3.08 
Shannon’s diversity index 2.98 ± 0.22 2.99 ± 0.39 3.19 ± 0.25 
Chao1 Index 47.90 ± 5.19 48.91 ± 3.14 51.47 ± 2.29 
a, b
 Different superscripts indicate a significant difference (P < 0.05). 365 
 366 
After four weeks the PRO-PULSE group had just completed a week of basal feeding. 367 
High-throughput analyses after four weeks demonstrated that rarefaction curves approached 368 
the saturation phase in all treatments at approximately 5,000- 10,000 sequence reads (Fig 369 
5.7a). The PCoA plot and dendrogram (Fig 5.7b and 5.7c, respectively) demonstrated little 370 
clustering effect between each the replicates from each treatment. Fig 5.7d illustrates that 32 371 
genera were identified (i.e. accounting for >0.01% of the reads). Twenty three of these genera 372 
were found in all treatments. One of these genera (an unknown genera from the Family 373 
Rhodobacteraceae) was unique to CON replicates, four (Enterococcus, Lactobacillus, 374 
Pediococcus and an unknown genera belonging to the Family Enterococcaceae) were unique 375 
to PRO-3 and no genera were unique to PRO-PULSE replicates. Three genera were present 376 
in both CON and PRO-3 treatments (Nocardia, Rhodoplanes and Deefgea) and a further one 377 
genera was found in both CON and PRO-PULSE treatments (Aeromonas). 378 
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 379 
Figure 5.7: Bacterial community composition and relatedness in the digesta of tilapia fed 380 
experimental diets after four weeks. (a) Comparison of rarefaction curves between 381 
allochthonous intestinal microbiota composition between fish fed experimental treatments. (b) 382 
PCoA plots where data points represent samples from fish in treatment CON (red triangles), 383 
PRO-3 (blue circles) and PRO-PULSE (orange squares). (c) Dendrogram showing the 384 
relatedness of intestinal microbiota from treatment replicates. Bootstrap values are indicated 385 
by green (25-50%), yellow (50-75%) or red (75- 100%) branches. (d) Venn diagram showing 386 
the number of genera (accounting for >0.01% reads averaged from six replicates) assigned to 387 
each treatment. The PRO-PULSE treatment had just completed a week of basal feeding, 388 
without probiotic. 389 
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After the fifth week of experimental feeding, the PRO-PULSE treatment had just 390 
completed a week of probiotic feeding. After five weeks, high-throughput analyses 391 
demonstrated that rarefaction curves approached the saturation phase in all treatments at 392 
approximately 4,000- 6,000 sequence reads (Fig 5.8a). Similarly to week four, after five 393 
weeks the PCoA plot and dendrogram demonstrated little clustering effect between each the 394 
replicates from each treatment (Fig 5.8b and 5.8c). Fig 5.8d illustrates that 24 genera were 395 
identified (i.e. accounting for >0.01% of the reads). Twenty two of these genera were found 396 
in all treatments. No genera were unique to individual treatments, one genera (Aquicella) was 397 
common to both CON and PRO-3 treatments and one genera (Pediococcus) was common to 398 
both PRO-3 and PRO-PULSE treatments.   399 
 Fig 5.9 shows the major bacterial constituents in the digesta of fish fed experimental 400 
diets at the phylum and genus levels after four weeks. At this time point the PRO-PULSE 401 
treatment had just completed a week of basal feeding, without probiotic. In all treatments the 402 
most abundant 16S reads belonged to the phylum Fusobacteria (CON = 70.38 ± 3.7%, PRO-3 403 
= 66.84 ± 10.46% and PRO-PULSE = 72.93 ± 11.26%), followed by Proteobacteria (CON = 404 
23.72 ± 3.85%, PRO-3 = 17.12 ± 5.08% and PRO-PULSE = 21.91 ± 10.93%). The 405 
abundance of reads assigned to these phyla did not differ significantly between treatments. 406 
Reads assigned to Firmicutes were the next most abundant. PRO-3 replicates contained a 407 
significantly higher proportion of reads assigned to Firmicutes (15.62 ± 7.11%) when 408 
compared with those in CON (5.33 ± 2.94%) and PRO-PULSE (4.75 ± 3.43%). Reads 409 
assigned to Firmicutes in CON and PRO-PULSE treatments did not differ from each other. 410 
Reads belonging to Actinobacteria and Cyanobacteria were present in lower proportions and 411 
did not differ significantly between treatments.  412 
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 413 
Figure 5.8: Bacterial community composition and relatedness in the digesta of tilapia fed 414 
experimental diets after five weeks. (a) Comparison of rarefaction curves between 415 
allochthonous intestinal microbiota composition between fish fed experimental treatments. (b) 416 
PCoA plots where data points represent samples from fish in treatment CON (red triangles), 417 
PRO-3 (blue circles) and PRO-PULSE (orange squares). (c) Dendrogram showing the 418 
relatedness of intestinal microbiota from treatment replicates. Bootstrap values are indicated 419 
by green (25-50%), yellow (50-75%) or red (75- 100%) branches. (d) Venn diagram showing 420 
the number of genera (accounting for >0.01% reads averaged from six replicates) assigned to 421 
each treatment. The PRO-PULSE treatment had just completed a week of probiotic feeding.  422 
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 423 
Figure 5.9: Comparison of allochthonous intestinal microbiota composition between fish fed 424 
dietary treatments after four weeks of experimental feeding. Heatmap shows bacterial OTU’s 425 
assigned at the phylum level and bars show OTU’s assigned at the genus level (showing 426 
genera accounting for >0.01%). The PRO-PULSE treatment had just completed a week of 427 
basal feeding, without probiotic. 428 
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After four weeks, at the genera level, proportionally, the most abundant reads in each 429 
treatment were assigned to Cetobacterium (CON = 70.38 ± 3.70%, PRO-3 = 66.84 ± 10.46% 430 
and PRO-PULSE = 72.93 ± 11.26%) followed by Plesiomonas (CON = 15.56 ± 6.53%, 431 
PRO-3 = 14.00 ± 5.10% and PRO-PULSE = 18.99 ± 10.31%; Fig 5.9). Reads belonging to 432 
both Cetobacterium and Plesiomonas were not significantly different between treatments. 433 
Proportions of reads assigned to Bacillus, Enterococcus and Lactobacillus were significantly 434 
higher in PRO-3 (3.33 ± 3.23, 3.47 ± 2.73 and 0.51 ± 0.24, respectively) when compared to 435 
CON and PRO-PULSE. Reads assigned to Lactobacillus were not detected in either CON or 436 
PRO-PULSE treatments whereas reads assigned to Enterococcus were only detected in 4/6 437 
replicates (averaging 0.01%) and 2/6 replicates (averaging <0.01%) in CON and PRO-438 
PULSE treatments, respectively. Reads assigned to Bacillus were detected in low proportions 439 
in all replicates from CON (0.06 ± 0.06%) and PRO-PULSE treatments (0.03 ± 0.01%). 440 
Reads belonging to Pediococcus were recovered in all PRO-3 replicates (0.63 ± 0.97%) but 441 
were only detected in 1/6 replicates from both CON and PRO-PULSE treatments at ca. 442 
0.01%. However, Pediococcus abundance was not statistically different between treatments. 443 
Reads assigned to Aeromonas were significantly lower in PRO-3 (0.01 ± 0.01%) when 444 
compared to CON (0.04 ± 0.03%) but not PRO-PULSE (0.01 ± 0.01%). Reads assigned to 445 
other genera were not significantly different between dietary treatments after four weeks. 446 
 447 
 448 
 449 
  450 
 451 
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Fig 5.10 shows the major bacterial constituents in the digesta of fish fed experimental 452 
diets at the phylum and genus levels after five weeks. At this time point, the PRO-PULSE 453 
treatment had just completed a week of probiotic feeding. Reads belong to Fusobacteria were 454 
the most abundant in digesta samples after five weeks of experimental feeding (CON = 81.26 455 
± 6.39%, PRO-3 = 80.69 ± 8.78% and PRO-PULSE = 72.71 ± 14.28%). Reads assigned to 456 
Firmicutes (CON = 9.86 ± 7.08%, PRO-3 = 11.74 ± 6.16% and PRO-PULSE = 15.38 ± 457 
8.27%) and Proteobacteria (CON = 8.38 ± 2.47%, PRO-3 = 7.27 ± 3.34% and PRO-PULSE = 458 
11.46 ± 7.55%) were the second and third most abundant, respectively. Reads assigned to 459 
Cyanobacteria and Actinobacteria were also present in smaller quantities. The abundance of 460 
reads assigned to each phylum was not statistically different between the dietary treatments.  461 
 After five weeks, at the genera level, proportionally, the most abundant reads in each 462 
treatment were assigned to Cetobacterium (CON = 81.26 ± 6.91%, PRO-3 = 80.69 ± 9.48% 463 
and PRO-PULSE = 72.71 ± 15.43%) followed by Plesiomonas (CON = 6.62 ± 3.32%, PRO-464 
3 = 5.62 ± 3.67% and PRO-PULSE = 10.86 ± 8.47%; Fig 5.10). Reads belonging to both 465 
Cetobacterium and Plesiomonas were not significantly different between treatments. The 466 
proportions of reads assigned to Enterococcus were significantly higher in PRO-PULSE 467 
(6.95 ± 5.95%) when compared to CON (0.81 ± 1.11%) but was no different to PRO-3 (2.28 468 
± 1.08%). Reads assigned to Bacillus and Pediococcus genera were numerically higher in 469 
PRO-PULSE (1.89 ± 1.15% and 0.26 ± 0.47%, respectively) when compared with PRO-3 470 
(1.00 ± 0.94% and 0.06 ± 0.12%, respectively). In CON replicates, Bacillus accounted for 471 
0.55 ± 0.28% of the total reads and Pediococcus was only found in a single replicate at 472 
<0.01%. Reads assigned to Lactobacillus were highest in PRO-3 treatment (1.21 ± 1.34%) 473 
when compared with both PRO-PULSE (0.60 ± 0.36%) and CON (0.10 ± 0.15%). Besides 474 
Enterococcus, there were no significant differences in the number of reads assigned to each 475 
genus between treatments after five weeks of experimental feeding. 476 
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 477 
Figure 5.10: Comparison of allochthonous intestinal microbiota composition between fish 478 
fed dietary treatments after five weeks of experimental feeding. Heatmap shows bacterial 479 
OTU’s assigned at the phylum level and bars show OTU’s assigned at the genus level 480 
(showing genera accounting for >0.01%). The PRO-PULSE treatment had just completed a 481 
week of probiotic feeding. 482 
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5.4 Discussion 483 
The intestine provides a key site of interaction with the external world and is a major 484 
portal for pathogenic invasion in fish (Ringø et al. 2007). It is essential therefore that the 485 
GALT is robust and provides an effective immunological barrier against pathogenic invasion. 486 
One of the ways that probiotics may improve barrier function is by regulating molecular 487 
mechanisms within the intestine through the activation of mucosal immunity. TLRs help 488 
direct the immune response by activating signalling cascades that increase the expression of 489 
soluble mediators, which recruit and regulate the immune and inflammatory cells eventually 490 
initiating or enhancing the immune responses (Perez-Sanchez et al. 2010). Studies in grouper 491 
have demonstrated that after 60 days, probiotics Psychrobacter spp. and Bacillus pumilus can 492 
regulate the gene expression of TLR1, TLR2 and TLR5 (Sun et al. 2014; Yang et al. 2014). 493 
Furthermore, in Chapter 3, supplementing tilapia diets at 3 g kg
-1
 resulted in the up-regulation 494 
of intestinal TLR2 gene expression. In the current study, after just two weeks, intestinal 495 
TLR2 was significantly up-regulated in treatment PRO-3 when compared to CON. This 496 
pattern persisted throughout all sampling points. Furthermore after three and four weeks 497 
TLR2 was significantly up-regulated in PRO-PULSE when compared with CON, although 498 
the up-regulation was greatest in PRO-3. This up-regulation likely comes from the interaction 499 
between TLR2 and its agonist, lipoteichoic acid which is present on the extracellular 500 
membranes of the probiotic species used.  501 
Collectively, TLR signalling is largely divided into two pathways: MYD88 dependent 502 
and TRIF dependent pathways (Kawai and Akira 2007a). Here, the gene expression of 503 
intestinal MYD88 was not affected by dietary treatment. Similarly, after 60 days, groupers 504 
fed diets supplemented with B. pumilus showed no differences with regards to intestinal gene 505 
expression of MYD88 (Yang et al. 2014). These studies suggest that at the intestinal level 506 
probiotics may activate a MYD88 independent pathway in order to regulate cytokine 507 
___________________________________________________________________ Chapter 5 
 
184 
 
expression. Within the intestine, NF-κB was significantly down-regulated in probiotic groups 508 
when compared to the control after three, four and five weeks, with the greatest down-509 
regulation occurring in PRO-3. Work conducted by Chang and Nie (2009) suggest that 510 
another group of the PRR family, peptidoglycan recognition proteins (PGRPs), could mediate 511 
several intracellular signalling pathways and also significantly inhibit NF-κB activity. TLR2 512 
may work with PGRPs in the recognition of bacterial components, including peptidoglycan 513 
(Zhu et al. 2013). Since TLR2 and PGRPs share a common function, an increased expression 514 
of TLR2, as observed in probiotic treatments here, may also result in the inhibition of NF-κB. 515 
Future work should be conducted to further elucidate this mechanism. As well as NF-κB, 516 
signalling pathways initiated by TLRs can use mitogen-activated protein kinase (MAPK) 517 
followed by activation protein 1 (AP-1) which can regulate inflammatory cytokine genes 518 
(Kawai and Akira 2007b).  519 
Further changes were observed in the transcription of immune genes in the HK, but 520 
only after five weeks. This suggests that there is a lag phase of at least three weeks between 521 
the probiotic modulating the localised immune response in the intestine and the systemic 522 
response in the HK. Similar to the intestine, HK levels of TLR2 mRNA were significantly 523 
higher in PRO-3 when compared with CON. However, unlike the intestine, HK gene 524 
expression of MYD88 was also significantly higher in PRO-3 and PRO-PULSE when 525 
compared with CON suggesting that the production of inflammatory cytokines is through a 526 
MYD88 dependent pathway in the HK. The HK gene expression of NFκB was not 527 
significantly different between treatments; similar to the intestine, signalling pathways 528 
initiated by TLRs within the HK may rely on MAPK and AP-1 transcription factors.  529 
In the present study, the pro-inflammatory cytokines TNFα and IL-1β were 530 
significantly up-regulated in both probiotic treatments and both tissues, when compared to 531 
the control. The extent of this up-regulation was dependent on the probiotic treatment (i.e. 532 
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continuous vs pulsed supplementation), duration of feeding as well as the organ being 533 
investigated (i.e. either intestine or HK). Higher levels of pro-inflammatory cytokines may be 534 
indicative of a host which has superior immune readiness. It has been reported that other 535 
probiotics can up-regulate the gene expression of both intestinal and HK TNFα and IL-1β in 536 
tilapia (Pirarat et al. 2011; He et al. 2013; Standen et al. 2013). This could have been a 537 
contributory factor in providing tilapia with protection after being exposed to A. hydrophila 538 
and Ps. fluorescens (Abumourad et al. 2013; Liu et al. 2013; Ren et al. 2013; Villamil et al. 539 
2014).  540 
Initially, intestinal gene expression of TGFβ and IL-10 were significantly up-541 
regulated in probiotic groups. This pattern of gene expression was also observed in the HK, 542 
but only after five weeks. This suggests that the host does not recognise the probiotics as a 543 
threat; thus an increase in anti-inflammatory cytokines such as TGFβ and IL-10 may be part 544 
of mucosal tolerance. Although the intestinal expression of TGFβ was highest in PRO-3 after 545 
two weeks, after three and four weeks no differences were observed. Furthermore, after five 546 
weeks TGFβ was significantly down-regulated in probiotic treatments. Liu et al. (2013) also 547 
investigated the gene expression of TGFβ in the intestine, HK and spleen at three time points 548 
after supplementing tilapia diets with L. brevis and L. acidophilus. Liu and colleagues 549 
observed a complex relationship between the probiotic and the host which resulted in both the 550 
up and down-regulation of TGFβ depending on probiotic species, feeding duration and tissue 551 
of interest. Together, these studies highlight the complex temporal effect of probiotic 552 
administration on intestinal, HK and splenic immune gene expression.  553 
In addition, significantly higher IEL’s were observed in the mid-intestine of fish in 554 
PRO-3 when compared with CON after five weeks. It would be tempting to suppose that 555 
these leucocytes were primarily macrophages since these are potent producers of 556 
inflammatory cytokines (Mills and Ley 2014). Furthermore, the serum of tilapia in PRO-3 557 
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contained the highest proportions of circulating monocytes at all sampling points; it is these 558 
monocytes which migrate from the bloodstream into tissues where they differentiate into 559 
macrophages. Along with an increased abundance of IEL’s, PRO-3 treated fish also exhibited 560 
a significantly higher number of goblet cells when compared to CON after five weeks. 561 
Together, these data suggest an improved barrier function, lending increased protection to the 562 
host against invading pathogens. Other studies have reported increased IEL and goblet cell 563 
abundance after probiotic supplementation after time periods ranging from 30 days to eight 564 
weeks (Pirarat et al. 2011; Standen et al. 2013; Chapters 3 and 4).  565 
Further evidence of probiotic modulation of the systemic immune system was 566 
observed from haemato-immunology samples. After five weeks, PRO-3 blood samples 567 
contained a significantly higher number of white blood cells when compared to CON. White 568 
blood cells are essential components to both the innate and adaptive immune response and 569 
consequently a higher abundance implies a stronger immune system. After supplementing 570 
tilapia diets with Ps. fluorescens, Eissa and Abou-El Gheit (2014) observed a higher 571 
abundance of circulating leucocytes when compared to fish being fed non-supplemented diets. 572 
An increase in leucocytes could have been at least partially responsible for the reduced 573 
mortality observed when the tilapia were challenged via IP injection with A. hydrophila in the 574 
same study.  575 
Importantly, the improvements to the tilapia immune response were not detrimental to 576 
growth performance which remained unaffected by dietary treatment. This is in agreement 577 
with other studies which report similar results after probiotic feeding of tilapia (Shelby et al. 578 
2006; Abd El-Rhman et al. 2009; Zhou et al. 2010; Pirarat et al. 2011; He et al. 2013; Liu et 579 
al. 2013; Standen et al. 2013; Ng et al. 2014) Chapter 3). However, this was in contrast to 580 
Chapter 4 where AquaStar
®
 Growout was reported to improve growth in tilapia after six 581 
weeks of supplementation at 3g kg
-1
. 582 
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It is important that a probiotic survives the gastric process and reaches the intestine 583 
where it can exert its beneficial properties. Chapter 3 demonstrated that supplementing tilapia 584 
diets with AquaStar
®
 Growout at 5g kg
-1
 resulted in the relative dominance (~99%) of 585 
probiotic 16S rRNA reads. In the current study, between 5-10% of reads in probiotic fed fish 586 
were assigned to probiotic genera. This discrepancy could be due to the different doses 587 
administered in the feed (5 g kg
-1
 in Chapter 3 and 3 g kg
-1
 here). In addition, it is well known 588 
that multiple biotic and abiotic factors may affect the gut microbiota and the colonisation 589 
dynamics of probiotics, including diet and environment (Ghanbari et al. 2015). Tilapia were 590 
fed an experimental diet in Chapter 3 and kept at 28°C, but fed a commercial diet and 591 
maintained at >30°C here. Although considerably less abundant (in relative terms) than in 592 
Chapter 3, it is clear that probiotics do not need to be dominant members of the intestinal 593 
microbiota in order to exert beneficial effects upon the host. This is supported by other 594 
studies where, after probiotic supplementation, researchers have reported low probiotic 595 
recovery, whilst reporting benefits to intestinal immunity and growth performance (Sáenz de 596 
Rodrigáñez et al. 2009; Yang et al. 2012; He et al. 2013; Liu et al. 2013). This said, the 597 
relatively small number of reads assigned to the probiotic species were enough to result in a 598 
significantly higher abundance of Firmicutes in PRO-3 when compared to both PRO-PULSE 599 
and CON after four weeks. High-throughput sequencing also revealed that regardless of 600 
treatment, reads belonging to Cetobacterium dominated the intestinal microbiota. This was 601 
further identified as Ct. somerae. This species is an important contributor to the production of 602 
vitamins, particularly vitamin B12, and is routinely found in the intestines of many fish 603 
species, including tilapia (Tsuchiya et al. 2008; He et al. 2013; Liu et al. 2013; Larsen et al. 604 
2014; Chapter 3).  605 
This is the first study which has investigated the TLR signalling pathway after 606 
probiotic supplementation in tilapia. Under the current experimental conditions, AquaStar
®
 607 
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Growout is capable of localised immune modulation after two weeks (or less) and after 608 
longer feeding periods (between four and five weeks) can modulate systemic immunity in the 609 
HK. Furthermore, the probiotic application was capable of improving parameters that likely 610 
lead to improved intestinal barrier function. Since innate immunity is non-specific, the 611 
improvements described here suggest that the host could be better equipped to retard a wide 612 
range of pathogens, increasing their resistance to multiple infections and diseases. Future 613 
studies should test this hypothesis by assessing intestinal resistance to enteropathogens 614 
through challenge trials. These improvements were greatest when supplementing the 615 
probiotic continuously as opposed to via a pulsed regime.  616 
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Chapter 6: General discussion 1 
 2 
 The intestinal microbiota is important for a number of host functions, including 3 
nutrition and digestion, localised immunity and gut development (Rawls et al. 2004; Bates et 4 
al. 2006; Rawls et al. 2007). One of the most important goals in studying the intestinal 5 
microbiota of fish is to develop effective strategies for manipulating microbial communities 6 
to promote and sustain the health of the host. The continual supplementation of probiotic 7 
cells can result in the temporal colonisation of the intestinal tract and modulation of the 8 
indigenous microbiota. In Chapters 3 and 4, the intestinal microbiota was investigated using 9 
culture based methods. The results from both trials revealed that the probiotics tested, 10 
whether supplemented as monospecies or a multispecies application and regardless of feeding 11 
regime tested, had no effect on the total viable counts. Changes were detected in 12 
allochthonous (Chapters 3 and 4) and autochthonous (Chapter 3 only) populations when 13 
microbial communities were enumerated on selective media, namely MRS, S & B and 14 
Bacillus selective agar. The limitations of culture based methods, mainly cultivability issues, 15 
are well known (Zhou et al. 2014). Several methods for culture-independent microbial 16 
analyses have been utilised to assess the intestinal microbiota of fish, but the most widely 17 
used technique is DGGE, a semi-quantitative approach separating OTU amplicons based on 18 
nucleotide denaturing properties (Ferguson et al. 2010; He et al. 2013; Liu et al. 2013). 19 
Chapters 3 and 4 used a DGGE approach to assess the effect of dietary probiotics on the 20 
allochthonous microbial communities in tilapia. However, it can often be difficult to 21 
accurately identify OTU’s present in environmental samples using this technique.  22 
The introduction and development of high-throughput sequencing technologies has 23 
increased our understanding of microbial diversity in complex environments, including the 24 
intestinal tract of fish (van Kessel et al. 2011; Roeselers et al. 2011; Desai et al. 2012; Wu et 25 
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al. 2012; Boutin et al. 2013; Carda-Diéguez et al. 2013; Wu et al. 2013; Ingerslev et al. 2014; 26 
Zarkasi et al. 2014; Falcinelli et al. 2015; Lyons et al. 2015). These techniques offer 27 
researchers the ability to obtain large numbers of sequence reads in a relatively short period 28 
of time, yielding datasets which are orders of magnitude larger than those produced by other 29 
culture-independent approaches. Chapters 3 and 5 investigated the effect of dietary 30 
AquaStar
®
 Growout on the allochthonous intestinal communities of tilapia using an Ion 31 
Torrent PGM. In Chapter 3, 16S reads belonging to probiotic genera accounted for >99% of 32 
the total reads in the AQ-5 treatment. In Chapter 5 reads belonging to probiotic genera only 33 
accounted for 5- 10% of the total reads, depending on the duration of feeding and probiotic 34 
feeding regime. An obvious reason for this could be that tilapia diets were supplemented with 35 
a higher dose in Chapter 3 (5 g kg
-1
) when compared to tilapia diets in Chapter 5 (3 g kg
-1
). It 36 
is well known that multiple biotic and abiotic factors may affect the gut microbiota and the 37 
colonisation dynamics of probiotics, including diet and environmental factors (Ghanbari et al. 38 
2015). Tilapia were fed an experimental diet in Chapter 3 and kept at 28°C, but fed a 39 
commercial diet and maintained at >30°C in Chapter 5.  40 
Analyses of intestinal bacterial communities have almost exclusively relied on 16S 41 
rRNA sequencing due to its universal phylogenetic distribution. Caution must be applied 42 
when interpreting this type of data since each bacterial strain can contain multiple copies of 43 
the 16S subunit (Wintzingerode et al. 1997). This can lead researchers to underestimate the 44 
abundance of taxa with lower 16S rRNA copy numbers such as Acidobacteria and 45 
overestimate taxa with higher 16S rRNA copy numbers such as Gammaproteobacteria and 46 
Firmicutes (Větrovský and Baldrian 2013). Větrovský and Baldrian also highlighted that 47 
whilst it is assumed copies of rRNA genes within an organism are the same, it has been 48 
demonstrated that 16S sequences from the same species or even the same genome can differ. 49 
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This makes it possible to compare the abundance of the same OTU between treatments, but 50 
care should be taken when comparing multiple OTU’s within the same treatment. 51 
The presence of several similar taxa (e.g. Proteobacteria, Firmicutes and 52 
Bacteroidetes) across such a large range of fish species and geographic locations suggest 53 
these bacterial groups may be important to host gut functions and contribute towards a core 54 
gut microbiome. Roeselers et al. (2011) hypothesised that the shared microbiota is shaped by 55 
evolutionary conserved aspects of the intestinal tract anatomy, physiology and immunity. 56 
Upon feeding rainbow trout fishmeal or plant based diets for 10 months, Wong et al. (2013) 57 
observed that despite large differences in growth performance, fillet quality and fish welfare, 58 
the intestinal microbiota composition remained fairly stable. Microbiological analyses from 59 
the current studies, specifically from high-throughput sequencing datasets, suggest tilapia 60 
may also have a core microbiome. This work demonstrates that regardless of diet, treatment, 61 
environment and rearing conditions certain OTU’s such as Bacillus, Enterococcus, 62 
Cetobacterium, Plesiomonas, Staphylococcus, Leuconostoc, Weisella and Bradyrhizobium 63 
may populate the intestinal tract of tilapia. 64 
It has been demonstrated in vitro that certain probiotics can be antagonistic towards 65 
pathogens (Aly et al. 2008a; Aly et al. 2008b; Abd El-Rhman et al. 2009; Apún-Molina et al. 66 
2009; Zhou et al. 2010b; Del'Duca et al. 2013; Liu et al. 2013; Villamil et al. 2014). Few 67 
studies have assessed the in vivo ability of probiotics to antagonise pathogens. High-68 
throughput sequencing data from the current study demonstrated that probiotic 69 
supplementation can significantly lower the abundance of 16S rRNA reads assigned to genera 70 
which contain pathogens including Legionella (Chapter 3) and Aeromonas (Chapter 5). Reads 71 
assigned to Mycobacterium and Streptococcus were also detected at lower abundances in 72 
AQ-5 when compared to the control in Chapter 3. This microbial shift could be through direct 73 
pathogen antagonism via the production of inhibitory compounds, competition for adhesion 74 
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sites and nutrients or indirectly via the host’s immune system. Since the gut is a major portal 75 
of entry and infection loci for a number of pathogens, including aeromonads, the relative 76 
reduction in abundance through probiotic supplementation could have important connotations 77 
when fighting disease. This topic warrants further investigation.   78 
High-throughput sequencing techniques have revolutionised our understanding of the 79 
fish intestinal microbiome and has provided a general overview of the taxonomic profile of 80 
the microbiota; however, metagenomic analyses will provide researchers with information 81 
regarding the entire genetic potential of the microbiota (Ghanbari et al. 2015). It is more 82 
difficult to investigate the microbiome’s contribution towards functionality and metabolic 83 
processes. An appreciation of this functionality is essential in generating a complete view of 84 
the ecology and functional capacity of the gut microbiome. Transcriptomic and proteomic 85 
approaches have been used on microbial samples for several years to assess their metabolic 86 
potential and activity, respectively. These approaches have been applied and termed 87 
‘metatranscriptomics’ and ‘metaproteomics’. Metatranscriptomics is the study of all of the 88 
mRNA sequences from complex microbial ecosystems to determine the active bacterial 89 
processes expressed whilst metaproteomics identifies all of the total proteins present in 90 
environmental samples. Metabolomics approaches identify and quantify the metabolites and 91 
other small molecules in a complex microbial system. It is only through a multi-disciplined 92 
and holistic approach, termed “meta’omics” (Fig 6.1) which will lead to improved 93 
mechanistic models of microbial community structure and function (Sorek and Cossart 2010; 94 
Franzosa et al. 2015). The link between community structure and functional analyses has 95 
only been made in a small number of fish intestinal microbiota studies (Xing et al. 2013; Xia 96 
et al. 2014). Xing et al. (2013) investigated the taxonomic and functional metagenomic 97 
profile of the turbot intestinal tract microbiome, reporting the dominance of Firmicutes and 98 
Proteobacteria. When predicting the metabolic potential the microbiome, researchers 99 
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observed that the genes present coded for core metabolic functions including carbohydrate 100 
and protein metabolism, amino acid and vitamin production and RNA metabolism. Xia et al. 101 
(2014) also reported the dominance of Proteobacteria and Firmicutes, as well as 102 
Bacteroidetes in the intestine of Asian seabass, Lates calcarifer. Further to this, authors 103 
determined that in response to starvation, genes relating to transcription and cell division 104 
were depleted and genes associated with organelle biogenesis and immunity were enriched. 105 
These studies provide the first insights into the functional contribution of the microbiome. 106 
Probiotic studies must utilise these methodologies to elucidate the interactions between 107 
probiotics, the hosts microbiome and the host.  108 
 109 
 110 
Figure 6.1: Simplified model demonstrating the meta’omic approach which will enable 111 
researchers to elucidate microbiota structure and function of environmental samples, 112 
including intestinal microbiota. Metagenomic approaches should be complemented by the 113 
parallel detection of mRNA transcripts expressed (metatranscriptomics), translated proteins 114 
(metaproteomics) and the metabolites produced (metabolomics). Source: Ghanbari et al. 115 
(2015). 116 
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 Multiple studies in tilapia have reported an improvement in growth performance after 117 
probiotic supplementation (Abdel-Tawwab et al. 2008; Aly et al. 2008b; Aly et al. 2008c; 118 
Wang et al. 2008; Abd El-Rhman et al. 2009; Zhou et al. 2010a; Zhou et al. 2010b; 119 
Gonçalves et al. 2011; Jatobá et al. 2011; Ayyat et al. 2014; Eissa and Abou-El Gheit 2014; 120 
Ridha and Azad 2015). In Chapter 4, a significant improvement in final weight, weight gain 121 
and SGR was observed in tilapia which were fed diets supplemented with AquaStar
®
 122 
Growout at 3g kg
-1
 for six weeks when compared with the control treatment and the initial 123 
probiotic feeding group. Work conducted in Chapter 3 suggests that this improved growth 124 
performance could be a result of an increased absorptive surface area, through improved 125 
perimeter ratio and longer and more numerous microvilli. The same dosage (3g kg
-1
)
 
did not 126 
result in significantly improved growth performance in Chapter 5, possibly due to a shorter 127 
feeding period (5 weeks as opposed to 6 weeks) or a different diet. Alternatively, this could 128 
be a consequence of introducing ‘noise’ into the data by the weekly removal of biomass for 129 
sampling purposes. Importantly, the focus of the third trial (Chapter 5) was not growth 130 
performance, but immunological benefits brought about by probiotic supplementation. It 131 
should be noted that growth performance similar to control treatments (i.e. no difference in 132 
growth performance) can be considered a positive outcome if the probiotic can manifest other 133 
benefits such as immune modulation or improvements in gut morphology, as observed in 134 
these chapters, which would likely use energy and resources. Only detrimental effects in 135 
growth performance can be considered negative as observed in Shelby et al. (2006), Ridha & 136 
Azad (2015), Abumourad et al. (2013) and Abd El-Rhman et al. (2009).   137 
 The present study indicated that the assessed probiotics may stimulate, or enhance, a 138 
localised immune response through an enhanced infiltration of IELs in the intestine. This was 139 
observed after eight weeks in Chapter 3, six weeks in Chapter 4 and five weeks in Chapter 5. 140 
Considering no changes were detected after four weeks in Chapters 3 and 5 it is likely that 141 
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this effect occurs between four and five weeks after the onset of probiotic feeding. Whilst 142 
these results are in line with other probiotic studies in tilapia (Pirarat et al. 2011; Standen et 143 
al. 2013), the type of IELs were not characterised here. Using Artemia as a vector for 144 
probiotic administration, Picchietti et al. (2008) used polyclonal antibodies ORa and mAb G7 145 
to determine specific IEL populations in the intestinal mucosa of gilthead seabream. 146 
Picchietti and colleagues observed higher abundances of Ig
+
 leucocytes and acidophilic 147 
granulocytes after both L. fructivorans and L. plantarum supplementation. Further to this, 148 
PRO-3 treatments in both Chapters 4 and 5 contained significantly higher goblet cell levels in 149 
the mid-intestine when compared to the control group after six and five weeks, respectively. 150 
Considering there was no difference after four weeks in Chapter 5, it is likely this effect also 151 
manifests between four and five weeks after the initiation of probiotic feeding. Together, 152 
larger populations of IELs and goblet cells residing in the tilapia intestine likely improve the 153 
barrier function, ultimately retarding pathogen attachment and their subsequent infection. 154 
Future work should investigate this further using translocation experiments such as the ex 155 
vivo intestinal sac method. After supplementing tilapia diets with L. plantarum and exposing 156 
the intestinal sacs to A. hydrophila, Ren et al. (2013) assessed a number of parameters within 157 
the intestinal sac (apical membrane). Unfortunately, no effort was made to quantify A. 158 
hydrophila levels on the basolateral side of the intestinal sac, which would enable researchers 159 
to fully assess pathogen translocation. This should be a focus of future research. 160 
 The present studies investigated the probiotic effect on intestinal and head kidney 161 
gene expression. Chapters 4 and 5 both reported an up-regulation in pro-inflammatory 162 
cytokines IL-1β and TNFα after feeding tilapia diets supplemented at 3g kg-1. This up-163 
regulation was also observed in the pulsed regime (3 g kg
-1
) in Chapter 5 but not in the pulsed 164 
treatment (at 1.5 g kg
-1
) in Chapter 4. Importantly, the up-regulation in pro-inflammatory 165 
genes was not excessive, as inferred by the corresponding up-regulation in anti-inflammatory 166 
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genes TGFβ and IL-10. Furthermore, histological analyses from intestinal sections from both 167 
Chapter 4 and 5 revealed no signs of inflammation or damage, suggesting that this extra 168 
mRNA is not translated in proteins associated with inflammation. When taking this into 169 
consideration, an increased abundance of pro-inflammatory mRNA levels is indicative of a 170 
host which is in a higher state of immune readiness. In addition, anti-inflammatory cytokines 171 
TGFβ and IL-10 were also up-regulated in Chapters 4 and 5, although the extent of this was 172 
also dependent on dose and feeding regime. These changes are likely indicative of tolerance 173 
mechanisms where the host does not interpret the presence of the probiotics as a threat. 174 
Changes in the intestinal gene expression were observed after two weeks of experimental 175 
feeding in Chapter 5 suggesting that these effects are fairly rapid. Conversely, changes in 176 
head kidney (HK) gene expression were only evident after five weeks (Chapter 5) of 177 
supplementation where an up-regulation of pro and anti-inflammatory cytokines was 178 
observed. After supplementing hybrid tilapia diets with two Lactobacillus species, Liu et al. 179 
(2013) observed changes in intestinal and HK gene expression levels of TNFα, IL-1β and 180 
TGFβ after 10 days. It could be speculated that the differences in the onset of gene expression 181 
by probiotics is dependent on the duration of feeding, feeding regime, probiotic species, host 182 
species and the tissue of interest. Considering these innate mechanisms have the potential of 183 
responding within a short period of time, future work should focus on the first few hours-days 184 
of probiotic feeding, as well as longer term probiotic feeding. As well as the intestine and HK, 185 
it is important to consider other immune-relevant tissues with regards to gene expression such 186 
as the spleen. To the author’s knowledge, only three studies have investigated splenic gene 187 
expression after probiotic supplementation in tilapia (Pirarat et al. 2011; Liu et al. 2013; 188 
Villamil et al. 2014). Future research should utilise high-throughput methodologies such as 189 
RNA-Seq and microarrays which would enable researchers to investigate multiple target 190 
genes from a large number of samples.  191 
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 The majority of gene expression conducted in fish probiotic studies focuses on the 192 
transcription of cytokines; however, these are only the end products to complex molecular 193 
pathways involving receptors (including TLR2), adaptor proteins (including MYD88) and 194 
transcription factors (including NFκB). Therefore efforts should be made to investigate the 195 
pathway rather than just the end products. Supplementing tilapia diets with AquaStar
®
 196 
Growout at 3g kg
-1
 significantly up-regulated intestinal TLR2 gene expression. TLR2 is 197 
activated by lipoteichoic acid, a major constituent in Gram-positive bacteria. This up-198 
regulation is likely a result of the increased abundance of Gram-positive probiotic bacteria 199 
and is particularly important since tilapia are susceptible to Gram-positive pathogens such as 200 
St. iniae and St. agalactiae. Interestingly, Chapter 5 demonstrated that cytokine production is 201 
driven by different molecular pathways in the intestine and the HK. In both cases, cytokine 202 
production was initiated by TLR2. In the intestine, the gene expression of MYD88 was not 203 
affected, suggesting that cytokine production is driven by a MYD88 independent pathway, 204 
perhaps relying on the adaptor protein TRIF instead (Kawai and Akira 2007a). In the HK the 205 
MYD88 dependent pathway was activated suggesting that cytokine production is driven by 206 
this adaptor protein. Furthermore, in both tissues NFκB was down-regulated in both probiotic 207 
treatments suggesting that MAPK and AP-1 are the transcription factors which link the 208 
adaptor proteins with the cytokines (Kawai and Akira 2007b). Further research should be 209 
conducted to confirm this. Importantly, all future research in this area should consider the 210 
entire molecular pathway as opposed to investigating cytokines as lone molecules since this 211 
provides more information on host-probiotic interactions.  212 
Despite providing a unique perspective regarding the transcriptomics in tissues of 213 
interest, an important aspect is to determine how gene expression is correlated to protein 214 
translation. Early work conducted in yeast by Gygi and colleagues (1999) determined that the 215 
correlation between mRNA and protein levels was insufficient to predict protein expression 216 
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levels from quantitative mRNA data. Since an up-regulation at the transcription level, may 217 
not represent an increase in the final protein, proteomics will contribute greatly to our 218 
understanding of gene function (Pandey and Mann 2000). Future work should investigate 219 
how probiotic supplementation can affect the host using a systems biology approach (i.e. 220 
transcriptomics and proteomics). The proteome has only been investigated in a few fish 221 
studies after probiotic supplementation (Brunt et al. 2008; Abbass et al. 2010; Sveinsdóttir et 222 
al. 2009) but the number of proteomic studies in fish in general are increasing slowly 223 
(Rodrigues et al. 2012). The routine utilisation of proteomic approaches in fish studies is 224 
hampered by the fact that many proteins and their functions have not been characterised in 225 
fish, the costs involved and issues associated with data interpretation.  226 
The probiotics investigated in the current work, whether supplemented as mono or 227 
multi species applications and regardless of feeding regime used, did not appear to have a 228 
great effect on immuno-haematological parameters. This is consistent with other studies 229 
which also report little or no effect on blood parameters after probiotic supplementation in 230 
tilapia (Abd El-Rhman et al. 2009; Mehrim 2009; Ridha and Azad 2012; Telli et al. 2014; 231 
Iwashita et al. 2015). Circulating WBC levels were significantly higher after five weeks of 232 
probiotic supplementation at 3g kg
-1
 (Chapter 5) indicating an improvement in the systemic 233 
immune response. It would be interesting to investigate whether this pattern continued after a 234 
longer feeding period. 235 
Throughout the current research, multiple immune benefits after probiotic 236 
supplementation have been reported. This is suggestive that the host will be better equipped 237 
to defend itself against invading pathogens. However sound this conclusion might appear it 238 
would be necessary to carry out in vivo challenge trials to test this theory, using pathogens 239 
which are destructive in tilapia aquaculture. When conducting these trials, the pathogen 240 
should be administered through oral routes (immersion, oral intubation or through the feed) 241 
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since this accurately reflects the way an enteropathogen would naturally infect the fish (as 242 
opposed to IP injection which bypasses the intestinal tract).  243 
On a final note, the current research focuses on probiotic use in juvenile tilapia. It 244 
would be pertinent to conduct further research to investigate whether similar effects, i.e. 245 
improved growth performance, intestinal morphology and immunity, could be observed in 246 
tilapia of different developmental stages e.g. in fry from first feeding or in adult fish. 247 
Furthermore, the trials described here lasted a relatively short period of time (maximum eight 248 
weeks). It is well known that the prolonged use of immunostimulants can lead to the immune 249 
system becoming de-sensitised and in extreme circumstances immune suppression in fish 250 
(Bricknell and Dalmo 2005). Considering an immuno-stimulatory role was exerted by the 251 
probiotics in the current research, it is important that longer term trials are conducted to 252 
investigate whether this effect is also true for probiotics. 253 
In conclusion, Chapter 3 demonstrated that monospecies applications B. subtilis, L. 254 
reuteri and P. acidilactici and multispecies applications AquaStar
®
 Growout could modulate 255 
the intestinal microbiota in a favourable manner. Chapter 4 investigated the effects of dosage 256 
and feeding regime of probiotics in tilapia diets. The results indicated that the continuous 257 
supplementation of AquaStar
®
 Growout at 3 g kg
-1
 can improve growth performance, up-258 
regulate the expression of genes involved in cell turnover and immunity and improve 259 
parameters relating to intestinal barrier function. These results were not observed when the 260 
probiotic was supplemented at a lower dose (1.5 g kg
-1
), fed in a pulsed regime (also at 1.5 g 261 
kg
-1
) or fed as an initial (first two weeks) probiotic feed. Chapter 5 demonstrated that the 262 
same dose used previously (3 g kg
-1
), and supplemented in a continuous or pulsed manner, 263 
could improve the localised and systemic immune response of tilapia. The extent of these 264 
improvements was dependent on feeding duration, feeding regime and parameter investigated. 265 
This work adds to a growing body of knowledge surrounding probiotic usage in key fish 266 
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species, including tilapia. With an increasing demand for seafood it is important that research 267 
is also conducted on other commercially important species, and indeed novel aquaculture 268 
species. Considering the probiotic concept is a relatively new one in aquaculture, when 269 
compared to its terrestrial counterpart, research to date has provided data on how probiotics 270 
may interact with the host fish including the indigenous microbiota, and how these 271 
interactions may bring benefits in the form of improved growth or health. Having said this, 272 
there is still a great deal of work to be conducted but the usage of probiotics has a promising 273 
future.  274 
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Abstract The intestinal microbiota andmorphology of tilapia
(Oreochromis niloticus) were investigated after the applica-
tion of a multi-species probiotic containing Lactobacillus
reuteri, Bacillus subtilis, Enterococcus faecium and
Pediococcus acidilactici (AquaStar® Growout). Tilapia
(55.03 ± 0.44 g) were fed either a control diet or a probiotic
diet (control diet supplemented with AquaStar® Growout at
5 g kg−1). After four and eight weeks, culture-dependent anal-
ysis showed higher levels of lactic acid bacteria (LAB), en-
terococci and Bacillus spp. in the mucosa and digesta of fish
fed AquaStar® Growout. At week four, polymerase chain re-
action denaturing gradient gel electrophoresis (PCR-DGGE)
revealed a higher similarity within the probiotic fed replicates
than replicates of the control group; after eight weeks, the
compositional dissimilarity of the microbiome profiles be-
tween the groups was greater than the dissimilarities within
each group (P < 0.05). High-throughput sequencing revealed
that the probiotic treatment significantly reduced the number of
operational taxonomic units and species richness in the digesta.
Significantly higher proportions of reads belonging to
Proteobacteria andCyanobacteriawere detected in the control
group whereas the probiotic-fed fish displayed a significantly
higher abundance of reads assigned to the Firmicutes (which
accounted for >99 % of reads). Bacillus, Cetobacterium and
Mycobacterium were the dominant genera in the digesta of
control fish whereas Bacillus, Enterococcus and Pediococcus
were the largest constituents in probiotic-fed fish. The addition
of AquaStar® Growout to tilapia diets led to increased popula-
tions of intraepithelial leucocytes, a higher absorptive surface
area index and higher microvilli density in the intestine. These
data suggest that AquaStar® Growout can modulate both the
intestinal microbiota and morphology of tilapia.
Keywords Probiotic . Intestinal microbiota .
High-throughput sequencing . Intraepithelial leucocyte (IEL) .
Microscopy . Tilapia
Introduction
In the context of aquaculture, a probiotic can be considered as
a microbial cell provided via the diet or rearing water that
benefits the fish host, fish farmer or fish consumer which is
in part achieved by improving the microbial balance of the
fish (Merrifield et al. 2010a). Considering that a probiotic
exerts its benefits via the modulation of the microbiome, there
is a paucity of comprehensive data detailing these changes in
fish. This is essential information given that the intestinal
microbiomes of fish are diverse and complex communities
primarily consisting of bacteria and, to a lesser extent, yeasts,
Archaea, viruses and protists (Romero et al. 2014). As with
mammals, the intestinal microbiota of fish have important
functions in host metabolism, mucosal development and mat-
uration, nutrition, immunity and disease resistance (Rawls
et al. 2004; Bates et al. 2006; Round and Mazmanian 2009).
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Tilapia production is the most widespread aquaculture type
in the world (FAO 2014). However, it is hampered from dis-
ease outbreaks, particularly from Streptococcus iniae,
Aeromonas hydrophi la and Edwardsie l la tarda .
Traditionally, these have been controlled by antibiotics, but
their abuse has resulted in the evolution of antibiotic resistance
(Defoirdt et al. 2011). As such, probiotics have been incorpo-
rated into many tilapia production systems. Over the past two
decades, a plethora of scientific investigations have focused
on testing the efficacy of probiotics on tilapia. Most research
concerning probiotic supplementation in tilapia has focused
on growth and immunostimulation with less attention on in-
testinal microbiology. Of the 187 finfish probiotic studies
discussed in recent reviews (Carnevali et al. 2014; Lauzon
et al. 2014; Merrifield and Carnevali 2014), only 74 (40 %)
investigated aspects of the gut microbiota. In tilapia, only
26 % (8 from 31) of the studies investigated the intestinal
microbiota. This minority of studies primarily used culture-
based approaches to enumerate probiont levels and, to a lesser
extent, total cultivable communities. More recently, polymer-
ase chain reaction denaturing gradient gel electrophoresis
(PCR-DGGE) has been used to assess the impact of a limited
number of probiotics on the tilapia intestinal microecology
(Zhou et al. 2009; Ferguson et al. 2010; Liu et al. 2013).
This limited understanding of the changes in the gut microbi-
ota prevents a full depiction of the mechanisms of action of
probiotics in fish and ultimately prevents the optimisation of
probiotic application strategies.
Therefore, the aim of this study was to assess the effects of
AquaStar® Growout (Biomin Holding GmbH, Austria), a
lyophilised probiotic mixture containing Bacillus subtilis,
Enterococcus faecium , Lactobacil lus reuteri and
Pediococcus acidilactici, on the gastrointestinal (GI) microbi-
ota of tilapia using a multidisciplinary approach, including
high-throughput sequencing. In addition, the impact of the
probiotic, and the potentially modulated microbial communi-
ty, on the host intestinal morphology was assessed.
Materials and methods
All experimental work involving fish was conducted under the
Home Office project licence PPL30/2644 and was in accor-
dance with the Animals (Scientific Procedures) Act 1986 and
the Plymouth University Ethical Committee.
Experimental design and diet preparation
Nile tilapia, Oreochromis niloticus, were transferred to the
Aquaculture and Fish Nutrition Research Aquarium
(Plymouth University, UK) where they were allowed 6 weeks
of acclimation. Three hundred and twenty tilapia were ran-
domly distributed to eight 150-l fibreglass tanks (40 fish per
tank; average weight = 55.03 ± 0.44 g). Fish were fed exper-
imental diets for eight weeks at a rate of 1–3 % of biomass per
day in four equal rations (both treatments received the same%
input each day); higher feeding rates were provided at the
beginning of the trial, but this was decreased incrementally
during the trial as fish grew larger and their appetite decreased.
Daily feed was adjusted on a weekly basis by batch weighing
following a 24-h starvation period. Fish were held at 28 ± 1 °C
with a 12:12 h light/dark photoperiod.Water quality was mon-
itored daily and maintained at pH = 6.5 ± 0.5 (adjusted with
NaHCO3 as necessary) and dissolved oxygen >6.0 mg l
−1.
Ammonium, nitrite and nitrate levels were monitored weekly
(0.07 ± 0.02, 0.04 ± 0.02 and 16.20 ± 2.30 mg l−1, respective-
ly), and regular water changes prevented the build-up of these
compounds as well as preventing background build-up of
probiotics.
Two iso-nitrogenous and iso-lipidic diets were formulated
using Feedsoft Professional® according to the known require-
ments of tilapia (NRC 2011) (Table 1). Dry ingredients were
mixed in small batches to ensure a homogenous mix before
Table 1 Dietary formulation and chemical composition (%)
Control Probiotic
Fishmeala 5.00 5.00
Soyabean mealb 37.26 37.26
Corn starchc 24.28 23.78
Lysamine pea proteind 5.00 5.00
Glutalysd 10.00 10.00
Wheat brane 10.00 10.00
Fish oil 4.50 4.50
Corn oil 2.95 2.95
Vitamin & mineral premixf 0.50 0.50
CMC-binderc 0.50 0.50
AquaStar® Growoutg 0.00 0.50
Proximate composition (% as fed basis)
Dry matter 92.89 92.10
Crude protein 35.74 35.88
Lipid 10.06 9.82
Ash 4.19 4.22
Energy (MJ kg−1) 20.06 20.00
a Herring meal LT92—United Fish Products Ltd., Aberdeen, UK
bDe-hulled, solvent extracted soybean meal, 48% protein (Sourced from
BioMar, Denmark)
c Sigma-Aldrich Ltd., UK
dRoquette Frêres, France
e Natural wheat bran, Holland & Barrett, UK
f Premier nutrition vitamin/mineral premix contains: 121 g kg−1 calcium,
vit A 1.0 μg kg−1 , vit D3 0.1 μg kg−1 , vit E (as alpha tocopherol acetate)
7.0 g kg−1 , copper (as cupric sulphate) 250 mg kg−1 , magnesium
15.6 g kg−1 , phosphorous 5.2 g kg−1
g Biomin Holding GmbH, Industriestrasse 21, 3130 Herzogenburg,
Austria
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adding the oil and warm (40 °C) water in a Hobart food mixer
(Hobart Food equipment, Australia) to form a consistency
suitable for cold press extrusion (PTM P6 extruder,
Plymouth, UK) to produce 3-mm pellets. The lyophilised pro-
biotic (AquaStar® Growout; Biomin Holding GmbH, Austria)
was added at 5 g kg−1 (as recommended by the manufacturer)
at the expense of corn starch and the basal diet devoid of the
probiotic served as a control diet. Diets were dried for 24 h in
an air convection oven set to 44 °C, broken up by hand and
stored in airtight containers at 4 °C until use. The proximate
composition of the diets was analysed using AOAC protocols
(1995) (Table 1). Probiotic viability was checked by spread
plating tenfold serial dilutions and counting statistically viable
plates (i.e. 20–200 colonies), using selective media (de Man,
Rogosa and Sharpe (MRS) media for LAB, Bacillus selective
agar for Bacillus spp. and Slanetz and Bartley media for
Enterococcus spp.; Oxoid, Basingstoke, UK). Fresh diets were
produced at the trial midpoint to ensure high probiotic viability.
Fish were sampled, as described in detail in the following
sections, after four and eight weeks of feeding on the experi-
mental diets. The weight of fish sampled (week four:
control = 89.12 ± 20.87 g and probiotic = 85.29 ± 20.29 g;
week eight: control = 162.28 ± 65.30 g and probiotic = 167.01
± 56.94 g) were not significantly different at either time point.
Tilapia survival rates during the feeding trial were >99 %.
Intestinal microbiological analyses
At weeks four and eight, two fish per tank were euthanized by
overdose (300 mg l−1) of tricaine methane sulphonate
(MS222; Pharmaq, Fordingbridge, UK). The GI tract was
aseptically removed, and faecal matter from the mid-
intestine was isolated and pooled by tank (thus n = 4 per
treatment) to assess allochthonous populations. Mid-intestine
mucosa samples were removed aseptically, washed with ster-
ile phosphate-buffered saline (PBS, Sigma Aldrich, UK),
homogenised and processed on an individual fish basis; thus,
n = 8. Intestinal samples were either used immediately for
culture-based analysis or stored at −20 °C for culture-
independent analysis.
Culture-dependent analysis
Samples were serially diluted with PBS, and 20μl was spotted
onto duplicate MRS agar, Slanetz and Bartley and Bacillus
selective media using the Miles and Misra method (Miles
et al. 1938) to assess autochthonous and allochthonous pre-
sumptive probiotic bacterial populations. Tryptone soya agar
(TSA) was used to determine the total aerobic heterotrophic
bacterial populations. Plates were incubated for 72 h at 28 °C,
and colony forming units (CFU g−1) were calculated by
counting colonies from statistically viable plates (between 3
and 30 colonies). Representative subsets of the presumptive
probiotics were identified by using 16S rRNA gene sequence
analysis using the protocol described in Ferguson et al. (2010).
Culture-independent analysis
At weeks four and eight, digesta samples from two fish per
tank were pooled and used for culture-independent analyses
(n = 4). DNAwas extracted using the QIAamp Stool Mini Kit
(Qiagen) with a lysozyme pretreatment (50 mg mL−1 in TE
buffer for 30 min at 37 °C) and a phenol-chloroform clean up,
as described elsewhere (Al-Hisnawi et al. 2014).
PCR-DGGE
PCR amplification of the 16S rRNAV3 region was conducted
using the reverse primer P2 and the forward primer P3
(Muyzer et al. 1993). A 40–60 % DGGE was performed,
and presumptive probiotic bands extracted, using a DCode
Universal Mutation Detection System (Bio-Rad laboratories,
Italy) according to Merrifield et al (2010b). The presumptive
probiotic nucleotide sequences were further identified using
BLAST in the NCBI nucleotide collection database.
High-throughput sequencing analysis
DNA extractions from week eight digesta samples were used
for high-throughput sequencing using primers 338R (5′-GCW
GCCWCCCGTAGGWGT-3′) and 27F (5′-AGAGTT TGA
TCM TGG CTC AG-3′). PCR products were purified
(QIAquick PCR Purification Kit; Qiagen) and quantified
using a Qubit® 2.0 Fluorometer (Invitrogen). Prior to sequenc-
ing, the amplicons were assessed for fragment concentration
using an Ion Library Quantitation Kit (Life Technologies TM,
USA), then concentrations were adjusted to 26 pM.
Amplicons were attached to Ion Sphere Particles using Ion
PGM Template OT2 400 kit (Life Technologies™, USA) ac-
cording to the manufacturer’s instructions. Multiplexed se-
quencing was conducted using Ion Xpress Barcode Adapters
(L i f e Techno log i e s™ ) and a 318™ ch ip (L i f e
Technologies™) on an Ion Torrent Personal Genome
Machine (Life Technologies™). Sequences were binned by
sample and filtered within the PGM software to remove low
quality reads. Data were then exported as FastQ files and
deposited in MG-RAST under the accession numbers 4,621,
988.3–4,621,995.3.
All phylogenetic analyses were performed after the remov-
al of low quality scores (Q < 20) with FASTX-Toolkit
(Hannon Laboratory, USA). Sequences were concatenated
and sorted by sequence similarity into a single fasta file,
denoised and analysed using the QIIME 1.8.0 pipeline
(Caporaso et al. 2010b). The USEARCH quality filter pipeline
(Edgar 2010) was used to filter out putative chimeras and
noisy sequences and carry out operational taxonomic
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unit (OTU) picking on the remaining sequences.. The taxo-
nomic affiliation of each OTU was determined based on the
Greengenes database (DeSantis et al. 2006) using the RDP
classifier (Wang et al. 2007) clustering the sequences at
95 % similarity with a 0.80 confidence threshold and a mini-
mum sequence length of 300 base pairs. Non-chimeric OTUs
were identified with a minimum pairwise identity of 95%, and
representative sequences from the OTUs were aligned using
PyNAST (Caporaso et al. 2010a). Representative sequences
belonging to probiotic genera, for both probiotic and control
treatments (if applicable) were further identified using the
NCBI nucleotide collection database BLAST.
To estimate bacterial diversity, the number of OTUs present
in the samples was determined and a rarefaction analysis was
performed by plotting the number of observed OTUs against
the number of sequences. Additionally, Good’s coverage,
Shannon-Wiener (diversity) and Chao1 (richness) indices
were calculated. The similarities between the microbiota com-
positions of the intestinal samples were compared using
weighted principal coordinate analysis (PCoA) and unweight-
ed pair group method with arithmetic mean (UPGMA).
Persistence of the probiotics after reverting
to non-supplemented diet
After reverting the probiotic-treated fish to the control diet at
the end of the trial (eight weeks), two fish were sampled on
days 3, 6, 9 and 18 post cessation of probiotic feeding to assess
probiotic persistence within the intestine by PCR-DGGE anal-
ysis. Presumptive probiotic bands were excised for sequence
analysis as described previously.
Intestinal histology
At weeks four and eight, two fish per tank were sampled for
histological appraisal of the mid-intestine. For light microsco-
py, the tissue samples were fixed in 10 % formalin and trans-
ferred to 70 % ethanol after 24 h. Samples were then
dehydrated in graded ethanol concentrations prior to embed-
ding in paraffin wax. In each specimen, multiple sections
(5 μm) were stained with haematoxylin and eosin (H & E)
and Alcian Blue-PAS to assess the mucosal fold length, intes-
tinal perimeter ratio (arbitrary units; AU), intraepithelial leu-
cocyte (IELs) levels and goblet cell abundance in the epithe-
lium. IELs and goblet cells were counted across a standardised
distance of 100 μm and then calculated by averaging the cell
numbers from all samples within each treatment.
After eight weeks, the mid-intestines from two fish per tank
were sampled for scanning electron microscopy (SEM) and
transmission electronmicroscopy (TEM). Samples (ca. 2 mm)
were washed in 1 % S-carboxymethyl-L-cysteine for 30 s
(SEM only) to remove any mucus before fixing in 2.5 % glu-
taraldehyde in sodium cacodylate buffer (0.1 M pH 7.2).
Samples were processed as descr ibed elsewhere
(Dimitroglou et al. 2009) and screened with a JSM 6610 LV
(Jeol, Tokyo, Japan) SEM or JEN 1400 (Jeol, Tokyo, Japan)
TEM. All electron micrographs were analysed with Image J
1.46r (National Institute of Health, USA) to determine micro-
villi length and density, as described elsewhere (Dimitroglou
et al. 2009).
An absorptive surface area index (ASI) was calculated ac-
cording to the following: ASI (AU) = microvilli length
(μm) × microvilli density (AU) × intestinal perimeter ratio
(AU).
Statistical analyses
All data are presented as mean ± standard deviation. PCR-
DGGE banding patterns were transformed into presence/
absence matrices based on band peak intensities (Quantity
One® version 4.6.3, Bio-Rad Laboratories, CA, USA). Band
intensities were measured (Quantity One® 1-D Analysis
Software, Bio-Rad Laboratories Ltd., Hertfordshire, UK)
and analysed using Primer V6 software (PRIMER-E Ltd.,
Ivybridge, UK). All data were checked for normality using a
Kolmogorov-Smirnov test and analysed using a t-test. Where
data were not normally distributed, data were analysed using a
Kruskal-Wallis test (Statgraphics Centurion XVI, Warrenton,
VA, USA). High-throughput sequencing data were uploaded
to Stamp v2.0.8, and t-tests were used to distinguish differ-
ences at each taxonomic level. In all cases, significance was
accepted at P < 0.05.
Results
Culture-dependent analysis
The effect of AquaStar® Growout on the heterotrophic intes-
tinal bacteria was determined using culture-based methods.
Total viable bacteria, lactic acid bacteria (LAB), enterococci
and Bacillus spp. counts in tilapia intestines were enumerated
on TSA, MRS, Slanetz & Bartley and Bacillus spp. selective
media, respectively. Table 2 displays the allochthonous and
autochthonous total viable cell counts (TVC) at weeks four
and eight. No significant differences were observed in TVC
levels between the treatments at either time points, with al-
lochthonous levels fluctuating around log 7 CFU g−1 and au-
tochthonous levels slightly lower, fluctuating around log 5–
6 CFU g−1. LAB, Bacillus spp. and enterococci levels were all
significantly higher in the digesta and mucosa of tilapia fed
probiotic-supplemented diets at both time points (P < 0.05).
The highest LAB levels were recorded at week eight in the
digesta of the probiotic fed fish (log 6.41 CFU g−1). Subsets of
these isolates were confirmed as the probiotics administered
by 16S rRNA sequence analysis and by migration to the same
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position as known B. subtilis, E. faecium, L. reuteri and
P. acidilactici samples in a PCR-DGGE.
PCR-DGGE
The influence of dietary AquaStar® Growout on the intestinal
microbial diversity in tilapia was investigated using PCR-
DGGE at weeks four and eight. PCR-DGGE analysis revealed
complex microbial communities in both treatments with sam-
ples containing 25–35 OTUs (Fig. 1). Presumed probiotic
bands were isolated from PCR-DGGE gels at both time points,
and sequencing revealed that the nearest neighbour for all
bands were the respective probiotic species; these were not
detected in control sample fingerprints (Table S1). Table 3 dis-
plays the microbial ecological parameters derived from the
PCR-DGGE fingerprints from weeks four and eight. At week
four, within group replicates similarity percentage analyses
(SIMPER) revealed a significantly higher percentage similarity
among replicates from the probiotic treatment when compared
with the control replicates (75.10 ± 7.80 vs. 51.91 ± 2.88, re-
spectively) (P = 0.02). This was not the case at week eight. The
number of OTUs, species richness, evenness and diversity
remained unaffected at weeks four and eight. Analysis of sim-
ilarities (ANOSIM) showed that the compositional dissimilar-
ity between the groups (61.51 %) was greater than those within
each group at week eight (R = 0.89 and P = 0.03).
High-throughput sequencing analysis
A total of 1,609,610 sequence reads were obtained from the
Ion Torrent® PGM; after removing low quality reads 68,
161 ± 2701 and 38,444 ± 4135 sequences were obtained for
the probiotic and control fish, respectively, and used for down-
stream analyses. Good’s coverage estimators for both treat-
ments were >0.99 indicating that sufficient sequencing cover-
age was achieved and that the OTUs detected in the samples
are representative of the sampled population (Table 4).
Rarefaction curves approached the saturation phase in both
treatments at approx. 30,000–40,000 sequence reads, al-
though the plateau was higher for those samples belonging
to the control group (Fig. 2a). Consequently, there was a sig-
nificantly higher number of OTUs and species richness
(Chao1) in the control group when compared to probiotic-
fed fish (Table 4). The PCoA plot demonstrates a clear sepa-
ration between each treatment (Fig. 2b) suggesting that there
is clear dissimilarity between the intestine microbiota of fish
fed control diets compared with fish fed a probiotic supple-
mented diet. This is supported by the UPGMAwhich shows
clear differentiation between control and AquaStar® Growout
replicates, with replicates clustering by treatment (Fig. 2c).
Figure 2d illustrates that 40 genera were present (i.e. account-
ing for >0.01 % of the reads) in control samples which were
not present in probiotic samples. Twenty-nine genera were
common to samples in both control and probiotic treatments.
Figure 3 shows the major bacterial constituents in the
digesta of fish fed either a control or AquaStar® Growout-
based diet identified to phyla and genera levels. Firmicutes
accounted for >99 % of 16S reads in probiotic-fed fish.
Firmicutes were also the dominant phyla in the digesta of
control fish although their presence was significantly lower
(44.80 % of reads; P = 0.01). Proteobacteria and
Cyanobacteria reads were significantly higher in control sam-
ples (8.50 and 25.11 %, respectively) than in the probiotic
samples (0.36%;P = 0.03 and 0.18%;P = 0.05, respectively).
Actinobacteria, Bacteroidetes, Fusobacteria, Nitrospirae,
Spirochaetes and the phylum TM6 were also present in both
treatments although their relative abundances were lower and
not significantly different between treatments.
The relative abundance of reads assigned to Enterococcus
was significantly (P ≤ 0.01) higher in the probiotic-fed fish
when compared to control fish (52.50 vs. 1.35 %, respective-
ly). Reads belonging to Burkholderia, Leuconostoc,
Acinetobacter, Legionella, Lactobacillus, Corynebacterium,
We i s e l l a , S p h i n g om o n a s , R h o d o c o c c u s a n d
Hyphomicrobium were all significantly more abundant in the
control samples when compared to the probiotic-fed fish
(P < 0.05). In the AquaStar® Growout-fed fish, after
Enterococcus, the next most abundant genera were Bacillus
(45.94 %) and Pediococcus (0.44 %). Lactobacillus reads
accounted for 0.08 % of sequences in probiotic samples.
Table 2 Total viable counts (log CFU g−1) of autochthonous (M) and
allochthonous (D) heterotrophic aerobic bacteria, LAB, enterococci and
Bacillus spp. in the GI tract of tilapia fed experimental diets after four and
eight weeks
Week Region Control Probiotic P value
TVC 4 D 5.34 ± 1.90 7.47 ± 0.67 0.14
M 5.85 ± 1.02 6.30 ± 0.48 0.35
8 D 7.36 ± 0.61 6.93 ± 0.53 0.39
M 4.93 ± 0.65 4.78 ± 0.43 0.63
LAB 4 D 3.34 ± 0.37a 5.91 ± 0.98b 0.03
M 2.80 ± 0.20a 4.64 ± 1.45b 0.02
8 D 3.10 ± 0.69a 6.41 ± 0.73b 0.04
M n.da 4.43 ± 0.86b <0.01
Bacillus spp. 4 D –c –c –c
M –c –c –c
8 D 2.66 ± 0.77a 6.39 ± 0.45b 0.03
M 2.00 ± 0.00a 4.91 ± 0.86b <0.01
Enterococci 4 D 2.77 ± 0.13a 5.09 ± 1.51b 0.04
M n.da 4.27 ± 1.59b 0.01
8 D n.da 6.28 ± 0.62b 0.02
M n.da 4.45 ± 0.73b <0.01
n.d. not detected
a, b Different superscripts indicate a significant difference (P < 0.05)
c No data available due to overgrowth on the plates
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Bacillus (34 %) also comprised a large component of the al-
lochthonous microbiota in control fish, and low levels of
Enterococcus (1.35 %), Lactobacillus (1.04 %) and
Pediococcus (0.15 %) sequence reads were also present.
BLAST searches using representative sequences belonging
to each of these genera confirmed the presence of
P. acidilactici, B. subtilis and L. reuteri in AquaStar®
Growout samples; however, these species were not present
in the control samples. In the control fish, the Bacillus spp.
were identified as B. megaterium and B. aquimaris,
Pediococcus spp. as P. pentasaceus, and Lactobacillus reads
were predominantly L. aviarius. Enterococcus reads in both
treatment groups were identified as E. faecium.
Cetobacterium (accounting for 13.80 % of the reads) and
Mycobacterium (5.27 %) were also present in the control
group; however, they were found at lower levels in the
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Fig. 1 Dendrograms representing the relatedness of the microbial
communities in the digesta of tilapia after 4 weeks (a) and 8 weeks (b)
of feeding with a control diet (green triangles) and probiotic diet (blue
triangles). PCR-DGGE fingerprints below represent amplified products
from the V3 region of the samples which correspond to those used in the
dendrogram
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probiotic treatment (0.02 and 0.31 % respectively; P > 0.05).
Streptococcuswas also found at 0.48% in control samples but
was not detected in three out of four replicates of the
AquaStar® Growout treatment (present at 0.01 % in the fourth
replicate).
Persistence of probiotics after reverting to the control diet
The persistence of each probiotic in the intestine of the
AquaStar® Growout-fed fish was assessed by PCR-DGGE
analysis on 3, 6, 9 and 18 days post reverting to the control diet
(Fig. 4). E. faeciumwas present 6 days after reverting to control
diets, although bands were only visible in two of the four rep-
licates. Bands representing amplicons from P. acidilactici,
L. reuteri and B. subtilis all showed signs of decreasing inten-
sity but were still present after 18 days of reverting to the con-
trol diet (Fig. 4). Sequence analysis confirmed that these OTUs
were the respective probiotic species (Table S1). The number of
OTUs, species richness, species evenness and diversity of mi-
crobial communities were altered after reverting to the control
diet; these parameters followed the same pattern, initially
decreasing from day 0 to day 6, before increasing at day 9
where they were at their highest post cessation of probiotic
feeding, before decreasing again on day 18 (Fig. 4).
Intestinal histology
Light microscopy was used to examine the mid-intestine of
fish fed either the control diet or AquaStar® Growout-
supplemented diet. Fish from both dietary treatments had an
intact epithelial barrier with extensive mucosal folds, abun-
dant IELs and numerous goblet cells (Fig. 5). At week four,
there were no differences between the control and probiotic
group when measuring fold length, perimeter ratio, IEL and
goblet cell abundance (Table 5). At week eight, the perimeter
ratio was lower in the control group compared to the probiotic
treatment (5.36 ± 1.24 vs. 6.48 ± 0.74, respectively), and sta-
tistical analysis suggests that this was approaching signifi-
cance (P = 0.09). After eight weeks of experimental feeding,
IEL abundance was significantly elevated in the AquaStar®
Growout treatment (40.01 ± 4.46 per 100 μm) when com-
pared to the control treatment (32.68 ± 4.81per 100 μm;
Table 3 Microbial community analysis of the allochthonous intestinal bacterial populations of tilapia from PCR-DGGE fingerprints after four and
eight weeks of experimental feeding
Microbial ecological parameters Similarity (ANOSIM)
N Richness Evenness Diversity SIMPER (%) R value P value Dissimilarity (%)
Week 4
Control 24.67 ± 4.19 2.37 ± 0.38 0.97 ± 0.01 3.10 ± 0.20 51.91 ± 2.88a
AquaStar® Growout 28.33 ± 0.47 2.61 ± 0.03 0.96 ± 0.00 3.22 ± 0.02 75.10 ± 7.80b
Week 8
Control 32.25 ± 2.38 2.89 ± 0.18 0.99 ± 0.00 3.43 ± 0.07 73.10 ± 3.60
AquaStar® Growout 31.33 ± 4.11 2.80 ± 0.29 0.97 ± 0.01 3.32 ± 0.17 57.63 ± 18.25
Pairwise comparisons
Control vs. AquaStar®
Growout (week 4)
0.78 0.10 56.77
Control vs. AquaStar®
Growout (week 8)
0.89 0.03 61.51
N = number of operational taxonomic units; Richness =Margalef species richness; Evenness = Pielou’s evenness;Diversity = Shannon’s diversity index;
SIMPER = similarity percentage within group replicates
a, b Different superscripts indicate a significant difference (P < 0.05)
Table 4 Number of reads assigned to OTUs and diversity/richness indices of allochthonous intestinal microbiota composition of fish fed a control diet
or probiotic diet after 8 weeks of experimental feeding
Treatment Raw 16S rRNA
reads
Reads >20 Phred
score
Reads assigned (after
USEARCH function)
Good’s
coverage
Number of
OTUs
Shannon’s
diversity index
Chao1 index
Control 244,815 ± 46,578 166,352 ± 38,556 38,444 ± 4135 1.000 ± 0.00 129.49 ± 10.44a 4.04 ± 0.71 136.08 ± 10.74a
AquaStar®
Growout
157,588 ± 8518 108,880 ± 5108 68,161 ± 2701 0.999 ± 0.00 90.16 ± 10.66b 3.87 ± 0.07 114.29 ± 9.87b
a, b Different superscripts indicate a significant difference (P < 0.05)
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P = 0.02). Mucosal fold length and goblet cell numbers
remained unaffected by dietary treatment (Table 5).
Microvilli density and length were analysed by SEM and
TEM, respectively, at eight weeks only. Fish in both treat-
ments appeared to have a healthy brush border with organised,
closely packed microvilli showing no signs of intracellular
gaps or necrotic enterocytes. The microvilli density in the
intestine of the AquaStar® Growout-fed fish (4.58 ± 0.69)
was significantly higher than the control-fed fish
(3.49 ± 0.75; P < 0.05) (Table 5). Numerical increases
(P = 0.08) in microvilli length (probiotic = 1.37 ± 0.19 μm
vs. control group = 1.19 ± 0.14 μm) and the perimeter ratio
(P = 0.09), combined with a significant increase in microvilli
density, resulted in a significant (P = 0.01) increase in the
absorptive surface area index (ASI) of the AquaStar®
Growout-fed fish (40.84 ± 5.17) compared to those receiving
the control diet (22.07 ± 3.85) (Table 5).
Discussion
The intestinal microbiomes of fish are complex communities
which have been demonstrated to impact host health, mucosal
development and differentiation, metabolism, nutrition and
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Fig. 2 Bacterial community composition and relatedness in the digesta
of tilapia fed either a control or probiotic supplemented diet for 8 weeks. a
Comparison of rarefaction curves between allochthonous intestinal
microbiota composition between fish fed a control diet or probiotic diet.
b PCoA plots where data points represent samples from fish fed a control
diet (blue circles) and probiotic diet (red squares). c UPGMA showing
hierarchical clustering of intestinal microbiota from each treatment.
Bootstrap values are indicated by red branches (75–100 %). d Venn
diagram showing the number of genera (accounting for >0.01 % reads)
exclusively assigned to control replicates, probiotic replicates and genera
which are common in both treatments
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Fig. 3 Comparison of
allochthonous intestinal
microbiota composition between
fish fed a control or probiotic diet
after 8 weeks of experimental
feeding.Heatmap shows bacterial
OTUs assigned at the phylum
level and bars show OTUs
assigned at the genus level
(showing genera accounting for
>0.25 % of total reads)
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disease resistance (Rawls et al. 2004; Bates et al. 2006; Round
andMazmanian 2009). These communities are sensitive to rear-
ing environment, seasonal and diet changes, including probiotic
supplementation (Merrifield et al. 2010a; Dimitroglou et al.
2011; Romero et al. 2014). The present literature available on
the impact of probiotics on the intestinal microbiomes of fish has
been investigated predominantly by culture-dependent means or
semi-quantitative techniques such as PCR-DGGE.
The present study used a multidisciplinary approach
consisting of culture-based techniques, PCR-DGGE and high-
throughput sequencing. The culture-dependent methods
employed demonstrated that probiotic feeding resulted in higher
LAB, Bacillus spp. and enterococci counts in the GI tract of
tilapia when compared to control-fed fish. Sequence analysis
confirmed that these isolates from the AquaStar® Growout-fed
fish were the specific probiotic species administered. Despite
these significant increases in bacterial groups, there was no sig-
nificant impact on the total viable counts at either time point.
However, since only a fraction of the total intestinal micro-
biota of fish is cultivable under laboratory conditions (Zhou
et al. 2014), and early estimates suggest up to 50 % of the
bacterial community in the tilapia intestine is non-cultivable
(Sugita et al. 1981), culture-independent methods were also
utilised in the current investigation in order to provide a com-
prehensive overview of microbial communities. Here, PCR-
DGGE revealed complex microbial communities in all repli-
cates from both treatments. Sequencing of excised bands con-
firmed the presence of B. subtilis, E. faecium, L. reuteri and
P. acidilactici in AquaStar® Growout-supplemented fish
whilst these species were not detected in fish fed the control
diet. At week four, SIMPER analyses revealed a significantly
higher percentage similarity between replicates from the pro-
biotic treatment when compared with the control replicates.
Additionally at week eight, ANOSIM showed that the com-
positional dissimilarity between the groups was significantly
greater than those within each group. This suggests that
AquaStar® Growout can modulate the GI microbiome and
may have a stabilising effect on the community.
The introduction of high-throughput sequencing technolo-
gies has increased our understanding of microbial diversity
and function in complex environments, including the gastro-
intestinal tract of fish (van Kessel et al. 2011; Roeselers et al.
1 N = total number of operational taxonomic units; 2 Richness = Margalef species richness: d
= (N-1)/ log(n); 3 Evenness = Pielou’s evenness: J’ = H’/ log(N); 4 Diversity = Shannon’s 
diversity index: H’ = - i (ln p(p i) where n = total number of individuals (total intensity units) 
and pi = the proportion of the total number of individuals in the ith species.
#
Values are expressed in terms of percentage relative abundance against the peak density at 
day 0.
n.d = not detected
Day 0 3 6 9 18
Abundance
#
E. faecium 100 41.31 24.43 n.d n.d
P. acidilactici 100 43.90 59.61 101.71 68.66
L. reuteri 100 64.64 62.11 52.95 63.91
B. subtilis 100 64.90 43.56 42.20 65.15
N1 30.50 ± 3.50 17.00 ± 3.08 18.00 ± 3.54 24.00 ± 6.75 18.00 ± 1.00
Richness
2
2.82 ± 0.33 1.69 ± 0.29 1.76 ± 0.29 2.25 ± 0.55 1.79 ± 0.10
Evenness
3
0.98 ± 0.00 0.98 ± 0.00 0.99 ± 0.00 0.99 ± 0.01 0.98 ± 0.00
Diversity
4
3.34 ± 0.10 2.77 ± 0.17 2.83 ± 0.22 3.08 ± 0.24 2.84 ± 0.04
Fig. 4 PCR-DGGE fingerprints
showing the persistence of the
probiotic bacteria within the
intestinal tract of tilapia, after
reverting to the control diet.
Numbers above lanes indicate
day post cessation of probiotic
provision. Each DGGE lane
represents a pooled sample from
two fish. The table shows
microbial diversity and
percentage band intensity (of
E. faecium, P. acidilactici,
L. reuteri and B. subtilis)
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2011; Desai et al. 2012; Wu et al. 2012; Boutin et al. 2013;
Carda-Diéguez et al. 2013; Wu et al. 2013; Ingerslev et al.
2014; Zarkasi et al. 2014; Falcinelli et al. 2015). At present,
there is a paucity of information on the intestinal microbiome
of tilapia using high-throughput sequencing; to the author’s
knowledge, this is the first study utilising high-throughput
sequencing to assess the intestinal microbial communities in
this fish species. In the present study, sequence libraries for
both treatments displayed Good’s coverage estimations of
>0.99, indicating that the intestinal microbiota had been fully
sampled. Firmicutes accounted for >99 % of 16S rRNA reads
in the AquaStar® Growout-fed fish, and although they
accounted for a significantly smaller proportion of the reads
in the control-fed fish, they remained the most abundant phy-
lum present . Concomitant ly, Proteobacteria and
Cyanobacteria were significantly more abundant in the
Fig. 5 Light (a–d), scanning
electron (e and g) and
transmission electron (f and h)
micrographs of the mid-intestine
of Nile tilapia fed either the
control (a, b and e, f) or probiotic
(c, d and g, h) diet at the end of
the experimental period. Goblet
cells (arrowheads) are filled with
abundant acidic mucins (blue: b
and d) in both treatments and
abundant IELs (arrows) are
present in the epithelia.
Abbreviations used are E
enterocytes, LP lamina propria, L
lumen, MV microvilli. Light
microscopy staining: a, c H & E;
b, d Alcian Blue-PAS. Scale
bars= 100 μm (a–d) 2 μm (f and
h) or 1 μm (e and g)
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control fish along with other notable phyla present including
Fusobacteria, Actinobacteria and Bacteroidetes. These phyla
have all been detected in varying levels in herbivorous fish
species (van Kessel et al. 2011; Roeselers et al. 2011;Wu et al.
2013) including tilapia (Zhou et al. 2009; Liu et al. 2013).
BLAST searches using single representative sequences from
Cyanobacteria revealed a high similarity to nucleotide se-
quences from soybean chloroplasts. It is possible that at least
some of these reads may have been artefacts derived from the
diets as opposed to the presence of Cyanobacteria
populations.
At the genera level, the most abundant 16S rRNA reads
belonged to Enterococcus and Bacillus followed by
Pediococcus. At a lower level, Lactobacillus spp. were also
detected. Confirming the cultivable and PCR-DGGE analy-
ses, the administered probiotic species, E. faecium, B. subtilis,
P. acidilactici and L. reuteri, were identified in the high-
throughput sequence libraries from the probiotic-fed fish. In
contrast, although these genera were present in the control-fed
fish, with the exception of E. faecium, the probiotic species
were not detected. E. faecium has routinely been detected as
an indigenous constituent of the gut of a number of fish (Sun
et al. 2009; Gopalakannan and Arul 2011; Desai et al. 2012;
Sahnouni et al. 2012; Bourouni et al. 2012) and shellfish spe-
cies (Cai et al. 1999) and its presence in the control tilapia in
this experiment is indicative that this species is native to the
tilapia intestine also. Members of the Lactobacillus and
Pediococcus genera have also been reported as indigenous
members of the intestinal microbiota of a number of fish spe-
cies (Cai et al. 1999; Ferguson et al. 2010; Jatobá et al. 2011;
Ringø et al. 2014). The relative abundance of a number of
potential pathogens (Legionella spp., Mycobacterium spp.
and Streptococcus spp.) was reduced, significantly in the case
of Legionella, by the application of dietary AquaStar®
Growout. This topic warrants further investigation.
Despite the numerous significant differences in OTU abun-
dances detected, 29 of the 69 (42 %) genera detected in this
study were common to both treatment groups. This may be
suggestive of a core microbiome, which, despite possible
modulation in terms of abundance, persists within the intestine
irrespective of probiotic treatment. This would infer that mem-
bers of these genera are well adapted to the selective pressures
present in the tilapia intestinal tract. Similarly, other studies
have identified a core microbiome in fish species, which ap-
pear to be present when individuals are reared in different
locations, different conditions or fed different diets
(Roeselers et al. 2011; Wong et al. 2013).
Due to the absolute dominance (as a proportion of total
number of reads) of the administered probiotics (i.e.
Enterococcus and Bacillus), it is perhaps not surprising that
the number of observed OTUs (those accounting for >0.01 %
of the reads) and the Chao1 index were significantly lower in
the probiotic group. Despite these changes, the diversity, as
indicated by Shannon-Wiener Index, was not significantly dif-
ferent between the two treatments. This suggests that the ap-
parent reduction of other OTUs may not necessarily be due to
their absolute reduction in abundance, but possibly their rela-
tive decrease as a proportion of the total bacterial reads given
the large number of probiotic 16S rRNA reads. Indeed, cau-
tion should be applied when interpreting high-throughput se-
quence libraries as 16S rRNA copy numbers can differ
amongst bacterial species (Fogel et al. 1999); this can lead to
incorrect conclusions when discussing true bacterial diversity
and taxon abundance (Wintzingerode et al. 1997). For exam-
ple, Bacillus and Enterococcus appear to be present at similar
levels given the proportion of reads assigned to these genera in
Table 5 Histological data from
the GI tracts of tilapia fed control
and AquaStar® Growout
supplemented diets after four and
eight weeks of experimental
feeding
Control Probiotic P- value
Week 4
Mucosal fold length (μm) 265.53 ± 34.56 284.27 ± 28.06 0.34
Perimeter ratio (AU) 5.55 ± 0.46 5.97 ± 1.20 0.66
IEL levels (per 100 μm) 34.71 ± 3.39 35.28 ± 2.27 0.75
Goblet cells (per 100 μm) 5.65 ± 1.51 6.88 ± 0.83 0.08
Week 8
Mucosal fold length (μm) 270.38 ± 51.29 282.04 ± 69.36 0.75
Perimeter ratio (AU) 5.36 ± 1.24 6.48 ± 0.74 0.09
IEL levels (per 100 μm) 32.68 ± 4.81a 40.01 ± 4.46b 0.02
Goblet cells (per 100 μm) 5.76 ± 0.41 6.23 ± 1.44 0.45
Microvilli length (μm) 1.19 ± 0.14 1.37 ± 0.19 0.08
Microvilli density (AU) 3.49 ± 0.75a 4.58 ± 0.69b 0.05
ASI (AU) 22.07 ± 3.85a 40.84 ± 5.17b 0.01
ASI Absorptive surface index
a, b Different superscripts indicate a significant difference (P < 0.05)
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the probiotic-fed fish; however, Bacillus strains have typically
been reported to contain 10 copies of the 16S rRNA gene
whereas Enterococcus spp. have frequently been reported to
contain four copies (Fogel et al. 1999). Therefore, estimating
the abundance (i.e. number of cells) of each bacterial species,
relative to other species, is problematic.
The observed modulation of the intestinal microbiome in
the present study influenced the host intestinal morphology.
Histological analysis revealed an increased population of IELs
in the mid-intestine of tilapia after eight weeks feeding on the
AquaStar® Growout diet. Similar results have also been report-
ed in tilapia fed monospecies probiotic applications of
P. acidilactici (Standen et al. 2013) or Lactobacillus
rhamnosus (Pirarat et al. 2011). Furthermore, after
eight weeks, microvilli density was significantly higher in
the mid-intestine of fish fed the probiotic when compared to
control groups. Higher microvilli density may reduce the ex-
posure of the tight junctions between enterocytes, and this may
help to provide a more effective barrier against potential path-
ogens. Further, due to increased microvilli density, combined
with numerical improvements of microvilli length and perim-
eter ratio, the absorptive surface area index was significantly
improved in the probiotic-fed fish. Consequently, fish fed
AquaStar® Growout may have a higher potential capacity for
nutrient utilisation.
After the eight-week feeding trial, PCR-DGGE analysis
was used to investigate the persistence of each of the probionts
in the intestine after the cessation of probiotic feeding. All four
probionts decreased in abundance after AquaStar® Growout
supplementation had ceased but were still detected for a num-
ber of days post transition to the non-supplemented control
diet. E. faecium was still detected for up to 6 days post
reverting to the control diet. The remaining three probiotics
were still present after 18 days of control feeding, demonstrat-
ing the temporal colonisation of the intestine of these species.
Similarly, P. acidilactici could be detected in the tilapia intes-
tine for at least 17 days after cessation of P. acidilactici pro-
visions (Ferguson et al. 2010). The ability of other probiotics
including Carnobacterium spp., Lactobacillus spp.,
Lactococcus spp., Leuconostoc spp. and Bacillus spp. to per-
sist in the gastrointestinal tract of salmonids and catfish has
been investigated, demonstrating temporal colonisation last-
ing from <3 days to >3weeks (Nikoskelainen et al. 2003; Kim
and Austin 2006; Balcázar et al. 2007; Ran et al. 2012). All
these persistence assays followed shorter probiotic supple-
mentation periods (between 7 and 32 days), compared to the
current 56-day study. From such studies, it is evident that the
length of time a probiont may remain in the intestine of fish,
after probiotic feeding has ceased, is dependent on the probi-
otic species, host species, environmental factors, dosage and
duration of probiotic supplementation.
In conclusion, all three microbiological methods used in
the present study (culture based, PCR-DGGE and high-
throughput sequencing) confirmed the presence of the
probiotics in the intestine of the AquaStar® Growout-fed fish.
Survival through the upper gastrointestinal tract is an essential
requirement of any probiotic, since it must survive the gastric
process in order to exert its beneficial effect in the intestine.
Under these conditions, AquaStar® Growout can stimulate the
localised immune response through the recruitment of IELs in
the intestinal mucosa, which may result in better protection
against localised pathogens. Intestinal translocation experi-
ments and disease challenge studies are required to validate
this hypothesis. Concomitantly with modulated microbiota
and IEL levels, AquaStar® Growout treatment enhanced intes-
tinal morphology by elevating the absorptive surface area.
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